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I. RESUMEN 
 
Aedes aegypti es una especie de mosquito originaria del continente africano. 
En los últimos 50 años ha experimentado una expansión acelerada hacia otros 
continentes; especialmente en áreas tropicales y subtropicales. Este insecto ha 
evolucionado con los seres humanos y ha aparecido una nueva subespecie, 
especializada en alimentarse a partir de sangre humana. Los mosquitos 
pertenecen al Phylum Arthropoda, que incluye varias especies como ácaros, 
gambas y langostinos, cucarachas y otros insectos inductores de reacciones 
alérgicas. La relación evolutiva y filogenética entre estas especies nos lleva a 
hipotetizar que los mosquitos contienen moléculas alergénicas que inducen 
respuestas alérgicas. La alta prevalencia de A. aegypti, y de otros mosquitos 
que viven en estrecho contacto con seres humanos, indica que la exposición a 
antígenos de este insecto ocurre frecuentemente. 
Se ha propuesto que los mosquitos inducen respuestas alérgicas 
cutáneas, inducidas por antígenos salivares que se inyectan en la piel de los 
seres humanos, u otros animales, durante la picadura. Bajo este supuesto, el 
concepto de alergia al mosquito se acuñó para describir los signos y síntomas 
alérgicos que aparecen en la piel de individuos atópicos después de las 
picaduras de mosquitos. Teóricamente, estas reacciones sólo podrían ser 
producidas por mosquitos hembras, ya que los machos no necesitan sangre 
como fuente de nutrientes. Un grupo de investigadores liderados por el Dr. 
Peng ha dedicado sus esfuerzos a analizar estas reacciones e identificaron 
cuatro alérgenos derivados de la saliva. Como resultado de sus estudios, se 
demostró que la alergia a mosquitos sigue un mecanismo de sensibilización y 
desensibilización natural caracterizada por la producción simultánea de 
anticuerpos IgE y varias subclases de IgG. 
En esta tesis, estudiamos la composición alergénica del mosquito A. 
aegypti y evaluamos su potencial alergénico y reactividad cruzada con otros 
alérgenos. En la mayoría de los experimentos, utilizamos sueros de pacientes 
alérgicos con asma y/o rinitis y sensibilizados a mosquitos y ácaros del polvo 
doméstico. Todos estos pacientes residían en áreas endémicas donde 
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abundan los mosquitos. El uso de estos sueros en los ensayos de unión a IgE-
específica nos ayudó en la identificación de los principales alérgenos 
potencialmente implicados en las reacciones alérgicas inducidas por A. aegypti. 
Uno de los pasos iniciales que deben seguirse para responder a la 
pregunta de si los mosquitos son, o no son, fuentes de alérgenos, consiste en 
la identificación de proteínas de unión a IgE. Usamos dos enfoques para 
identificar alérgenos potenciales. Uno de ellos fue el análisis del Alergenoma de  
A. aegypti, utilizando herramientas de proteómica. Las proteínas totales de A. 
aegypti se extrajeron a partir de cuerpos del insecto y el espectro de proteínas 
se separó mediante electroforesis bidimensional. Los spots que unieron IgE 
específica se identificaron por immunoblot utilizando sueros individuales y una 
mezcla de sueros obtenidos de 15 pacientes alérgicos de la isla caribeña de 
Martinica. Los spots que resultaron positivos se localizaron en los geles 2-D 
teñidos con Coomassie y su identificación molecular se realizó por 
espectrometría de masas. Siguiendo este esquema, se identificaron diez 
proteínas diferentes y también se detectaron variantes, o isoformas, para 
algunas de ellas. Los 10 alérgenos identificados fueron: Heat shock cognate-
70, Tropomiosina, Proteasa de aspártico lisosómica, Arginina o Creatina 
quinasa, Gliceraldehído-3-fosfato deshidrogenasa, Proteína de unión al calcio, 
Fosfoglicerato mutasa, proteína dependiente de voltaje con actividad de canal 
selectiva de aniones, proteína de unión a ATP y una proteína de función 
biológica desconocida. Curiosamente, encontramos que la mezcla de tres 
alérgenos parece ser suficiente para identificar más del 80% de los individuos 
sensibilizados a A. aegypti. 
En un segundo enfoque, la tropomiosina natural de A. aegypti se purificó 
mediante una combinación de cromatografía de exclusión por tamaño y de 
intercambio iónico. Estas proteínas purificadas se seleccionaron utilizando 
experimentos de unión a IgE-específica en sueros de individuos alérgicos 
sensibilizados a las tropomiosinas de ácaro y gamba. El análisis de las 
fracciones purificadas mostró que en A. aegypti, la tropomiosina consiste en 
una mezcla de al menos 4 versiones (isoformas y variantes). Dos de estas 
versiones, las tropomiosinas con códigos UNIPROT: Q17H75 y Q17H80, se 
encontraron en mayores cantidades relativas. El análisis de la secuencia de 
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aminoácidos de estas tropomiosinas, y los experimentos de inhibición, 
indicaron que la variante Q17H75 tenía un mayor grado de homología con otras 
tropomiosinas y mayor conservación de epítopos putativos de unión a IgE, que 
la variante Q17H80, lo que sugiere que Q17H75 es más alergénica y de mayor 
reactividad cruzada. 
Como resultado de estos experimentos, se registraron seis nuevos 
alérgenos de mosquitos en la base de datos de alérgenos: Aed a 5 (proteína 
sarcoplásmica de unión Ca+), Aed a 6 (Porina 3), Aed a 7 (proteína de función 
biológica no definida), Aed a 8 (Heat shock cognate-70), dos variantes de 
tropomiosina (Aed a 10.0101 y Aed a 10.0201) y Aed a 11 (proteasa de 
aspártico lisosómica). 
Con el fin de estudiar más a fondo el papel de Aed a 10.0101, Aed a 
10.0201 y Aed a 8 en la sensibilización a mosquitos, las versiones 
recombinantes se expresaron en E. coli. rAed a 10.0101 se clonó en el vector 
de expresión pCOLDIV y se expresó bajo choque térmico a 15º C . rAed a 
10.0201 y rAed a 8 se clonaron en el vector de expresión pET14b(+) y se 
expresaron bajo la estimulación con IPTG. Las proteínas recombinantes se 
purificaron por afinidad y se determinaron sus propiedades fisicoquímicas. rAed 
a 8, rAed a 10.0101 y rAed a 10.0201 mostraron actividad de unión a IgE e IgG 
e inhibieron la reactividad de anticuerpos contra su homólogo natural contenida 
en el extracto de mosquito. Igualmente mostraron capacidad de activación de 
basófilos e indujeron la proliferación de esplenocitos obtenidos de ratones 
inmunizados con estas moléculas. Además, rAed a 10.0101 y rAed a 10.0201 
presentaron espectros de dicroísmo circular típicos de proteínas α-helicoidales 
y similares al espectro de rDer p 10. Estos resultados demostraron que los 
alérgenos recombinantes son similares a los alérgenos nativos y que cumplen 
con los requisitos inmunológicos y bioquímicos necesarios para ser utilizados 
de una manera similar al nativo. 
El estudio de la respuesta inmune inducida por rAed a 8 reveló que 
después del protocolo de inmunización, los ratones BALB/c produjeron niveles 
bajos de IgE y altos niveles de varios subtipos de IgG, especialmente IgG2a, 
que ha sido propuesto como indicador de una inmunoterapia exitosa y como 
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anticuerpo bloqueador que inhibe la reactividad de la IgE con el alérgeno. Dado 
que el contenido de endotoxina de la muestra utilizada en la inmunización fue 
muy bajo, estos resultados sugieren que rAed a 8 tiene propiedades inmuno-
reguladoras. Otros estudios con antígenos salivares utilizados en la 
inmunización de ratones mostraron resultados similares. La historia natural de 
la alergia a la picadura de mosquitos se caracteriza por la producción de 
subclases de IgG y conduce a la desensibilización de los individuos afectados. 
Las propiedades inmuno-reguladoras de rAed a 8, y otros componentes del 
mosquito, se deben seguir estudiando. 
Además de estos descubrimientos, algunos estudios han sugerido que 
los mosquitos y otros insectos podrían inducir respuestas alérgicas por 
alérgenos no-salivares. Estas sugerencias se han basado en los siguientes 
puntos: 1) Los individuos alérgicos de diferentes países que sufren de asma y/o 
rinitis alérgica están sensibilizados frente los antígenos de los mosquitos; 2) El 
detritus del mosquito permanece suspendido en el aire y está presente en el 
polvo doméstico y 3) El análisis del genoma de A. aegypti indica que varios 
alérgenos, homólogos a los presentes en otras especies de Artrópodos, son 
expresados por este insecto.  
Basados en estas observaciones, planteamos la hipótesis de que A. 
aegypti contiene proteínas que inducen diferentes tipos de respuestas alérgicas 
en individuos atópicos y que algunos de esos alérgenos presentan reacción 
cruzada con alérgenos de otras especies de artrópodos. Varios estudios han 
sugerido que las proteínas de los mosquitos tienen reactividad cruzada con 
alérgenos derivados de artrópodos. Inicialmente, estudiamos la reactividad 
cruzada entre extractos de A. aegypti, Dermatophagoides pteronyssinus, 
Blomia tropicalis, D. farinae, Periplaneta americana y Litopenaeus vannamei. 
Nuestros resultados demuestran que el mosquito tiene alta reactividad cruzada 
con el camarón, seguido por los ácaros y la cucaracha. Utilizando un grupo de 
34 sueros de pacientes con alergias respiratorias, encontramos que el 64,7% 
de los individuos alérgicos estaban sensibilizados a A. aegypti y que esta 
prevalencia era similar a la prevalencia de sensibilización a ácaros y más alta 
que la prevalencia de sensibilización a gambas y cucarachas. Además, el 9% 
de los pacientes estaban mono-sensibilizados a mosquitos. Con el fin de 
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identificar los componentes de reactividad cruzada en el extracto de mosquito, 
se realizó un experimento de inhibición del immunoblot. Identificamos más de 
10 bandas de reactividad cruzada y cuatro de ellas se caracterizaron por 
espectrometría de masas. Las bandas corresponden a las proteínas: proteína 
de unión a odorante, citocromo C mitocondrial, ciclofilina (PPIasa) y una 
proteína de función biológica desconocida "AAEL001668-PA". Curiosamente, 
encontramos que la tropomiosina representa aproximadamente el 40% de la 
reactividad a IgE, lo que significa que este no es el alérgeno más importante 
involucrado en la sensibilización a mosquitos. 
La tropomiosina es un pan-alérgeno expresado por varias especies 
diferentes y responsable en gran medida de la reactividad cruzada entre los 
artrópodos. Se analizó la reactividad cruzada entre las tropomiosinas del ácaro 
(rDer p 10) y de A. aegypti (rAed a 10.0101 y rAed a 10.0201), desde un punto 
de vista molecular y funcional. Se encontró que rDer p 10 y rAed a 10.0101 
presentaron mayor capacidad inhibitoria de la unión a IgE en comparación con 
rAed a 10.0201 utilizando el suero de los individuos alérgicos al ácaro del polvo 
doméstico. Además, la reactividad cruzada entre rDer p 10 y las tropomiosinas 
derivadas de mosquito indujo la activación de basófilos re-sensibilizados con 
sueros de pacientes que contenían altos niveles de IgE-específica contra rDer 
p 10. 
rAed a 10.0101 y rAed a 10.0201 se utilizaron para inmunizar ratones 
BALB/c y se observó que la IgG1 específica producida por estos animales 
presentó reactividad cruzada con rDer p 10, las tropomiosinas de mosquito y 
con sus homólogos naturales presentes en el extracto. Los sueros de los 
ratones también inhibieron la activación de basófilos sensibilizados con 
anticuerpos específicos de rDer p10. También se estudió la reactividad cruzada 
a nivel de células T. Los esplenocitos de los ratones inmunizados con rAed a 
10.0101 proliferaron tras la estimulación con rAed a 10.0101 y en menor grado 
a rAed a 10.0201 y rDer p 10. En contraste, los esplenocitos de ratones 
inmunizados con rAed a 10.0201 experimentaron una proliferación similar tras 
la estimulación con las tres tropomiosinas. El mapeo de epítopos utilizando 28 
péptidos solapantes que cubrían la secuencia completa de Aed a 10.0101 
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reveló cinco regiones de aminoácidos que contienen epítopos T implicadas en 
esta reactividad cruzada. 
En conclusión, hemos demostrado que A. aegypti es una fuente 
importante de alérgenos que pueden jugar un papel en enfermedades 
alérgicas, especialmente en áreas tropicales y subtropicales. Los alérgenos de 
los mosquitos pueden participar potencialmente en el inicio (fase de 
sensibilización) y en la exacerbación de las respuestas alérgicas. Varios 
alérgenos están involucrados en estos fenómenos y algunos de ellos tienen 
reactividad cruzada con alérgenos derivados de artrópodos. Nuestros estudios 
con tropomiosinas revelaron que la reactividad cruzada puede ocurrir a nivel 
molecular y funcional, involucrando  anticuerpos, basófilos y linfocitos T. Los 
alérgenos de los mosquitos pueden producirse como moléculas recombinantes 
con propiedades biológicas y estructurales similares a las de los alérgenos 
naturales. Los estudios de la respuesta inmunológica inducida en ratones por 
rAed a 8 indicaron que este alérgeno puede tener un papel inmuno-regulador 
intrínseco. Más estudios epidemiológicos y utilizando los alérgenos purificados 
son necesarios para entender la alergia a mosquito. 
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II. SUMMARY 
 
Aedes aegypti is a mosquito species originary from the African continent. In the 
last 50 years it has experienced an accelerated spread into other continents, 
especially to tropical and subtropical areas. This insect has co-evolved with 
humans and a new sub-species, specialized on feeding on human blood, has 
appeared. Mosquitoes are part of the Phylum Arthropoda, which includes 
several species like mites, cockroaches, shrimps and other insects that induce 
allergic responses. The evolutionary relationship among these species leads us 
to the hypothesis that mosquitoes would also contain allergenic molecules 
which induce allergic responses in humans. The high prevalence of A. aegypti 
and other mosquitoes living in close contact with humans, indicate that 
exposure to their antigens occurs frequently. 
It is well established that mosquitoes induce cutaneous allergic 
responses through salivary antigens that are injected in the skin of humans, or 
other animals, during blood feeding. Under this assumption, the concept of 
mosquito allergy was coined to describe the allergic signs and symptoms that 
appear in the skin after mosquito bites in atopic individuals. Theoretically, these 
reactions could only be produced by female mosquitoes, since males don’t 
need blood as their source of nutrients. A group of researchers directed by Dr. 
Peng dedicated their efforts to analyse these reactions and identified 4 saliva-
derived allergens. As a result of their studies, it was demonstrated that 
mosquito allergy follows a mechanism of natural sensitization and 
desensitization characterized by the simultaneous production of IgE and IgG 
antibody subclasses. 
In this thesis, we studied the allergenic composition of the mosquito A. 
aegypti and evaluated their allergenic potential and cross-reactivity with other 
insect and mite allergens. In the majority of the experiments, we used sera from 
allergic patients with asthma and/or rhinitis and sensitized to mosquitoes and 
house dust mites. All these patients resided in areas where mosquitoes are 
abundant. The use of these sera in the specific IgE-binding assays helped us in 
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the identification of the main allergens potentially involved in the allergic 
reactions. 
One of the initial steps that we followed to answer the question of 
whether, or not, mosquitoes are the source of allergens consisted in the 
identification of IgE-binding proteins. We used two approaches to identify 
potential allergens. One of then was the analysis of the A. aegypti Allergenome, 
using proteomic tools. Total A. aegypti proteins were extracted from mosquito 
bodies and the protein spectrum separated by 2-dimensional electrophoresis. 
The IgE-binding spots were identified by immunoblotting using pooled and 
individual sera from 15 allergic patients from the Caribbean island of Martinique. 
The spots that resulted positive were located on the Coomassie stained 2-D 
gels and their identity determined by mass spectrometry. Following this 
scheme, ten different proteins were identified and several variants or isoforms 
were also detected. The 10 identified allergens were: Heat shock cognate-70, 
Tropomyosin, Lysosomal aspartic protease, Arginine or Creatine kinase, 
Glyceraldehyde-3-phosphate dehydrogenase, Calcium-binding protein, 
Phosphoglycerate mutase, Voltage-dependent anion-selective channel activity 
protein, ATP-binding protein and an Unknown protein. Interestingly, we found 
that the mixture of three allergens seems to identify more than 80% of A. 
aegypti sensitized individuals. 
In a second approach, the natural tropomyosin from A. aegypti was 
purified by a combination of size exclusion and ionic exchange chromatography. 
These purified proteins were screened by means of specific IgE-binding 
experiments using the sera from allergic individuals sensitized to mite and 
shrimp tropomyosins. The analysis of the purified fractions showed that in A. 
aegypti, tropomyosin consists of a mixture of at least 4 versions (isoforms and 
variants). Two of these versions, with UNIPROT codes: Q17H75 and Q17H80, 
were found in higher concentrations. Amino acid sequence analysis and 
inhibition experiments indicated that tropomyosin Q17H75 had a higher degree 
of homology with other tropomyosins and preserved more putative IgE-binding 
epitopes than Q17H80, suggesting that Q17H75 is more allergenic and cross-
reactive. 
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As a result of these experiments, 6 novel mosquito allergens were registered in 
the allergen database, namely, Aed a 5 (Sarcoplasmic Ca+ (EF-hand) binding 
protein), Aed a 6 (Porin 3), Aed a 7(Undefined protein), Aed a 8 (Heat shock 
cognate-70), two variants of tropomyosin (Aed a 10.0101 and Aed a10.0201) 
and Aed a 11 (Lysosomal aspartic protein). 
In order to further study the role of these and other allergens in mosquito 
sensitization, the recombinant versions were expressed in E. coli. rAed a 
10.0101 was cloned in the expression vector pCOLDIV and expressed under 
cold-shock in E. coli. rAed a 10.0201 and rAed a 8 were cloned in the 
expression vector pET14b(+) and expressed under stimulation with IPTG. The 
recombinant proteins were purified by affinity and their physicochemical 
properties determined. rAed a 8, rAed a 10.0101 and rAed a 10.0201 showed 
IgE and IgG-binding activity and inhibited the antibody reactivity of the natural 
counterpart contained in the mosquito extracts. They also showed basophil 
activation capacity and induced the proliferation of splenocytes obtained from 
mice immunized with these molecules. Furthermore, rAed a 10.0101 and rAed a 
10.0201 presented circular dichroism spectra typical for α-helical proteins and 
similar to the rDer p 10 spectrum. These results demonstrated that the 
recombinant allergens are similar to the native allergens and that they fulfil the 
immunological and biochemical requisites needed to be used in allergy 
research. 
The study of the immune response induced by rAed a 8 revealed that 
after immunization, the BALB/c mice produced low levels of IgE and high levels 
of IgG subclasses, specially IgG2a, which has been postulated as an indicator 
of successful immunotherapy and a blocking antibody that inhibit the reactivity 
of the IgE with the allergen. Since the endotoxin content of the sample used in 
the immunization was very low, these results strongly suggest that rAed a 8 has 
immune-regulatory properties. Other studies with salivary antigens used for the 
immunization of mice showed similar results. Furthermore, the natural history of 
mosquito bite allergy is characterized by the production of IgG subclasses and 
leads to the desensitization of the affected individuals. The immune-regulatory 
properties of rAed a 8, and other mosquito components, should be further 
studied. 
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In addition to these discoveries, some studies have suggested that mosquitoes, 
and other insects, may potentially induce different allergic responses by 
allergens not restricted to the saliva. These suggestions are based on the 
following points: 1) Allergic individuals from different countries who suffer from 
asthma and/or allergic rhinitis have specific IgE against mosquito antigens; 2) 
Mosquito detritus remains suspended in the air and is present in settled house 
dust and 3) The analysis of A. aegypti genome indicates that several allergens, 
homologues to those present in other Arthropod species, are expressed by this 
insect. Based on these facts, we hypothesized that Aedes aegypti contains 
proteins which induce different forms of allergic responses in atopic individuals, 
and that some of those allergens cross-react with allergens from other 
arthropod species. 
Several studies have suggested that mosquito proteins cross-react with 
arthropod-derived allergens. Initially, the cross-reactivity among A. aegypti, 
Dermatophagoides pteronyssinus, Blomia tropicalis, D. farinae, Periplaneta 
americana and Litopenaeus vannamei was studied with whole extracts 
prepared from these sources. Our results showed that mosquito strongly cross-
reacts with shrimp, followed by mites and cockroach. Using a group of 34 sera 
from patients with respiratory allergies, we found that 64.7% of the allergic 
individuals were sensitized to A. aegypti and that this prevalence was similar to 
the prevalence of IgE-sensitization to mites and higher than the prevalence of 
sensitization to shrimp and cockroach. Furthermore, 9% of the patients were 
mono-sensitized to mosquito. In order to identify the cross-reactive components 
in the mosquito extract, an immunoblotting inhibition experiment was performed. 
More than 10 cross-reactive bands were identified and 4 of them further 
characterized by Mass Spectrometry. The bands corresponded to the proteins: 
Odorant Binding Protein, Mitochondrial cytochrome C, Cyclophilin (PPIase) and 
an unknown protein “AAEL001668-PA”. Interestingly, we found that 
tropomyosin accounts for approximately 40% of the IgE reactivity, which means 
that it is not the most important allergen involved in mosquito IgE-sensitization. 
Tropomyosin is a pan-allergen expressed by several different species 
and responsible to a great extent for the cross-reactivity among arthropods. We 
analysed the cross-reactivity between mite tropomyosin (rDer p 10) and A. 
 xi 
S
u
m
m
a
ry
 
aegypti tropomyosins (rAed a 10.0101 and rAed a 10.0201) from a molecular 
and functional point of view. We found that rDer p 10 and rAed a 10.0101 
presented a greater inhibitory capacity of the IgE-binding than rAed a 10.0201 
using the sera from house dust mite allergic individuals. In addition, the cross-
reactivity of rDer p 10 and the mosquito-derived tropomyosins induced the 
activation of stripped basophils sensitized with sera of patients containing high 
levels of Der p 10-specific IgE.  
rAed a 10.0101 and rAed a 10.0201 were used to immunize BALB/c mice 
and we observed that the specific IgG1 produced by the animals cross-reacted 
with rDer p 10, the mosquito tropomyosins and with their natural counterparts in 
the extract. The murine sera also inhibited the activation of basophils sensitized 
with Der p 10-specific antibodies.  
We also studied the cross-reactivity at the T-cell level. Splenocytes from 
mice immunized with rAed a 10.0101 showed strong proliferation upon 
stimulation with rAed a 10.0101 and to a lesser extent with rAed a 10.0201 and 
rDer p 10. In contrast, splenocytes from mice immunized with rAed a 10.0201 
experienced similar proliferation indexes upon stimulation with the 3 
tropomyosins. Epitope mapping using 28 overlapping peptides covering the 
whole sequence of Aed a 10.0101 revealed that 5 T cell epitope-containing 
regions are involved in this cross-reactivity. 
In conclusion, we have demonstrated that the mosquito species A. 
aegypti is an important source of allergens that may play a role in allergic 
diseases, especially in tropical and subtropical areas. The mosquito allergens 
may potentially participate in the onset and exacerbation of the allergic 
responses. Several allergens are involved in these phenomena and some of 
them cross-react with arthropod-derived allergens. Our studies with 
tropomyosins reveal that cross-reactivity may occur at the molecular and 
functional levels, involving antibodies, basophils and T lymphocytes. Mosquito 
allergens can be produced as recombinant molecules that mimic the natural 
allergen. Studies of the immune response elicited by rAed a 8 in mice indicate 
that this allergen may have an intrinsic immune-regulatory role. Further analysis 
with the purified allergens and epidemiological studies are necessary.
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A. The role of arthropods in the allergic responses 
Allergic diseases, like asthma, rhinitis, atopic dermatitis and papular urticaria 
are health problems affecting a large number of individuals, who usually face a 
worsening of the allergic manifestations in several moments of their lives. It has 
been estimated that 25% of the global population is affected by an allergic 
disease and this percentage is raising (1). 
Arthropods encompass a great diversity of animal taxa known from the 
Cambrian to the present days. Arthropod evolutionary relationship is still a 
matter of debate. It has been widely accepted that they include four living 
groups: Myriapods, Chelicerates (which include the class Arachnida that 
contains mite species like Dermatophagoides pteronyssinus and Blomia 
tropicalis), Insects (which includes cockroach and mosquito species like 
Periplaneta americana and Aedes aegypti, respectively) and Crustaceans 
(which include shrimp species like Litopenaeus vannamei). These groups are 
known collectively as Euarthropoda. Furthermore, two other living groups, the 
soft bodied Onychophorans (velvet worms) and the microscopic tardigrades 
(water bears) are close relatives of the Euarthropods and together are referred 
to as Pan-arthropoda (2).  
However, the analysis of several groups of genes that involve not only 
the nuclear, ribosomal and mitochondrial genes, but also expressed sequence 
tags (ESTs) from cDNA libraries, revealed an arthropod phylogeny tree as 
shown in Figure 1. 
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Figure 1. Phylogenetic framework for extant Arthropoda. Dashed lines within 
Arachnida indicate morphological grouping. Some arthropod species as sources of 
allergens in Acari, Malacostraca and Insecta are shown. Modified from (3). 
 
Arthropods are similar to another Phylum, the annelid worms, which are also 
characterized by segmentation and the structure of their nervous and blood 
vascular systems. Furthermore, in 1997 the concept of Ecdysozoa, a clade 
consisting of pan-arthropods and a group of lesser-known worms named the 
Cycloneuralia, comprising the Priapulids, Kinorhynchs, Loriciferans, Nematodes 
(e.g. Ascaris lumbricoides) and Nematomorphs was introduced (4). 
Arthropods are among the most important sources of allergens, including 
3 major groups that are involved in allergic diseases. Insects and Arachnids are 
common sources of inhalant allergens, while Crustaceans are sources of food 
allergens. Mites and cockroaches are sources of indoor allergens and members 
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of the Arachnid and Insect classes, and play an important role in respiratory 
allergies, like asthma. Human exposure to these two arthropods is perennial 
and the airborne particles which appear for short periods of time upon 
disturbance, carry their allergens which are inhaled and may induce 
sensitization and allergic symptoms.  
House dust mites (HDM) are ubiquitous in human habitats and one of the 
most frequent sources of indoor allergens responsible for allergic sensitization 
and reactions in the upper and lower respiratory tract (5, 6). It is estimated that 
1% to 2% of the world’s population might be affected by HDM allergy, which is 
equivalent to 65 to 130 million of individuals (7). Although HDM are consistently 
found in most places with a high ambient humidity, prevalence of allergic 
responses induced by these species is variable. According to the European 
Community Respiratory Health Survey I, the mean prevalence of sensitization 
among allergic patients is 21.7% (8). In Latin America HDM are common in 
Peru, Brazil, Venezuela, Colombia, Costa Rica, Puerto Rico and other countries 
(9-15), where the prevalence of sensitization ranges from 60% to 97% (16-18). 
More than 80% of prevalence is found in the pediatric population in Taiwan (19). 
Cockroaches are other important indoor allergen sources which include 
more than 4,600 species and are particularly relevant in the USA and other 
countries. The best studied cockroach species are the German cockroach 
(Blattella germanica), which dominates in the US, as well as the American 
cockroach (Periplaneta americana) and the oriental or common cockroach 
(Blatta orientalis). A strong association between cockroach allergy, allergic 
rhinitis, and asthma has been demonstrated (20-22). In the USA, exposure and 
sensitization to cockroach allergens are associated with increased asthma 
morbidity in children (21, 22). 
Consumption of seafood, including shrimps, is associated with the 
development of allergic reactions. These reactions might be produced by the 
ingestion of food containing the allergens, but also by contact, or inhalation (23, 
24). Allergic sensitization to shrimp is variable and depends on the level of 
consumption and exposure. In a population of 17,366 adult allergic patients 
from different regions of Europe covering the Northern Maritime (Reykjavik), 
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Northern (Vilnius), Central (Lodz), Balkan (Sofia), Alpine (Zurich), 
Mediterranean (Athens, Madrid) and Atlantic seaboard (Utrecht) areas, 4.67% 
were sensitized to shrimps (25). In a study with 8,203 individuals in the USA it 
was found that 0.9% to 1.2% of 20 to 59 years old individuals had anti-shrimp 
specific IgE; this prevalence decreased to 0.7% in the population having >60 
years of age (26). 
Arthropods are evolutionary related and share homologous proteins that 
play a key role in the frequently described allergenic cross-reactivity. Since 
cockroaches and mosquitoes are members of the class Insecta, a high degree 
of cross-reactivity between them is expected. In turn, the proximity of these 
animals with shrimps, followed by mite species, suggests some degree of 
cross-reactivity (See figure 1). 
 
B. Taxonomical classification of Mosquitoes 
Mosquitoes are arthropods that belong to the class Insecta, order Diptera and 
members of a family of the nematocerid flies Culicidae (from the Latin culex, 
genitive culicis, meaning ‘midge’ or ‘gnat’). The word ‘mosquito’ (formed by 
‘mosca’ and the diminutive ‘ito’) is from the Spanish or Portuguese language for 
‘little fly’. Mosquitoes resemble crane flies (family Tipulidae) and chironomid 
flies (family Chironomidae). The females of many species of mosquitoes are 
blood-eating pests and dangerous vectors of disease. However, members of 
the similar looking Chironomidae and Tipulidae are not.  
Three subfamilies are recognized within the family Culicidae: 
Toxorhynchitinae, Anophelinae and Culicinae. Toxorhynchitinae includes only 
one genus, while Anophelinae consists of nearly 400 species and the subfamily 
Culicinae contains more than 2,600 mosquito species. More than 40 genera 
and 3,000 mosquito species are distributed worldwide (table 1) (27), showing a 
strong capacity to easily adapt to different environmental conditions. Some of 
these species are more clinically relevant than others, because they affect 
humans directly, or indirectly. These species include, but are not limited to, A. 
aegypti, A. vexans and Culex quinquefasciatus (28-30). Adult female 
mosquitoes require blood-feeding to produce eggs. In this process, they bite 
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and inject saliva before sucking the victim’s blood (31). Mosquito saliva contains 
various substances such as lysozymes, antibacterial glucosidases, 
anticoagulants, antiplatelet aggregating factors and vasodilators (32-36). It also 
contains allergens that may induce local cutaneous reactions and, in some 
cases, a systemic response in atopic individuals (37-40). Allergens derived from 
the emanations and detritus of mosquitoes are also present in the air and in 
house dust, and may be inhaled and induce various immune responses (41, 
42). 
 
Table 1. Taxonomical classification and distribution of the main mosquito species 
associated with mosquito allergy. 
Subfamily 
Tribe 
Genera 
No. of sub-
genera 
No. of 
species 
Distribution 
Species associated with 
mosquito allergy 
Anophelinae Anopheles 7 455 Cosmopolitan 
Anopheles (An.) stephensi, An. 
minimus, An. sinensis 
 Bironella 3 8 Australasian  
 Chagasia - 4 Neotropical  
Culicinae      
Aedeomyiini Aedeomyia 2 6 
Afrotropical, 
Australasian, 
Oriental, 
Neotropical 
 
Aedini Aedes 23 363 
Old world, 
Nearctic 
Aedes (Ae.) aegypti, Ae. 
vexans, Ae. communis, Ae. 
togoi, Ae. albopictus, Ae. 
triseriatus 
 Argimeres 2 58 
Australasian, 
Oriental 
 
 Ayurakitia - 2 Oriental  
 Borichinda - 1 Oriental  
 Eretmapodites - 48 Afrotropical  
 Haemagogus 2 28 
Principally 
neotropical 
 
 Heizmannia 2 39 Oriental  
 Ochlerotatus 22 550 Cosmopolitan 
Ochlerotatus (Oc.) triseriatus, 
Oc. hendersoni 
 Opifex - 1 New Zealand  
 Psorophora 3 48 New world  
 Udaya - 3 Oriental  
 Verrallina 3 95 
Principally 
Australasian, 
Oriental 
 
 Zeugnomyia - 4 Oriental  
Culicini Culex 23 763 Cosmopolitan 
Culex (Cx.) quinquefasciatus, 
Cx. tritaeniorhynchus, Cx. 
pipiens, Cx. pipiens pallens, Cx. 
tarsalis 
 Deinocerites - 18 
Principally 
neotropical 
 
 Galindomyia - 1 Neotropical  
 Lutzia 3 7 
Afrotropical, 
Australasian, 
Oriental, 
Neotropical, 
Palearctic oriental 
 
Culisetini Culiseta 7 37 
New world, 
Nearctic 
Culiseta inornata 
Ficalbiini Ficalbia - 8 
Afrotropical, 
Oriental 
 
 Mimomyia 3 44 
Afrotropical, 
Australasian, 
Oriental 
 
Hodgesiini Hodgesia - 11 Afrotropical,  
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Australasian, 
Oriental 
Mansoniini Coquillettidia 3 57 
Old world, 
Neotropical 
 
 Mansonia 2 23 
Old world, 
Neotropical 
 
Orthopodomyiini Orthopodomyia - 38 
Afrotropical, 
Nearctic, 
Neotropical, 
Oriental, 
Palearctic 
 
Sabethini Isostomyia - 4 Neotropical  
 Johnbelkinia - 3 Neotropical  
 Kimia - 5 Oriental  
 Limatus - 8 Neotropical  
 Malaya - 12 
Afrotropical, 
Australasian, 
Oriental 
 
 Maorigoeldia - 1 New Zealand  
 Onirion - 7 Neotropical  
 Runchomyia 2 7 Neotropical  
 Sabethes 5 38 Neotropical  
 Shannoniana - 3 Neotropical  
 Topomyia 2 54 Principally Oriental  
 Trichoprosopon - 13 Neotropical  
 Tripteroides 5 122 
Principally 
Australasian, 
Oriental 
 
 Wyeomyia 15 140 
Principally 
neotropical 
 
Toxorhynchitini Toxorhynchites 4 88 
Afrotropical, 
Australasian, 
Neotropical, 
Palearctic oriental, 
Oriental 
 
Uranotaeniini Uranotaenia 2 265 
Afrotropical, 
Australasian, 
Oriental, 
Neotropical 
 
 
 
C. The mosquito species Aedes aegypti  
There are more than 3,000 mosquito species, but some of them represent a 
problem of higher relevance for humans for their ability to invade areas with 
different environmental conditions and their capacity to act as vectors for 
pathogens that cause diseases. A. aegypti is one of those species. A. aegypti is 
found in North, Central and South America, Africa, Asia and Oceania (43) and is 
very abundant throughout tropical and subtropical regions of America, Africa, 
and Asia, as well as in the Indian Ocean islands, and northern Australia (44) 
(Figure 4). Although it is not recognized that A. aegypti has invaded Europe, 
there are some studies that have shown its transient presence in some 
European countries (45-47). 
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Figure 4. Global distribution of A. aegypti. Modified from (43). 
 
A. aegypti is particularly specialized in feeding on humans. It originated in the 
forest areas of sub-Saharan Africa as a “wild”, black-pigmented insect biting 
species known as A. aegypti formosus. This species is still found in the forest of 
this region. As a cause of the global spread of A. aegypti, facilitated by the 
commercial trades and the growing capacity of humans to move to different 
countries, a brown-pigmented species, namely A. aegypti aegypti, evolved to 
specialize in biting and feeding on humans (28, 48). This species has been 
reintroduced along the coast of East Africa and is considered a ‘domestic’ 
species (49). In the Rabai region of Kenya, domestic A. aegypti readily enter 
homes, prefer to lay eggs in nutrient-poor river and rain water stored in 
containers indoors (50). They are resistant to starvation as larvae (51) and have 
developed a strong preference for biting humans (50, 52). Black-pigmented 
populations of the native African subspecies A. aegypti formosus, known in 
Rabai as the ‘forest’ species, were found just hundreds of meters away, 
avoiding homes, laying their eggs in tree holes and rock pools outdoors, and 
preferring to bite non-human animals. 
McBride et al., confirmed the preference of domestic A. aegypti for 
humans. They demonstrated that this behavior is related to the over-expression 
of Odorant Receptors (but not ionotropic receptors, or Odorant binding proteins) 
in the antennae of the insect, codified by the gene Or4, that recognizes the 
human volatile odorant Sulcatone (53). The evidence clearly shows that 
humans are at high risk of being exposed to females of A. aegypti, specifically 
to the saliva antigens released during mosquito bites. The presence of this 
insect in human homes suggests that other non-saliva-derived antigens may be 
present in the environment and that humans can be exposed to them through 
 
 
10 
 
In
tro
d
u
c
tio
n
 
other routes of exposure. In this case, not only the female A. aegypti mosquito 
might constitute a source of antigens, but also other male mosquito species. 
D. Allergic reactions induced by mosquito bites 
When an atopic individual is bitten by a mosquito, a “normal” inflammatory local 
reaction consisting of a rash and heat emanation, with the subsequent 
appearance of a wheal and flare, and itching, appears. However, in atopic 
individuals, mosquito bites induce severe local, or systemic atypical reactions 
(ecchymotic or vesiculated), such as anaphylaxis, angioedema, generalized 
urticaria or wheezing (54, 55). Local cutaneous reactions consist of immediate 
wheals and flares peaking at 20 min and delayed pruritic indurated papules 
peaking at 24–36 h (56, 57). Large local reactions consist of itchy red, warm 
swellings appearing within minutes. Itchy papules and ecchymotic, vesiculated, 
blistering, bullous or even Arthus-type reactions may appear from 2 to 6 h after 
the bites (58, 59). Mosquito bite induced allergic reactions are classified in four 
types: (1) local reactions (immediate and delayed), (2) severe, delayed 
reactions with scar formation (via a cell-mediated mechanism), (3) exaggerated 
local reactions, and (4) systemic anaphylaxis (60).   
Papular urticaria may also appear as a hypersensitivity reaction after 
mosquito bites, or after the bites of other arthropods. Some evidence supports 
the involvement of type I, III and IV hypersensitivity reactions and, therefore, the 
participation of IgE and IgG antibodies (61, 62). Immunoglobulin and 
complement depositions have also been detected in the skin (63, 64). In some 
cases, the mosquito bite may also induce a strong reaction involving an 
extensive part of the body such as the face, hands, arms, feet, or legs. These 
reactions appear a few hours after a mosquito bite, which makes it unlikely to 
be due to a bacterial infection. Simons and Peng coined this clinical disorder as 
the Skeeter syndrome (54). 
The allergic immune reaction raised against saliva-derived mosquito 
allergens follows a mechanism that occurs after the first exposure, followed by 
the induction of the typical signs and symptoms of an allergic reaction after 
subsequent bites. When the affected individuals are chronically exposed, they 
experience desensitization. The natural history of sensitization and 
 11 
 
In
tro
d
u
c
tio
n
 
desensitization to mosquito bites has been classified in 5 well-defined clinical 
stages: (1) no reaction after the initial bite in individuals who have never been 
bitten, (2) delayed cutaneous lesions appear after approximately 24 h in 
individuals after subsequent bites, (3) wheals appearing within approximately 15 
min in individuals after repeated bites, (4) no delayed reactions occur and only 
immediate wheals are noted in individuals after further exposures to mosquito 
bites, and (5) there is a loss of the immediate reaction in individuals who are 
repeatedly exposed to a large number of mosquito bites (65-67).  
The immune response raised against saliva-derived mosquito allergens 
involves humoral and cellular components (Figure 2). When a non-allergic 
individual was exposed to 100 bites of C. quinquefasciatus every 2 weeks for 10 
months, the levels of specific IgE and IgG antibodies increased with each 
exposure and developed a positive skin prick test (SPT) against a mosquito 
extract, with a wheal size which correlated with serum antibody levels (56). The 
reaction disappears after 21 weeks of exposure and the antibody levels 
decreased (68).  
In real life, the process of sensitization and desensitization requires more 
time because the individuals try to avoid contact with mosquitoes. Kulthanan et 
al. (55) showed that the required interval between sensitization and 
desensitization is of approximately 4 years in a population in Thailand. The 
participation of specific IgE in the local, systemic, immediate and delayed 
reactions has been demonstrated (38, 69-71). The role of IgG seems to be 
restricted to the immediate local reactions, but not to the systemic reactions 
(72). In the early allergic response, in addition to the antibodies the levels of 
histamine and leukotriene C4 also increased (73). 
 
 
 
 
 
 
 
12 
 
In
tro
d
u
c
tio
n
 
 
 
Figure 2. Immune allergic response induced by mosquito bites. Image prepared by 
JFC. 
 
The immune response of saliva-derived allergens has been studied in animal 
models of mosquito allergy, showing controversial results. A study showed that 
A. aegypti bites induce a Th2 immune response with immediate and late 
reactions, higher levels of IgE and IgG1 and lymphoproliferation (74). The 
allergic reaction may also induce mast cell degranulation. This induces changes 
in vascular permeability, the extravasation of fluid and the recruitment of 
neutrophils. This response is accompanied by hyperplasia of the lymph nodes 
and the recruitment of dendritic cells, B lymphocytes, macrophages and T 
lymphocytes (75). T cells seem to play a role in the late responses induced by 
A. aegypti bites, since passive transfer of spleen cells, but not serum from mice 
sensitized with salivary components of A. aegypti, induced these reactions (76).  
The immune response induced by mosquito bites in animal models 
varies according to the degree of exposure. In an animal model of allergy 
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caused by A. aegypti saliva allergens, mice were exposed four times to 
approximately 50 female mosquitoes at 14-day intervals, to resemble the 
natural mechanism of cutaneous sensitization (77). Mosquito sensitized mice 
produced IL-4, IL-5 and IL-13, but not IFN-γ or IL-17 in bronchial alveolar lavage 
fluids and showed signals of airway remodeling. In contrast, the mice didn’t 
experience smooth muscle hyper-reactivity. In addition, high titers of IgE, IgG1 
and IgG2a were also observed. In another study, Chen et al. (74) and Wang et 
al. (78), showed that mice exposed to 6 female mosquito bites, twice a week for 
four weeks, induced IgE and IgG1 but not IgG2a production. These results 
suggest that low intensity/acute exposure could preferentially induce antibodies 
of the Th2 profile, while an intense/chronic exposure is able to induce a mixed 
pattern with both Th1/Th2 antibody productions.  
These results correlate with the natural history of 
sensitization/desensitization. In the mosquito sensitization process, humans 
present an early wheal reaction, which disappears following the natural course 
of the immune response. The mechanisms involved in the desensitization 
process to mosquito allergens are still unknown. However, it may be partially 
explained by the induction and presence of specific IgG during the immune 
response, which may play a protective role. 
 
E. Cross-reactivity 
The classic concept of cross-reactivity indicates that this phenomenon occurs 
when the antibodies induced by exposure to an antigen react with a different 
protein with structural homology to the antibody-inducing molecule. In the case 
of allergens, these molecules belong to highly conserved protein families (as is 
the case for tropomyosin and profilins), which are present in different species 
and share cross-reactive IgE epitopes. These allergens are named pan-
allergens, and are responsible of co-sensitization to different species. Allergenic 
cross-reactive responses may have an important clinical relevance. For 
example, patients sensitized to shrimps are very likely to have a positive skin 
prick test response to other crustaceans (79). Patients with oral allergy 
syndrome may become sensitized to pollen proteins through inhalation and then 
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experience an IgE-mediated allergic reaction against food antigens that are 
similar in structure to the pollen proteins (80, 81). In the context of 
immunotherapy, cross-reactivity may be advantageously exploited by the 
treatment with a single molecule, or a single allergenic species which may 
induce desensitization and protection against other similar species. Nowadays, 
cross-reactivity represents a major diagnostic and therapeutic challenge. 
Cross-reactivity has been well documented at the antibody level. 
However, it can also involve T-cell epitopes with other possible clinical 
implications. Westernberg et al. (82) reported that epitope conservation across 
allergen species is the major determinant of immunogenicity and the driver of 
poly-sensitization in allergic patients. They showed that within and beyond the 
dominant IgE binding allergens, there are peptides and antigens that are highly 
preserved across pollens and that this conservation is positively correlated with 
their likelihood to elicit an immune response. On the basis of these 
observations, they hypothesized that cross-reactive T cells elicited by allergen 
exposure will: 1) be boosted and selectively expanded by exposure to additional 
allergens containing the preserved epitope and, 2) generate help for any B cell 
specific for an allergen cross-reactive at the T-cell level through a classic 
antigen bridge–linked T-cell/B-cell help mechanism, regardless of whether the 
IgE response is cross-reactive. Two structurally related molecules may share 
cross-reactive B epitopes, inducing antibody-mediated immunological 
responses. However, the exposure to the cross-reactive homologue allergen 
doesn’t imply that clonal expansion occurs if cross-reactive T-epitopes are 
missing. 
Cross-reactivity involving mosquito-derived allergens has been scarcely 
studied and mainly focused on salivary antigens. The sera from individuals 
allergic to mosquito bites react with several common proteins present in the 
saliva, salivary gland and whole body extracts of C. quinquefasciatus, A. 
aegypti, A. albopictus and Anopheles minimus (42). This high degree of cross-
reactivity has resulted in apparent sensitization to some mosquito species to 
which the affected individuals had not been previously in contact (70, 83). The 
D7 protein family related allergen, Aed a 2, from A. aegypti, is one of the most 
important cross-reactive allergens related to mosquito bite allergy, which is 
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involved in more than 70% of the cases (84). Cross-reactivity between salivary 
gland extracts of C. quinquefasciatus, O. triseriatus and several species of 
Aedes has also been demonstrated in immunized rabbits, where the allergens 
Aed a 1 and Aed a 2 play an important role (38, 70). 
Some individuals may also develop the so-called ‘wasp/mosquito 
syndrome’. Individuals afflicted with this syndrome have specific IgE against a 
44-kDa hyaluronidase allergen in mosquitoes and wasps (85). The existence of 
cross-reactivity between chironomids and mosquitoes has also been suggested 
in individuals allergic to chironomids (86). A study conducted in Reykjavik, 
Iceland, showed that most individuals sensitized to D. pteronyssinus also had 
specific IgE against mites (Lepidoglyphus destructor), shrimps, cockroaches 
and mosquitoes (87). 
 
F. Role of tropomyosin in allergic cross-reactivity 
Tropomyosins belong to a two-stranded alpha-helical coiled-coil protein family 
(Pfam PF00261) found in cell cytoskeletons. They are integral components of 
actin filaments that play a critical role in regulating the function of actin filaments 
in muscle and non-muscle cells. Muscle tropomyosin isoforms are involved in 
regulating the interactions between actin and myosin. Non-muscle tropomyosin 
isoforms function in all cells and are involved in a range of cellular pathways 
that control and regulate the cytoskeleton and other key cellular functions. 
These proteins consist of rod-shaped coiled-coil hetero-, or homo-dimers that lie 
along the α-helical groove of most actin filaments. There is no three-
dimensional structure available from any allergenic tropomyosin, but a predicted 
model of A. aegypti tropomyosin (Uniprot: Q17H75) is presented in Figure 3. 
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Figure 3. Molecular model of A. aegypti tropomyosin generated by Swiss-Model 
(template PDB 1c1.2.B). 
 
 
 
Tropomyosin is a well described allergen from diverse sources. There are 
several tropomyosin allergens currently registered in the World Health 
Organization and International Union of Immunological Societies (WHO/IUIS) 
Allergen Nomenclature data set (http://www.allergen.org) and Allergome 
database (http://www.allergome.com/). Most of the allergenic sources are 
shrimps, lobsters, prawns, crabs, fish, Mollusks and snails. This allergen is also 
common in mites, helminths, cockroaches and other insects.   
A phylogenetic analysis conducted by Leung et al. (88) found that 
tropomyosins in arthropods share a 91.7% homology (76.1–100%) and in 
mollusks 77.2% (65.1–99.3%). Homology between crustacean and mollusks 
tropomyosins ranges from 56 to 68% and between vertebrate and invertebrate 
from 53 to 57% (89). This high degree of homology indicates that tropomyosin 
is a pan-allergen, as has been confirmed and described in several studies (79). 
Although tropomyosin is considered an important allergen, only a few studies 
have demonstrated its role in the allergic response. Sensitization can occur by 
ingestion (seafood), inhalation (mites, cockroaches), or parasite infection 
(Ascariasis, Anisakiasis). The clinical impact of Ascaris lumbricoides 
tropomyosin (Asc l 3) was demonstrated in a population from a tropical country 
(90, 91).  
The IgE frequency of sensitization to tropomyosin is variable, but usually 
low. Tropomyosin from shrimp, Pen a 1, binds up to 75% of all shrimp-specific 
IgE antibodies (89, 92). In Africa and South America, the prevalence of 
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sensitization to mite tropomyosin is approximately 50% (93, 94), higher than in 
developed countries (95, 96). 
There are studies directed to identify B and T epitopes from allergenic 
tropomyosins. Ayuso et al. (97, 98) identified several IgE binding sites using 
peptides covering the whole sequence of the shrimp tropomyosin Pen a 1. Eight 
of these peptides corresponded to 5 sites that contained cross-reactive epitopes 
in shrimp, lobster, house dust mite, and cockroach. Epitope 1 (residues 43–55) 
in region 1; epitope 2 (residues 87–101) in region 2; epitopes 3a (residues 137–
141) and 3b (residues 144–151) in region 3; epitope 4 (residues 187–197) in 
region 4; and epitopes 5a (residues 249–259), 5b (residues 266–273), and 5c 
(residues 273–281) in region 5. These regions had from 56% to 98% of 
homology within other tropomyosins. Ravkov et al. (99) reported 17 T-cell 
epitopes from shrimp tropomyosin restricted to multiple MHC class II alleles, 
which is an important data for the design of peptide-based immunotherapy of 
shrimp-allergic patients.  
The genome of A. aegypti contains 11 genes that codify for different 
variants, or isoforms of tropomyosin (100). The amino acid sequences of 11 
tropomyosin proteins deduced from these genes are deposited in the protein 
database Uniprot. Currently, there are no studies reporting the identification, or 
biochemical and immunological characterization of the native forms of these 
tropomyosins. 
 
G. Reported A. aegypti allergens 
Atopic individuals exposed to mosquito develop an allergic response to different 
allergens contained in the saliva, salivary glands and the insect body. Four 
saliva-derived allergens from A. aegypti have been reported in the WHO/IUIS 
Allergen database (Table 2). 
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Table 2. Reported A. aegypti allergens 
Allergen 
Molecular 
weight 
(kDa) 
Biological function 
Number of 
aminoacids 
Frequence of reactivity  
(% positives) 
IgE 
Skin prick 
test 
Salivary allergens previously reported 
Aed a 1 68 Apyrase 562 -------- 
29 - 
43 
Aed a 2 37 Salivary D7 protein 321 43 11 
Aed a 3 30 
Undefined 30 kDa 
salivary protein 
273 -------- 32 
Aed a 4 67 α-glucosidase 579 36 -------- 
Novel non-salivary allergens reported herein 
Aed a 5 17.9 
Sarcoplasmic Ca+ (EF-
hand) binding protein 
191 26.2 -------- 
Aed a 6 24.7 
Porin 3 
 
282 33.3 -------- 
Aed a 7 27.4 
Undefined protein 
 
204 26.6 -------- 
Aed a 8 69 
Heat Shock cognate 
protein-70 
655 60 -------- 
Aed a 10 32 Tropomyosin 285/284* 33.3 -------- 
Aed a 11 32.6 
Lysosomal aspartic 
protease 
387 40 -------- 
*Two variants (Aed a 10.0101 and Aed a 10.0201) are reported for tropomyosin 
 
 
1. Saliva-derived A. aegypti allergens 
a. Aed a 1 
This 68 kDa allergen is a member of the apyrase (ATP diphosphohydrolase) 
protein family, expressed exclusively in the mosquito saliva. It interferes with 
platelet aggregation in human blood, hydrolyzing ADP and ATP released by 
platelets and other cells (101). It shows homology with members of a family of 
enzymes with 5′-nucleotidase activity (102). The capacity of this molecule to 
block platelet aggregation has further encouraged its study for the treatment of 
thrombosis (32). In one study, 9 of 31 allergic patients (29%) sensitized to A. 
aegypti had a positive skin test to rAed a 1 (39). IgE and IgG reactivity testing 
suggested that C-terminal residues (residues 150–562) from this allergen 
contain B cell epitopes (103). Its biological activity was demonstrated in 
immunized rabbits which produced antibodies that recognized the native 
molecule in A. vexans and A. albopictus (70).  
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b. Aed a 2 
This allergen belongs to the D7 protein family, which are highly conserved in 
insects that require blood feeding for reproduction. As it is the case with Aed a 
1, this allergen is exclusively expressed in the salivary glands of female 
mosquitoes (104). Aed a 2 contains a N-terminal and a C-terminal domain, 
which bind to leukotrienes and biogenic amines that are released as a 
mechanism of defense against the mosquito bites (105). The gene encoding 
this protein was first identified in a cDNA library of A. aegypti salivary glands 
and obtained as a recombinant protein by expression in insect cells infected 
with baculovirus, which conserved antibody binding capacity and skin reactivity 
as the natural protein. Immunogenic and allergenic properties of rAed a 2 have 
been demonstrated in mice, which produced specific IgG1 and IgE that reacted 
with the recombinant and natural allergens. Sensitized mice showed a positive 
skin test to the recombinant allergen (106). The presence of homologues of Aed 
a 2 and antibody cross-reactivity assays showed that this allergen has 
allergenic cross-reactivity with proteins from other mosquito species (70, 107).  
c. Aed a 3 
This allergen has been obtained by molecular cloning and expression in insect 
cells infected with baculovirus. Aed 3 is expressed as a 30-kDa protein which 
binds specifically to collagen and prevents the interaction of collagen with 
platelet glycoprotein IV, integrin α2β1 and von Willebrand factor (108), making it 
a potential molecule with antithrombotic capacity. It has been suggested that 
this allergen may also be used for the diagnosis of mosquito allergy. 
d. Aed a 4 
This 67 kDa allergen is an α-glucosidase which has been obtained as a 
recombinant protein by expression in insect cells infected with baculovirus and 
showed IgE and IgG binding capacity; 46% of 13 allergic individuals had a 
positive specific IgE determination against Aed a 4; healthy individuals showed 
no IgE reactivity (109). 
rAed a 1, rAed a 2 and rAed a 3 are among the most relevant allergens, 
that can be used for the diagnosis of mosquito bite allergy. A mixture of these 
three allergens is enough to identify approximately 65% of mosquito-allergic 
patients (110). The clinical relevance of other allergens remains to be studied. 
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2. Body-derived A. aegypti allergens 
As a result of this project, 6 novel A. aegypti allergens where included in the 
WHO/IUIS Allergen database: Aed a 5 (Sarcoplasmic Ca+ (EF-hand) binding 
protein), Aed a 6 (Porin 3), Aed a 7 (Undefined protein), Aed a 8 (Heat Shock 
cognate protein-70), Aed 11 (Lysosomal aspartic protease) and two variants of 
tropomyosin (Aed a 10.0101 and Aed a 10.0201). 
 
H. Other diseases induced or transmitted by mosquito bites 
Mosquito bite allergy is associated with other diseases. Children and individuals 
with primary or secondary immunodeficiency are most at risk for mosquito-bite 
allergy (59, 111, 112). Several cases have been described in which 
sensitization to mosquito bites is accompanied with natural killer (NK) cell 
lymphoproliferative disorders, the presence of T cells infected with Epstein-Barr 
virus, or lymphocytosis associated with HIV infection (113-116). The study by 
Asada et al. (117) demonstrated that mosquito saliva induces 
lymphoproliferation, increasing the expression of an oncogene in NK cells, 
which apparently plays an important role in the etiology of mosquito allergy.  
It has been shown that the inflammatory and/or allergic response induced 
by mosquito bites, especially Anopheles spp., favors infection with Plasmodium 
spp., thereby facilitating the occurrence of malaria (118, 119). Therefore, 
mosquito-sensitized individuals seem to be at a greater risk of contracting 
malaria. A. aegypti is responsible for transmitting many medically important 
viruses, such as those which cause Zika, Chikungunya and dengue. A. aegypti 
is the main cause of dengue problems in Central and South America, Southeast 
Asia, and the Western Pacific, with an estimated 50 million infections every year 
(120).  
The role of the mosquito is not only as a virus carrier. Using Semliki 
Forest virus and Bunyamwera virus, Pingen et al (121) showed that these 
viruses exploit the inflammatory reaction induced after the mosquito bite and the 
innate immune response driven by neutrophils to replicate and disseminate in 
vivo, and infect the virus-permissive myeloid cells.  
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I. Can mosquitoes induce allergic reactions by non-saliva derived 
antigens? 
Although there is no clear evidence about this possibility, there are several 
reasons to believe that mosquitoes have body-derived allergens that may 
induce allergic responses, other than cutaneous eruptions. First, allergic 
individuals suffering from asthma and/or allergic rhinitis have specific IgE 
against mosquito antigens contained in whole body extracts. In a study 
conducted in India, it was shown that 47% of the population with asthma and/or 
allergic rhinitis were sensitized to mosquito allergens, as determined by skin-
prick tests, serum IgE antibodies and bronchial provocation tests with whole 
mosquito body extracts (122). A study performed with Indian patients suffering 
from bronchial asthma and allergic rhinitis showed that the diagnosis of these 
allergic responses with mosquito extracts is reliable (123). Second, mosquito 
body particles (detritus) may remain suspended in the ambient air. In these 
circumstances, individuals may inhale mosquito debris and develop an allergic 
response (41, 124). Third, clinical symptoms have been reported upon the 
inhalation of other insects, especially in occupational and urban settings. The 
mechanism associated with the inhalation of mosquito allergens may be similar 
to those implicated with other insects that induce, or exacerbate, allergic 
asthma and rhino-conjunctivitis upon inhalation of their allergens. Airborne 
allergens from cockroaches (125-127), moths (128) and honeybees (129)  have 
been detected in settled dust and air of homes, schools and working places in 
the USA. The presence of these allergens is associated with the development 
of allergic responses. Cases of allergic sensitization to the common housefly 
Musca domestica, where a cross-reactive component was discarded, have 
been reported (130). Fourth, the analysis of the A. aegypti genome indicates 
that this insect expresses several proteins homologues of allergens from mites, 
cockroaches, or shrimps, which may play a role in the pathophysiology of the 
allergic responses by cross-reactivity, or specific sensitization. This is a clear 
case for molecules such as tropomyosin (with homologues in several 
arthropods), heat shock protein-70 (with homologues in mites, mold, yeast and 
wasp) and peptidyl-prolyl isomerase (with homologues in mites, mold, plants 
and yeast). Figure 5 shows the distribution of allergenic arthropods in indoor 
dust. 
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Figure 5. Distribution of select allergenic arthropods in indoor dust. Modified from 
(124). 
 
 
The study of Kausar et al. (41) showed important contributions to the raised 
explanations and identified two allergens of 30 and 33 kDa which may 
correspond to major mosquito body allergens. The evaluation of specific IgE-
sensitization to a whole body extract from the mosquito species C. 
quinquefasciatus in 200 allergic patients with bronchial asthma and/or allergic 
rhinitis showed that 35% had positive a skin prick test and a positive specific 
IgE determination. RAST inhibition experiments with Spodoptera spp., Prosopis 
spp., Ricinus spp., Alternaria spp., Mucor spp., horse dander, and M. domestica 
extracts did not inhibit the C. quinquefasciatus extract, suggesting that this 
sensitization was not produced by cross-reactivity with these species. However, 
whole body extracts of A. aegypti and A. stephensi produced a similar inhibition 
comparable to C. quinquefasciatus. IgE reactivity against C. quinquefasciatus 
using an extract prepared from airborne particles showed that mosquito 
antigens remain suspended in the air. Another study (124) reported that 
mosquitos (Aedes spp.) and plant-associated aphids (Aphis spp.) were two of 
the most ubiquitous Arthropods detected in the dust from homes in the United 
States (Figure 5). 
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J. The study of allergens in the “omic era” 
Classic approaches to the identification and characterization of allergens 
include the purification from natural sources (131-134) and the construction of 
cDNA libraries from which the nucleotide sequence codifying the allergen of 
interest can be detected, manipulated and used to express the recombinant 
protein (135-137). In this project, we have identified and characterized a novel 
A. aegypti allergen (Aed a 10: tropomyosin) by the purification of the natural 
protein, which has advantages over other techniques, as long as the availability 
of the source of allergen material is not limited. The application of these 
techniques is time-consuming and may lead to a poor identification of the most 
relevant spectrum of allergens, which are not detected, or underestimated.  
The advent of the “omic era” has opened new perspectives that applied 
to the study of allergens allows a more comprehensive identification and 
characterization of the allergens from a species, together with information of 
their abundance, pos-translational modifications, physicochemical 
characteristics and interaction in the scene of the biochemical pathways. 
Furthermore, the development to next-generation sequencing technologies has 
provided the tools to achieve a massive parallel sequencing, leading to a more 
rapid and efficacious way to sequence genomes, analyse the expression of 
genes and identify polymorphisms that may lead to the expression of allergen 
isoforms with variable allergenic and immunologic characteristics. 
A good example which shows the advantages of the omic tools applied to 
the identification of allergens was conducted with the house dust mite D. farinae 
(138). The presence of 25 of the previously described D. farinae allergens 
registered in the International Union of Immunological Societies Allergen 
Nomenclature Sub-Committee database was confirmed. Furthermore, 12 novel 
allergenic proteins, including ferritin, cofilin (an actin-binding protein), secreted 
inorganic pyro-phosphatase (denominated Der f 30-32, respectively), ubiquinol–
cytochrome c reductase binding protein–like protein (denominated Der f 24), 
myosin alkali light chain protein and DFP2, were identified. The methodological 
approach combined high-throughput sequencing of the genome and 
transcriptomic, and the characterization of IgE-binding components of the mite 
using proteomic tools. In addition to the identified allergens, the microbiome of 
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D. farinae was also described. This information is valuable for the allergologists 
because provides the bases to better understand the allergenicity of the mite 
molecules in the context of the internal and external environment. The results 
from the analysis of the genome and transcriptome from this mite species 
helped to propose a list of potential allergens that present allergen homologues 
in Dermatophagoides spp. and other mite species. The results presented by 
Chan TF et al. shows a long list of allergens from mites; some of them are 
potential molecular markers of genus or species and others are cross-reactive 
molecules. 
In a similar approach, the allergens from Tyrophagus putrescentiae were 
identified by next-generation sequencing combined with MS/MS shotgun 
proteomics. This analysis led to the identification of three previously-
uncharacterized allergens, Tyr p 28, Tyr p 35, and Tyr p 36, which have been 
officially assigned by the WHO/IUIS Allergen Nomenclature Sub-committee 
(139). 
Proteomic is defined as the in-depth analysis of protein repertoires within 
a given species, organ, or organelle, at a given time (140). This definition 
applied to the study of allergens, has led to the concept of “Allergenome”. The 
application of proteomics in the field of Allergy research is of great interest for 
the identification and structural characterization of allergens and the study of 
immune epitopes. Furthermore, proteomics can provide semi-quantitative or 
quantitative information about these molecules in different allergen extracts. 
Application of proteomic tools to the study of allergens is also advantageous 
because it involves the study of the molecules with their natural post-
translational modifications, variants and isoforms (141-143) and gives 
information of their biological relevance. For instance, in an attempt to find 
homologues of the birch pollen allergen, Bet v 1 in the kiwi fruit, the screening of 
cDNA libraries allowed the identification of the allergens Act d 8 and Act c 8 
from two kiwi species (144). However, they were not relevant because of their 
very low representation in the kiwi extracts. Analysing the protein content of this 
fruit, it was found that other Bet v 1 homologue, namely the allergen Act d 11, is 
contained in high concentrations in the allergenic extracts, representing an 
important and clinically relevant cross-reactive allergen (145). 
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At the experimental level, the proteomic study of allergens requires the 
separation of a complex spectrum of proteins. The task may be accomplished 
using bi-dimensional polyacrylamide gel electrophoresis (2D-PAGE), but other 
high resolution methods based on electrophoretic or chromatographic 
separations can also be applied. Afterwards, antibody reactive proteins can be 
identified by immunological methods and characterized by mass spectrometry. 
Biological samples are first subjected to isoelectric focusing (i.e., first 
dimension) and further separated according to molecular masses (i.e., second 
dimension). Separated proteins are identified with colorimetric reagents 
(Coomassie blue or silver staining) and incubated with sera collected from 
allergic individuals in Western blot experiments. Antibody-binding spots are 
further analyzed by MS/MS, exploiting the information from protein databases, 
when possible. If no reliable results are obtained using protein databases, 
transcriptomic information (i.e., data from RNA sequencing) is highly valuable to 
identify new allergens of clinical relevance. These combined approaches based 
on “omics” technologies are almost enough to identify every possible allergen, 
as it is the case with grass pollen (146), ragweed (147) and mites (148). There 
are two main approaches to analyze proteins by proteomic tools: the bottom-up 
approaches, where proteins are separated, digested with an enzyme (usually 
using trypsin), and the resulting peptides identified by MS and the top-down 
(where complete proteins are analyzed) (149) (Figure 6). 
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Figure 6. Top-down and bottom- up strategies for mass spectrometry identification of 
proteins. 
 
Bottom-up strategy, which is the most frequently used, can be performed by two 
different procedures. Peptide mass fingerprint (PMF) which requires separation 
of proteins by 2D-PAGE, enzymatic digestion into peptides and MS analysis 
(149). The obtained peptide mass profile is compared against generated in-
silico digestion of the protein sequences available in databases (150). A second 
approach is the peptide fragmentation fingerprint (PFF), which produces 
fragmentation data from one, or more unique peptides to unambiguously 
identify parent proteins (149) and produce more confident results (150).  
Choopong et al. (151) studied the proteome and allergenome of the mite 
species D. farinae, using SDS-PAGE (1DE) and 2DE-IgE immunoblotting 
followed by LC-MS/MS and database search for protein identification. They 
identified 40 IgE-binding spots corresponding to 35 different proteins. Some of 
these proteins matched previously reported allergens. Several minor allergens 
that have never been previously reported were also identified, including 
deoxyribonuclease-2-beta, alpha-enolase, fructose biphosphate aldolase, 
glyceraldehydes 3-phosphate dehydrogenase, phosphoenolpyruvate 
carboxylase, NADH dehydrogenase, cytochrome-b, aldehyde dehydrogenase, 
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or Alt a 10, actins, heat shock protein-60, glutamate dehydrogenase, ATP 
synthetase, citrate synthase, phosphoglycerate kinase, serine hydroxymethyl 
transferase, transketolase-like protein, and hexoseaminidase. 
The proteome and transcriptome of the mosquito species A. aegypti have 
been previously studied to: a) discover potential receptors for insecticidal 
proteins (152, 153), b) to understand the mechanisms of infection for some 
viruses (154, 155), c) to study the molecular mechanisms associated to the 
insect bite (156, 157) and d) to find novel approaches to control the infestation 
of this mosquito (158). However, there is no study that uses proteomic tools to 
contribute to the elucidation of its allergenic components and understanding of 
the role of A. aegypti in allergic diseases. 
The information presented in the introduction has been partially 
published in the following article: 
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of mosquito allergens and discuss the types of immune 
 responses induced by mosquito bites and the inhalation of 
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 Introduction 
 Mosquitoes are insects belonging to the order Diptera 
and members of a family of the nematocerid flies Culici-
dae (from the Latin culex, genitive culicis, meaning 
‘midge’ or ‘gnat’)  [1] . The word ‘mosquito’ (formed by 
‘mosca’ and the diminutive ‘ito’) is from the Spanish or 
Portuguese for ‘little fly’  [2] . Mosquitoes resemble crane 
flies (family Tipulidae) and chironomid flies (family Chi-
ronomidae). The females of many species of mosquitoes 
are blood-eating pests and dangerous vectors of disease 
whereas members of the similar-looking Chironomidae 
and Tipulidae are not.
 At least 14 orders of arthropods, containing over 400 
different genera and more than 15,000 species, evolved to 
feed on blood from warm vertebrate animals  [3] . Three 
subfamilies are recognized within the family Culicidae, 
namely Toxorhynchitinae, Anophelinae and Culicinae. 
Toxorhynchitinae includes only one genus, while Anoph-
elinae consists of nearly 400 species. More than 2,600 
mosquito species belong to the subfamily Culicinae. More 
 Key Words 
 Mosquito allergy ·  Aedes aegypti · Immunoglobulin E · 
Recombinant allergens · Cross-reactivity 
 Abstract 
 Allergies caused by mosquito bites may produce local or sys-
temic reactions. The inhalation of mosquito allergens may 
also cause asthma and/or allergic rhinoconjunctivitis in sen-
sitized individuals. The mechanisms implicated in the devel-
opment of these immune responses involve IgE antibodies, 
different subtypes of IgG and proinflammatory cytokines as 
well as basophils, eosinophils and mast cells. Several aller-
genic components have been identified in the saliva and 
bodies of mosquitoes and some of these are present in dif-
ferent mosquito species. The most common species impli-
cated in allergic reactions belong to the genera  Aedes ,  Culex 
and  Anopheles . Several  Aedes aegypti allergens have been 
cloned and sequenced. The recombinant molecules show 
IgE reactivity similar to that of the native allergens, making 
them good candidates for the diagnosis of mosquito aller-
gies. Allergen-specific immunotherapy with mosquito ex-
tracts induces a protective response characterized by a de-
creased production of IgE antibodies, increased IgG levels, a 
reduction in the severity of cutaneous and respiratory symp-
toms and the need for medication. The aims of this review 
are to summarize the progress made in the characterization 
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than 40 genera and 3,000 species of mosquitoes are dis-
tributed worldwide ( table 1 )  [4] . Some of these species are 
more clinically relevant than others because they affect 
humans, directly or indirectly. These species include, but 
are not limited to,  Aedes  aegypti, Aedes vexans  and  Culex 
 quinquefasciatus  [5–7] . Adult female mosquitoes require 
blood-feeding to produce eggs. In this process, they bite 
and inject their saliva before sucking their victim’s blood 
 [8] . Mosquito saliva contains various substances like ly-
sozymes, antibacterial glucosidases, anticoagulants, anti-
platelet aggregating factors and vasodilators  [9–13] . It 
also contains allergens that may induce local cutaneous 
reactions and, in some cases, a systemic response in atop-
ic individuals  [14–17] . Allergens derived from the ema-
nations and detritus of mosquitoes are also present in the 
air and in house dust, and may be inhaled and induce 
various immune responses  [18, 19] .
 The term ‘mosquito allergy’ is used to describe a series 
of signs and symptoms caused by mosquito bites. Indi-
viduals may experience a variable degree of symptoms 
after a mosquito bite consisting of unusual large local ec-
chymotic and vesiculated reactions and, in some cases, 
systemic reactions, such as generalized urticaria, angio-
edema or wheezing and even anaphylaxis  [20–23] . How-
ever, it has also been shown that mosquito debris remains 
suspended in the air and produces an allergic respiratory 
response similar to that caused by other airborne aller-
gens, such as those from the dust mite and cockroach  [18, 
24, 25] .
 Allergies caused by mosquitoes have a negative im-
pact on the affected population, on their quality of life 
and, in some cases, even put their lives at risk. Although 
the general opinion is that mosquito allergy may be 
highly prevalent, there are only a few epidemiological 
studies supporting this perception. In a cross-sectional 
study conducted in Mexico City, 82% of the patients 
who were admitted to the allergy service reported that 
they were allergic to mosquito bites; however, only 2.5% 
of them showed positive skin reactions to this insect 
 [26] . In another study, conducted in India, it was shown 
that 47% of the population with asthma and/or allergic 
rhinitis were sensitized to mosquito allergens, as deter-
mined by skin-prick tests, serum IgE antibodies and 
bronchial provocation tests with whole mosquito body 
extracts  [25] . There is no epidemiological data about 
mosquito allergy in South America, where several mos-
quito species and mosquito-borne diseases are highly 
prevalent.
 Mosquito sensitization may also be associated with 
other diseases.  Children and individuals with primary or 
secondary immunodeficiency are most at risk for mos-
quito-bite allergy, especially those living in areas heavily 
exposed to mosquitoes and their allergens  [23, 27, 28] . 
 Several cases have been described in which sensitization 
to mosquito bites is accompanied with natural killer (NK) 
cell lymphoproliferative disorders, the presence of T cells 
infected with Epstein-Barr virus or lymphocytosis associ-
ated with HIV infection  [29–32] . The study by Asada et 
al.  [33] demonstrated that mosquito saliva induces lym-
phoproliferation, which, in turn, increases the expression 
of an oncogene in NK cells, which apparently plays an 
important role in the etiology of mosquito allergy. It has 
been shown that the inflammatory and/or allergic re-
sponse induced by mosquito bites, especially  Anopheles 
spp., favors infection with  Plasmodium spp., thereby fa-
cilitating the occurrence of malaria  [34, 35] . Therefore, 
mosquito-sensitized individuals seem to be at a greater 
risk of contracting malaria.
 Allergy to house dust mites is one of the most impor-
tant risk factors for asthma in tropical regions. The main 
species involved are  Blomia tropicalis and  Dermatopha-
goides pteronyssinus  [36–38] . Mosquitoes are abundant in 
these latitudes, since the climatic conditions of tropical 
regions favor the life cycle and proliferation of mosquito 
species  [39–42] ; this fact might favor high exposure to 
their allergens. Mosquitoes, like mites, may also be an im-
portant environmental factor that induces or exacerbates 
allergic diseases. Moreover, studies on mosquitoes, mites 
and cockroaches indicate that these arthropods have 
some allergens in common  [43–46] . These allergens have 
not been investigated and identified yet, despite the fact 
that cross-reactivity between mites and mosquito may 
play a significant role in the prevalence and clinical man-
ifestations of allergic respiratory and dermatological 
 diseases.
 Immunological Basis of the Allergic Reactions 
Produced by Mosquitoes 
 Symptoms and Clinical Stages of Reactivity 
 Mosquito bites produce a local reaction consisting of 
a rash and heat, with the subsequent appearance of a 
wheal and flare, and itching in nonatopic individuals. The 
term ‘mosquito allergy’ refers to reactions which cause 
severe or atypical (ecchymotic or vesiculated) local or sys-
temic reactions, such as anaphylaxis, angioedema, gener-
alized urticaria or wheezing. Four types of reactions occur 
as the consequence of a mosquito bite: (1) local reactions 
(immediate and delayed), (2) severe, delayed reactions 
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with scar formation (via a cell-mediated mechanism), (3) 
exaggerated local reactions, and (4) systemic anaphylaxis 
 [47] . Local cutaneous reactions consist of immediate 
wheals and flares peaking at 20 min and delayed pruritic 
indurated papules peaking at 24–36 h  [48, 49] . Large local 
reactions consist of itchy red, warm swellings appearing 
with minutes, itchy papules and ecchymotic, vesiculated, 
blistering, bullous or even Arthus-type reactions, appear-
ing 2–6 h after the bites  [20, 23, 50] .
 Sensitization may occur after the first exposure to a 
mosquito bite. Subsequent bites may induce the charac-
teristic signs and symptoms of an allergic reaction. Based 
on clinical observations, the natural history of sensitiza-
tion and desensitization to mosquito bites has been clas-
sified into 5 well-defined clinical stages: (1) no reaction 
after the initial bite in individuals who have never been 
bitten, (2) delayed cutaneous lesions appear after ap-
proximately 24 h in individuals after subsequent bites, 
(3) wheals appear within approximately 15 min in indi-
viduals after repeated bites, (4) no delayed reactions oc-
cur and only immediate wheals are noted in individuals 
after further exposures to mosquito bites, and (5) there 
is a loss of the immediate reaction in individuals who are 
repeatedly exposed to huge numbers of mosquito bites 
 [51–53] .
 Evidence suggests that mosquitoes might also induce 
allergic respiratory symptoms through the inhalation of 
suspended allergens that derive from their bodies and 
emanations. The available evidence and similar findings 
with regard to other flying insects suggest that asthma 
and allergic rhinitis might be exacerbated by the inhala-
tion of mosquito allergens, in a similar way to other air-
borne allergens derived from arthropods such as mites, 
moths  [54] , bees  [55] and cockroaches  [56] .
 Humoral and Cellular Response to Mosquito Bites 
 Immunological changes that occur during the process 
of sensitization and desensitization have been studied in 
humans and in animal models, and involve the humoral 
as well as the cellular components of the immune re-
sponse. In a prospective study  [48] on the natural course 
of the allergic response against mosquito bites, a nonal-
lergic individual was exposed to 100 bites of  C. quinque-
fasciatus every 2 weeks for 10 months. The levels of spe-
cific IgE and IgG antibodies increased steadily with each 
exposure. Skin tests with a mosquito extract were posi-
tive, and the size of the wheal correlated with IgE and IgG 
antibody levels. However, after 21 weeks of exposure, the 
levels of specific antibodies to the extract decreased. Al-
though these results demonstrate that an individual may Su
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be desensitized to mosquito bites, in real life, such indi-
viduals try to avoid contact and thus reduce the number 
of bites, thereby requiring more time for desensitization. 
In a population of children from Winnipeg, Man., 
 Canada, high levels of specific IgE and IgG occurred in 
the first 6 months, but had decreased by adolescence, sug-
gesting that these children were desensitized naturally by 
exposure  [57] . Kulthanan et al.  [21] showed the required 
interval between sensitization and desensitization in a 
population in Thailand to be approximately 4 years.
 The participation of specific IgE in mosquito allergy 
has been demonstrated by immediate skin reactivity in-
duced by the passive transfer of specific IgE antibodies 
 [58] . These antibodies were associated with local and sys-
temic, and immediate or delayed reactions. It has been 
demonstrated that specific IgE levels are higher in the 
serum of individuals allergic to at least 1 of 10 mosquito 
species distributed worldwide than those in nonallergic 
individuals  [44] . Brummer-Korvenkontio et al.  [22] 
 showed that individuals sensitized to  Aedes communis 
with immediate and delayed reactivity had high levels of 
specific IgE and IgG4 to  A. communis . Peng et al.  [14] 
showed that individuals sensitized to mosquito bites who 
experienced acute systemic reactions had higher specific 
IgE levels than nonallergic individuals. In these cases, 
there was also a positive and significant correlation be-
tween the size of the sting wheals and the levels of serum 
antibodies. It seems that IgG antibodies may play a role 
in immediate local reactions, but not in systemic reac-
tions. A study by Reunala et al.  [59]  demonstrated that 
between 82–90% of children in Finland, Kenya and 
 Mexico had specific IgE antibodies against  A. communis 
and  A. aegypti , with the presence of IgG4 antibodies in 
the children being 85, 41 and 20%, respectively. The titers 
of specific antibodies were associated with the degree of 
exposure. It was demonstrated that in the early allergic 
response caused by mosquito bites, in addition to the lev-
els of the antibodies, those of histamine and leukotriene 
C4 also increased  [60] . In a mouse model of mosquito 
allergy,  A. aegypti induced a Th2 immune response with 
immediate and late reactions and higher levels of IgE and 
IgG1 antibodies compared to mice that were nonsensi-
tized. A higher lymphoproliferation was also observed in 
sensitized mice treated with mosquito extracts  [61] .
 Mast cells may also play a role in allergic symptoms 
caused by mosquito bites. Demeure et al.  [62] showed 
that the bites of  Anopheles  stephensi activated mast cell 
degranulation in healthy mice; this induced changes in 
vascular permeability, the extravasation of fluid and the 
recruitment of neutrophils at the bite site. This response 
was accompanied by hyperplasia of the lymph nodes and 
the recruitment of dendritic cells, B lymphocytes, macro-
phages and T lymphocytes. These effects were not ob-
served in mast cell-deﬁcient animals, unless they were re-
constituted with mast cells. An important finding in this 
study was that the in vitro degranulation of mast cells oc-
curs in the absence of IgE, suggesting that the saliva may 
be responsible for the inflammatory response.
 Other Manifestations of Mosquito Allergy 
 Papular urticaria may also appear as a hypersensitivity 
reaction after mosquito bites, or after the bites of other 
arthropods. The exact immune mechanisms behind pap-
ular urticaria are unknown, but some evidence support 
the involvement of type I, III and IV hypersensitivity re-
actions, and therefore the participation of IgE and IgG 
antibodies. Abdel-Naser et al.  [63]  showed that a group of 
patients with papular urticaria had specific IgG against 
 Culex pipiens antigens. The levels of these antibodies cor-
related with the size of both immediate and delayed skin 
reactions and specific IgE levels  [64] . Immunoglobulin 
and complement depositions have also been detected in 
the skin, suggesting that these participate in the mecha-
nism of papular urticaria lesions  [65, 66] .
 In some cases, the mosquito bite may also induce a 
strong reaction involving an extensive part of the body 
such as the face, hands, arms, feet or legs. These reactions 
are often misdiagnosed as cellulitis. However, they appear 
a few hours after the mosquito bites, which makes it un-
likely to be due to a bacterial infection. Simons and Peng 
named this clinical disorder Skeeter syndrome  [20] .
 Mosquito Allergens 
 It has been suggested that there may be differences in 
the allergenic composition of mosquito saliva, salivary 
glands and whole body extracts. Mosquito saliva contains 
allergens that sensitize atopic individuals  [64] . Sixteen 
IgE-reactive proteins with a molecular weight of between 
16 and 95 kDa have been detected in the saliva and salivary 
glands of 10 different mosquito species distributed world-
wide  [44] . When analyzed with sera from allergic indi-
viduals, allergens in the saliva of  C. quinquefasciatus  with 
a molecular weight of 35.5, 32.5 and 22.5 kDa showed a 
frequency of IgE reactivity of 41, 28 and 24%, respectively 
 [67] . Fourteen IgE reactivity fractions with a molecular 
weight of between 23 and 93 kDa were identified using 
sera from allergic patients in extracts from the salivary 
glands of  Aedes togoi ,  Culex tritaeniorhynchus and  C. pip-
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iens pallens . In addition, mice immunized with these ex-
tracts produced mainly IgG1 that recognized bands of 31, 
37 and 57.5 kDa  [17] , respectively, suggesting that these 
antigens could play a protective immune response.
 Several studies have shown that mosquito saliva is not 
the only source of allergens. In fact, extracts used for aller-
gen-specific immunotherapy and diagnosis are produced 
from saliva, salivary glands or whole mosquito bodies. Al-
though these preparations have different biological activi-
ties, all are useful for the diagnosis of allergic individuals 
 [68] . In Yazd, Iran, a subtropical city with a warm, dry 
climate, 32.6% of 95 patients with allergic rhinitis had a 
positive skin test to whole-body mosquito extracts. The 
frequency of reactivity to mould, cockroach and mite ex-
tracts was lower  [24] . These results suggest that the anti-
gens contained in mosquito bodies are important envi-
ronmental factors associated with allergic rhinitis in this 
region. An extract prepared from airborne particles col-
lected in the homes of mosquito-allergic patients could 
block the binding of IgE antibodies to the antigens con-
tained in a whole-body extract of  C. quinquefasciatus  [18] . 
This study proposes that mosquito allergens are present in 
the environment and that they retain their immunological 
properties, as shown in ELISA inhibition experiments. 
When inhaled, these allergens can induce an allergic re-
sponse in atopic individuals sensitized to mosquito bites. 
The clinical manifestations of this response are different 
from those caused by insect stings  [69] . Similar findings 
have been described in south-eastern Minnesota, where 
large amounts of outdoor  Lepidoptera allergens have been 
detected, suggesting that the inhalation of insect debris 
could play an important role in the ethiopathogenesis of 
allergic respiratory diseases  [54] . Other biting insects such 
as fleas are also a source of indoor allergens, but their role 
as inducers of allergic diseases is less known  [70] . Mos-
quito saliva primarily induces skin reactions, while the an-
tigens that are suspended in the air may induce respira-
tory symptoms. Therefore, it is important to identify and 
characterize the allergens associated with these different 
clinical manifestations, in order to design better strategies 
for diagnosis and treatment. Allergen cross-reactivity 
must also be fully delineated to the contribution of spe-
cies-specific or cross-reacting allergens.
 We have demonstrated that the sera from mite-allergic 
individuals contain specific IgE antibodies that react with 
more than 10 allergens from an  A. aegypti extract  [71] . 
Although the clinical relevance of these allergens in aller-
gic symptoms is unknown, the results suggest that mos-
quitoes are a source of aeroallergens, which may play a 
role in allergic respiratory diseases. Wongkamchai et al. 
 [19]  reported the presence of 16 allergens in the saliva, 
6  in the salivary glands and 2 in whole-body extract of 
4 mosquito species. These allergens are not common to 
all three sites, suggesting that allergic symptoms are re-
lated to the route of exposure (i.e. cutaneous or respira-
tory) and are associated with unique allergens. It is still 
necessary to further investigate if the allergens present in 
the saliva can induce respiratory symptoms.
 Although several allergens have been identified in 
mosquito extracts, only a few from the saliva have been 
characterized in terms of their role in the allergic re-
sponse. Most reported mosquito allergens belong to 
 A.  aegypti  spp. ( table  2 ) (see http://www.allergome.org 
and http://www.allergen.org).
 Characterized Allergens 
 Aed a 1 
 This allergen shows homology with apyrase (ATP di-
phosphohydrolase) and has a molecular weight of 68 kDa. 
It interferes with platelet aggregation in human blood by 
hydrolyzing ADP and ATP released by the platelets and 
other cells  [72] . It also has homology with members of a 
family of enzymes with 5 ′ -nucleotidase activity, also pres-
ent in humans and rats  [73] . The serum of mosquito-al-
lergic individuals may have specific IgE against this apy-
rase  [44] . The truncated Aed a 1 (residues 150–562) was 
found to react with serum specific IgE and IgG antibodies 
of allergic individuals, suggesting that this fragment con-
tains B cell epitopes  [74] . In another study, 9 of 31 sensi-
tized individuals (29%) had a positive skin test to rAed a 
1  [15] . Rabbits immunized with Aed a 1 produced poly-
clonal sera that reacted with allergens in the saliva ex-
tracts of  A. vexans and  Aedes albopictus  [44] . Apyrase ac-
tivity was detected in the salivary glands of  Ochlerotatus 
triseriatus and  Ochlerotatus hendersoni  [75] , suggesting 
the presence of homologous allergens to Aed a 1. Because 
apyrase from mosquitoes inhibits platelet aggregation in-
duced by collagen and thrombin, it has been suggested 
that it could be of therapeutic use in treating thrombosis 
 [9] . It seems that Aed a 1 is expressed only in the salivary 
glands, which suggests that individuals may come into 
contact with this molecule through mosquito bites. How-
ever, it has still to be established whether this allergen can 
be detected in the environment and if it is capable of in-
ducing sensitization through inhalation.
 Aed a 2 
 This allergen belongs to the family of proteins called 
D7, which are highly conserved in insects that require 
blood for feeding and reproduction and are released in 
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the saliva just after piercing the skin. Aed a 2 contains an 
N-terminal and a C-terminal domain, capable of binding 
to leukotrienes and biogenic amines that are released by 
an individual as a mechanism of defense against the mos-
quito bite  [76] . The gene encoding this protein was first 
identified in a cDNA library constructed from the sali-
vary glands of  A. aegypti . Northern blot assays and in situ 
hybridization showed that the mRNA of the protein is 
only present in the salivary glands of female mosquitoes, 
suggesting that it plays an important role in blood feed-
ing  [77] . This molecule has been cloned and obtained as 
a recombinant protein by expression in insect cells in-
fected with baculovirus. It retains the ability to bind to 
specific human IgE antibodies and induces skin reactiv-
ity in a similar way to the natural protein  [78] . Mice im-
munized with rAed a 2 produced IgG1 and IgE antibod-
ies capable of binding to the recombinant and natural 
allergens. Sensitized mice showed a positive skin test to 
the recombinant allergen, which suggests that this pro-
tein induces a Th2 response, characteristic of an allergic 
reaction. Aed a 2 cross-reacts with proteins from other 
species of  Aedes ( A. vexans ,  A. albopictus ,  A. communis 
and  A. togoi ),  C. quinquefasciatus and  O. triseriatus  [44] . 
The saliva of  C. quinquefasciatus contains allergens ho-
mologous to Aed a 2  [79] . These allergens are homolo-
gous with the family of proteins D7 and show high struc-
tural homology with the protein THP12 of the hemo-
lymph of  Tenebrio molitor , which is part of the family of 
pheromone-binding proteins and odorants that partici-
pate in the transport of hydrophobic molecules  [80] . It 
seems that Aed a 2 should be included in preparations for 
the diagnosis and immunotherapy of mosquito allergy, 
since it has a significant frequency of IgE reactivity  [44] 
and may participate in cross-reactivity among various 
species. Because recombinant Aed a 2 is biologically and 
immunologically similar to the native purified allergen, 
it could be used in the diagnosis and immunotherapy of 
mosquito allergies as well. This would overcome the dif-
ficulty of obtaining this molecule from the saliva. Aed a 
1 and Aed a 2 seem to be expressed only in mosquito 
salivary glands.
 Additional Allergens 
 The allergens Aed a 3 and Aed a 4 have been obtained 
by molecular cloning and expression in insect cells infect-
ed by baculovirus. Aed 3 is expressed as a 30-kDa protein 
which binds specifically to collagen. It prevents the inter-
action of collagen with physiological ligands, such as plate-
let glycoprotein IV, integrin α2β1 and von Willebrand fac-
tor, blocking platelet aggregation induced by collagen 
 [81] . This property suggests its potential use as an anti-
thrombotic drug. It has been suggested that this allergen 
may also be valuable for the diagnosis of mosquito allergy. 
It has been shown that a mixture of rAed a 1, rAed a 2 and 
rAed a 3 can identify approximately 65% of mosquito-al-
lergic patients  [82] . It has been shown that 36% of  A. ae-
gypti- allergic individuals have specific IgE against Aed a 4, 
suggesting that its inclusion in vaccine preparations might 
be desirable  [83] . Aed a 7 is recorded in the Allergome plat-
form, as an allergen with homology to tropomyosin. How-
ever, no further information is currently available about its 
biological and structural properties.
 Table 2.  Reported A. aegypti allergens
Allergen Molecular
weight, kDa
Biological function Amino acids, n Frequency of reactivitya 
(patients, n/% posi tives)
References
IgE antigenic
challenge
Aed a 1 68 antiplatelet aggregant (apyrase) 562 – 31/29; 28/43 [15, 44, 74–76, 80]
Aed a 2 37 transport of hydrophobic molecules
(pheromone and odorant)
321 21/42.8 28/11 [16, 44, 78–80]
Aed a 3 30 antiplatelet aggregant (aegyptin) 273 – 28/32 [81, 82]
Aed a 4 67 not described 579 25/36 – [83]
Aed a 7 32.3 muscle contraction (tropomyosin) 284 – – see Allergome
Other mosquito species may also contain homologous allergens, as described in the text.
a Based on serology (IgE) or skin test (antigenic challenge).
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 Allergen Cross-Reactivity 
 Allergen cross-reactivity occurs when IgE antibodies 
induced by exposure to an allergen react with a different 
protein with structural homology to the antibody-induc-
ing allergen. This phenomenon is common among aller-
gens from mites and other arthropods  [84, 85] . The sera 
from individuals allergic to mosquito bites react with sev-
eral common proteins present in the extracts of  C. quin-
quefasciatus ,  A. aegypti ,  A. albopictus and  Anopheles min-
imus , with molecular weights between 35.5 and 75.4 kDa 
 [19] . These results suggest that exposure to 1 species may 
induce sensitization to other species to which the indi-
vidual has not been previously exposed. In the province 
of Manitoba in Canada, the most prevalent mosquito spe-
cies and the main sensitizer is  A. vexans . Individuals al-
lergic to  A. vexans also show skin test reactivity to 5 other 
species not reported in Manitoba.
 Mosquito-allergic individuals in Shanghai in China 
also have specific IgE against  A. vexans allergens, de-
spite the fact that this species has not been reported in 
this region  [43, 44] . It can be speculated that, in these 
cases, allergen-specific immunotherapy with allergen 
extracts prepared from a single mosquito species might 
be sufficient to confer protection against other species. 
However, this should be carefully analyzed because spe-
cies-specific allergens may exist and participate in the 
sensitization process. Vaccine preparations lacking spe-
cies-specific allergens might thus be ineffective. A com-
ponent-based molecular diagnosis would be of great 
value in these cases.
 Rabbits immunized with rAed a 1 produce serum an-
tibodies that react with extracts from  A. vexans and 
 A.  albopictus  [44] , indicating that these 2 species have ho-
molog allergens to that which is present in  A. aegypti . In 
the salivary gland of  O. triseriatus and  O. hendersoni , a 
protein with apyrase activity has been detected; this might 
be a homolog of Aed a 1  [75] . Serum from rabbits immu-
nized with rAed a 2 also reacted with extracts of  C. quin-
quefasciatus ,  O. triseriatus and several species of  Aedes 
 [16, 44] , indicating the participation of this allergen in the 
cross-reactivity among these 3 species.
 C. quinquefasciatus ,  A. aegypti and  A. stephensi ex-
press D7 family proteins; 73.1% of sera with IgE reactiv-
ity to  C. quinquefasciatus also have specific IgE antibodies 
to whole-body extracts of  A. aegypti and  A. stephensi  [80] . 
The D7 family is highly conserved in many species of 
blood-sucking insects and mites (ticks), so it is possible 
that cross-reactivity among these species may involve this 
protein family.
 Studies of cross-reactivity between mosquitoes and 
wasps, dust mites, cockroaches and shrimp are scarce. 
However, some individuals develop the so-called ‘wasp/
mosquito syndrome’, which involves a cross-reactivity 
phenomenon between these species. Individuals afflict-
ed by this syndrome have specific IgE against a 44-kDa 
hyaluronidase in mosquitoes and wasps  [86] . The exis-
tence of cross-reactivity between chironomids and mos-
quitoes, based on the results of positive skin tests to 
 C. pipiens and serum IgE reactivity to  A. communis , has 
also been suggested in individuals allergic to chirono-
mids  [45] . A study conducted in Reykjavik, Iceland, 
showed that most individuals sensitized to  D. pteronys-
sinus also had specific IgE against mites  (Lepidoglyphus 
destructor) , shrimps and, to a lesser extent, cockroaches 
and mosquitoes  [87] . There were virtually no mites in 
the dust samples collected from mattresses in the homes 
of these individuals  [46] , indicating an absence of expo-
sure to mite allergens. The sensitization to mites in this 
population could therefore be attributed to exposure to 
cross-reactive allergens from mosquitoes or other ar-
thropods.
 Cross-allergenicity has important clinical and epide-
miological implications, such as polysensitization to var-
ious sources of allergens in the same or different taxo-
nomic groups. To circumvent this problem, a better diag-
nosis could be achieved by identifying the specific 
molecules involved in the allergic response, which may be 
performed using highly purified recombinant or natural 
allergens in order to define the IgE-binding profile of 
each patient. Component-resolved diagnosis would allow 
a component-resolved immunotherapy, in which only 
the allergens involved in sensitization could be adminis-
tered and not irrelevant allergens or nonallergenic mol-
ecules  [88] .
 Sensitization to arthropods seems to be a predisposing 
factor for the onset of cutaneous and allergic respiratory 
responses to mosquitoes. Cross-reactivity among mos-
quitoes and other arthropods has been suggested. How-
ever, the main allergens involved here have not been iden-
tified. In the tropics, mosquitoes and the mite species 
 D.  pteronyssinus and  B. tropicalis are very common. 
Therefore, it is probable that cross-reactivity between 
these arthropods may have an impact on the prevalence 
and manifestations of allergic diseases. We have shown 
that 40% of allergic individuals from the tropical Carib-
bean island, Martinique, have specific IgE against  A. ae-
gytpi . Furthermore, ELISA inhibition assays showed that 
 A. aegypti contains allergens that cross-react with  D. pter-
onyssinus allergens  [89] . Two tropomyosin isoallergens 
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(Uniprot code: Q17H75 and Q17H80) of 32 kDa purified 
from a whole-body mosquito extract reacted with 33% of 
the mosquito-positive sera. They also showed cross-reac-
tivity with the shrimp allergens: nPen m 1 and rLit v 1 
 [71] . These results confirm that there is a high frequency 
of sensitization to  A. aegytpi in mite- and shrimp-allergic 
individuals in Martinique. Species-specific as well as 
cross-reactive allergens, such as tropomyosin, are in-
volved in IgE sensitization.
 Allergen-Specific Immunotherapy 
 There are only a few studies on mosquito immuno-
therapy. The natural history of mosquito allergy suggests 
that after prolonged exposure to mosquito bites, desensi-
tization may occur. This is accompanied by a decrease in 
the serum levels of specific IgE and an increase in spe-
cific IgG antibodies  [21, 48] . The abundance of  A. com-
munis in Finland in the summer is accompanied by in-
creasing levels of IgE, IgG1 and IgG4 in the population. 
The increase in IgG subclasses may also play a protective 
role  [90] . These observations suggest that immunothera-
py with mosquito extracts or recombinant allergens could 
induce a protective response against subsequent expo-
sures. Several studies have shown that immunotherapy 
with allergen extracts is effective for treating mosquito 
allergy. In a group of 20 mosquito-allergic individuals 
with a positive skin test and positive specific IgE determi-
nations to  A. communis , the subcutaneous application of 
whole-body extract for 18 months induced the disappear-
ance of the skin lesions as well as respiratory and eye 
symptoms that appeared after the mosquito bite. The 
treatment also reduced the need for antiallergic medica-
tion. These effects were not observed in the control group 
that did not receive immunotherapy. No adverse reac-
tions occurred during the treatment  [91] . A randomized, 
double-blind, placebo-controlled trial showed that im-
munotherapy with extracts of  C. quinquefasciatus for 
1  year in 40 patients with asthma and/or rhinitis im-
proved allergic symptoms and decreased bronchial hy-
perreactivity  [92] . In addition, there was a slight decrease 
in IgE levels accompanied by a significant increase in 
IgG4, which is indicative of effective immunotherapy. 
These changes were not observed in the placebo group 
 [92] . Administration of mosquito extracts mixed with ex-
tracts of other insects has shown efficacy in treating al-
lergy to various insects. In another double-blind, place-
bo-controlled study, the group of patients treated for 
12 months with one or mixed extracts of cockroach, mos-
quito or fly, showed decreased skin test reactivity and 
lower IgE levels after the 12 months of immunotherapy. 
Moreover, skin test results, allergic symptoms and bron-
chial hyperreactivity were significantly lower in the group 
treated with the extract compared with the placebo group. 
The treatment induced significantly lower IgE and higher 
IgG4 levels than in the placebo group  [93] .
 Conclusions 
 Mosquito allergy is distributed worldwide, but is es-
pecially common in tropical regions and in areas where 
mosquitoes are abundant. Few studies have investigated 
the epidemiology and immunological mechanisms im-
plicated in mosquito allergy. Early efforts to identify 
mosquito allergens focused mainly on the saliva. It was 
assumed that the bites were the only source of exposure 
to their allergens. However, airborne mosquito allergens 
may also play a sensitizing role. Studies on the cross-
reactivity among different species of mosquito and oth-
er sources of allergens are scarce. However, the few 
available studies suggest an important degree of cross-
reactivity between mosquitoes and other arthropods. A 
small number of mosquito allergens have been obtained 
and characterized by molecular cloning. Two recombi-
nant allergens from  A. aegypti , Aed a 1 and Aed a 2, have 
been isolated and obtained as highly purified molecules. 
The rate of sensitization to these two allergens is often 
less than 50%, which suggests that other allergens may 
play an important role. Studies have shown that allergen 
immunotherapy with mosquito-allergenic extracts is ef-
fective. More research is needed to produce a more spe-
cific diagnosis and effective treatment for mosquito 
 allergies.
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IV. HYPOTHESIS 
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Aedes aegypti contains salivary as well as somatic allergens. Somatic allergens 
may comprise species specific as well as cross-reactive allergens.  
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A. Main objective 
The main objective of this thesis was to study the allergenic components from 
the mosquito Aedes aegypti in the immune response in humans and mice 
 
B. Specific objectives:  
The specific objectives of this thesis were to: 
1. Prepare whole body allergenic extracts from the mosquito species 
A. aegypti and analyse its total and IgE-binding protein spectrum 
using the sera from allergic individuals 
2. Analyse the allergenome of A. aegypti, from its proteome, 
separated by 2D-electrophoresis 
3. Purify natural IgE-binding tropomyosin from the whole body 
extract by high performance liquid chromatography. 
4. Characterize the identified IgE-binding proteins by Mass 
spectrometry approaches. 
5. Obtain at least two pure recombinant allergens by expression in 
bacteria and analyse their IgE-binding capacity 
6. Study the folding and allergenicity of the recombinant mosquito 
allergens, by circular dichroism and basophil activation test, 
respectively. 
7. Immunize mice with A. aegypti body extract and recombinant A. 
aegypti allergens 
8. Analyse the antibody, cytokine and proliferative response of the 
mice immunized with A. aegypti allergens 
9. Study the molecular and cellular cross-reactivity between A. 
aegypti and other arthropod-derived allergens, using the allergenic 
extracts and the purified allergens. 
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VI. RESULTS 
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A. Identification of novel IgE-binding proteins from the mosquito 
species A. aegypti using a proteomic approach 
 
In this part of the project, a comprehensive identification and characterization of 
mosquito allergens was achieved by a combination of 2-dimensional 
electrophoresis, immunoblotting and mass spectrometry. Ten different proteins 
were identified and their clinical significance in allergy diagnosis explored. Five 
identified allergens were deposited in the WHO/IUIS allergen nomenclature 
database under the names of Aed a 5, Aed a 6, Aed a 7, Aed a 8 and Aed a 11. 
The study of the role of mosquitoes in the pathophysiology of the allergic 
responses requires the identification of the IgE-binding molecules. Several 
approaches may be used for this purpose. We decided to apply proteomic tools 
that allowed the study of a large panel of molecules at the same time. The 
proteome and transcriptome of A. aegypti have been studied to discover 
potential receptors for insecticidal proteins, to understand the mechanisms of 
infection for some viruses, to study the molecular mechanisms associated with 
mosquito bites and find novel approaches to control the infestation of this 
mosquito. However, these tools had never been applied in the field of mosquito 
allergy research. The advantages of Proteomic sciences applied to allergy 
research is evidenced in studies with mites, fish, insects and chicken, leading to 
an important growth of the list of allergens from these species.  
For further information see the following paper: 
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Abstract
Background: Saliva and muscle-derived mosquito allergens have been purified and
characterized. However, the complete set of allergens remains to be elucidated. In
this study, we identified and characterized IgE-binding proteins from the mosquito
species Aedes aegypti.
Methods: Serum was obtained from 15 allergic individuals with asthma and/or
rhinitis and sensitized to mosquito. IgE binding was determined by ELISA. Total pro-
teins from freeze-dried bodies of A. aegypti were extracted and IgE-reactive proteins
were identified by 2D gel electrophoresis, followed by Western blot with pooled or
individual sera. IgE-reactive spots were further characterized by mass spectrometry.
Results: Twenty-five IgE-reactive spots were identified, corresponding to 10 differ-
ent proteins, some of which appeared as different variants or isoforms. Heat-shock
cognate 70 (HSC-70) and tropomyosin showed IgE reactivity with 60% of the sera,
lysosomal aspartic protease, and “AAEL006070-PA” (Uniprot: Q177P3) with 40%
and the other proteins with <33.3% of the sera. Different variants or isoforms of
tropomyosin, arginine or creatine kinase, glyceraldehyde-3-phosphate dehydroge-
nase (GPDH), calcium-binding protein, and phosphoglycerate mutase were also iden-
tified. The mixture of three allergens (Aed a 6, Aed a 8, and Aed a 10) seems to
identify more than 80% of A. aegypti-sensitized individuals, indicating that these
allergens should be considered when designing of improved mosquito allergy diag-
nostic tools.
Conclusions: The newly identified allergens may play a role in the pathophysiology
of mosquito allergy in the tropics, and some of them might be important arthropod-
related proteins involved in cross-reactivity between A. aegypti and other allergenic
arthropods.
K E YWORD S
Aedes aegypti, allergen, allergenome, insect allergy, mosquito
1 | INTRODUCTION
Allergic respiratory diseases affect 10-30% of the population world-
wide.1,2 Several arthropods, including house dust mites (HDM), cock-
roaches and shrimps, participate in the onset and severity of allergic
asthma, rhinitis, and other allergic diseases, such as food allergies.3-5
Mosquitoes are worldwide distributed6 and contain several IgE-bind-
ing proteins7; some of which cross-react with allergens from other
arthropods.8 Aedes aegypti is a mosquito that can spread dengue fever,
chikungunya, Zika fever, yellow fever viruses, and other diseases.9
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Aedes aegypti can also induce recurrent allergic cutaneous reac-
tions upon insect bites.7 Four saliva-derived allergens, Aed a 1 (apyr-
ase), Aed a 2 (D7 family protein), Aed a 3 (salivary protein), and Aed a
4 (a-glucosidase), are currently registered in the World Health Organi-
zation and International Union of Immunological Societies (WHO/IUIS)
Allergen Nomenclature data set (http://www.allergen.org). Up to 65%
of mosquito bite-allergic patients have specific IgE against a mixture of
Aed a 1, Aed a 2, and Aed a 3.10 We have previously reported a novel
nonsalivary allergen, Aed a 10 (tropomyosin), which cross-reacts with
other tropomyosins from several arthropods. IgE binding against Aed a
10 was demonstrated in allergic individuals with asthma and/or allergic
rhinitis.11 Aedes aegypti has additional IgE-binding proteins that remain
to be characterized. This insect contains at least eight allergens in the
saliva12 and Western blot studies with body extract revealed at least
12 allergens reacting with the sera from individuals with asthma, or
allergic rhinitis. The knowledge of the complete repertoire of allergens
from A. aegypti is limited, and further efforts for the identification and
characterization of these molecules are warranted.
In this study, we analyzed the allergenome of A. aegypti by 2D
electrophoresis and the combination of immunoblotting and MS. The
frequency of IgE binding of each protein was determined by
immunoblotting with individual sera.
2 | MATERIALS AND METHODS
2.1 | Serum samples
Serum was obtained from 15 allergic patients who attended an out-
patient Allergy Clinic in Fort de France, Martinique (Table 1). A
serum pool was prepared mixing equal volume of seven sera (# 3, 5,
8, 12, 13, 14, and 15), in order to have a more complete representa-
tion of specific IgE to the tested allergens. Serum was also obtained
from nonallergic individual with total IgE of 47 kU/L. All individuals
were skin-tested with a panel of common standardized inhalant aller-
gens and with a commercially available Aedes communis extract (Stal-
lergenes, Antony, France). Individuals who developed a wheal
>3 mm to the extracts were considered to have a positive skin prick
test (SPT). Serum was obtained after written consent in the context
of the approved study entitled: “Etude Epidemiologique des causes
Allergiques de l’asthme en Martinique,” funded and approved by
“Fonds de’aide a la qualite de soins de ville” from “la Caisse Generale
de securite sociale de la Martinique” and the “Comite departemental
de la Martinique contre les maladies respiratoires et la tubreculose
(CDMMRT).”
2.2 | Total protein extraction
Defatted and lyophilized A. aegypti mosquito bodies material was
purchased from GREER laboratories (Lenoir, NC, USA). Total protein
was extracted with ReadyPrepTM Protein Extraction Kit (Bio-Rad,
Hercules, CA, USA) following the manufacturer’s instructions. Briefly,
200 mg of mosquito were mixed with 2-D rehydration buffer, soni-
cated and centrifuged and the supernatant further treated with
ReadyPrep 2-D Cleanup Kit (Bio-Rad) following manufacturer’s
instructions. Briefly, sample was incubated with precipitating reagent
1 followed by precipitating reagent 2. The precipitate was washed
with wash reagent 1. The pellet was mixed with milliQ water and
incubated with wash reagent 2. The pellet was air-dried and
TABLE 1 Clinical details and sensitization profiles of 15 allergic individuals used in the study
Serum Age (years) Gender Diagnosis Total IgE IU/mL Specific IgE against Aedes aegypti (O.D.)
1 4 M Asthma, rhinitis, conjunctivitis 1659.0 0.511
2 5 F Asthma 1474.0 0.248
3 4 M Asthma, conjunctivitis 2187.0 0.458
4 4 F Rhinitis, conjunctivitis 2604.0 1.221
5 11 M Asthma, rhinitis, conjunctivitis 2095.4 1.679
6 6 M Rhinitis, conjunctivitis 552.00 0.513
7 4 F Asthma, rhinitis 429.58 1.111
8 27 F Rhinitis 545.50 0.355
9 3 M Rhinitis 2853.0 1.982
10 5 F Asthma, rhinitis, conjunctivitis 591.00 0.485
11 3 F Asthma, rhinitis 1615.0 0.573
12 6 M Rhinitis, conjunctivitis 647.00 0.501
13 31 M Rhinitis 97.400 0.382
14 9 M Asthma 1260.0 0.379
15 6 M Rhinitis 324.00 0.319
Mean 8.53 60% M 1433.3 0.714
F, female; M, male.
O.D.: optical density, measured by ELISA.
All patients developed a wheal diameter >3 mm after skin prick test with extracts of Aedes communis, D. pteronyssinus, D. farinae, Blomia tropicalis,
shrimp, and cockroach.
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resuspended with ReadyPrep 2D rehydration/sample buffer (8 mol/L
urea, 2% CHAPS, 50 mmol/L DTT, 0.2% Bio-Lyte 3/10 ampholyte,
0.001% bromophenol blue). Protein concentration was measured
using RC DC Protein Assay (Bio-Rad).
2.3 | 2D electrophoresis
Isoelectric focusing (IEF) was performed using 11 cm, pH 3-10 lin-
ear IPG strips (Bio-Rad). Strips were rehydrated with 200 lL of
rehydration buffer containing 200 lg of protein, at room tempera-
ture. Proteins were focused at 50 lA/IPG strip for a total of
26 000 V/h at 20°C using the PROTEAN i12 IEF System (Bio-
Rad). After focusing, the strips were washed 10 minutes in equili-
bration buffer 1 containing 6 mol/L urea, 20% v/v glycerol, 2% w/
v SDS, 0.375 mol/L Tris-HCl (pH 8.8), and 2% DTT, followed by
equilibration buffer 2 containing 6 mol/L urea, 20% v/v glycerol,
2% w/v SDS, 0.375 mol/L Tris-HCl (pH 8.8), and 2.5% w/v
iodoacetamide. Afterward, IPG strips were washed with SDS-PAGE
running buffer (25 mmol/L Tris, 192 mmol/L glycine, and 0.1%
SDS) and applied onto the top of 12.5%, 11 cm, Criterion TGX
Precast Gels (Bio-Rad). Strips were covered with ReadyPrep Over-
lay Agarose (Bio-Rad) and electrophoresis performed at 200 V for
65 minutes. Gels were stained with GelCode Blue stain reagent
(Life Technologies, Carlsbad, CA, USA). Precision Plus Protein Stan-
dard Plugs (Bio-Rad) were used to determine the molecular
weights.
2.4 | SDS-PAGE, IgE immunoblot and inhibition
analysis
Proteins from A. aegypti were separated by one-dimensional elec-
trophoresis. Proteins from the one-dimensional and two-dimensional
gel electrophoresis were electrotransferred to nitrocellulose mem-
branes and IgE binding evaluated using the serum pool or individual
sera as described in.11
For the inhibition experiments, proteins from the one-dimen-
sional gel electrophoresis were electrotransferred to nitrocellulose
membranes and incubated with sera 1 and 5, previously adsorbed
with 10 lg/mL of rAed a 10.0101 or rAed a 10.0201, obtained as
described in.11 Specific IgE binding was detected as described previ-
ously.
2.5 | Selection of specific IgE binding spots
Coomassie-stained and immunoblotted 2D gels were compared using
GeneTools image analysis software (Synoptics, Cambridge, UK). Each
immunoreactive spot was located on the image of the corresponding
immunoblot and Coomassie-stained gel. The molecular mass and iso-
electric point (IEP) of each spot were calculated by comparison with
the standard and the IEP gradient. Each spot detected in the immu-
noblot was compared with a grid after alignment with the Coomas-
sie-stained gel. Spots that matched with similar molecular weight
and IEP were further characterized by MS.
2.6 | MS analysis
Spots of interest from 2DE were excised and analyzed using either
peptide mass fingerprint (PMF) or peptide fragment fingerprint (PFF);
at the CIC bioGUNE, Derio, Spain.
2.7 | Tryptic digestion
Gel spots were washed with 50 mmol/L ammonium bicarbonate,
incubated with DTT (10 mmol/L in ammonium bicarbonate) at 56°C
for 20 minutes, followed by iodoacetamide (50 mmol/L in ammo-
nium bicarbonate) for 20 minutes in the dark. Spots were dried and
incubated with trypsin (12.5 lg/mL, in ammonium bicarbonate,
10 lL) for 20 minutes on ice. After rehydration, the supernatant was
discarded. Gel pieces were incubated overnight at 37°C. After diges-
tion, acidic peptides were extracted with 0.1% TFA and dried in a
RVC2 25 Speedvac concentrator (Christ, Germany).
2.8 | PMF analysis
Peptide mass fingerprint analysis was performed using matrix-
assisted laser desorption time of flight (MALDI-ToF/ToF) equipment
in a MALDI-LIFT-ToF AUTOFLEX III Smartbeam (Bruker Daltonics,
Billerica, MA, USA). One microliter of digested sample was loaded
onto a target plate (Bruker 384 ground steel) with 1 lL of HCCA
matrix. Data-dependent MS acquisitions were performed with charge
state of 1 over a survey m/z range of 500-4000. Ionization was per-
formed with a solid-state laser of 360 nm and 200 Hz. Laser inten-
sity energies were varied depending on the analysis required. For
MS, 30-50% of intensity was used and around 90% for MS/MS. Res-
olution was always over 7500 along all mass-window range for MS
analysis. Data acquisition was performed manually. Routinely 1400
scans were collected for PMF, whereas the most intense peaks were
selected for MS/MS (400 scans for parent selection and 1600 scans
for fragments). Calibration was performed externally, with pepmix
(Bruker Daltonics), and internally, with trypsin peptides.
The spectra obtained were processed using Flex analysis 3.0 and
Biotools 3.2 (Bruker Daltonics). Database searching was performed
using MASCOT 2.2.07 (Matrixscience, London, UK) against a custom
database filled with all the Uniprot entries corresponding to A. ae-
gypti (16 654 sequences; 7 684 696 residues). For identifications
where one peptide was assigned to protein, data were researched
against SwissProt (Uniprot) (546 439 sequences; 194 445 396 resi-
dues), and NCBI (51 471 198 sequences; 18 460 256 539 residues)
databases to confirm the identification. In all searches, for protein
identification the following parameters were adopted: car-
bamidomethylation of cysteine (C) as fixed modification and oxida-
tion of methionine (M) as variable modifications, 50 ppm of peptide
mass tolerance, 0.7 Da fragment mass tolerance and up to two
missed cleavage points.
Spots not identified by PMF, or identified with poor confidence
were re-analyzed by PFF using nano-liquid chromatography-tandem
mass spectrometry (nLC-MS/MS).
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2.9 | PFF analysis
Separation of tryptic peptides was performed using NanoAcquity
nano-LC (Waters Corporation, Milford, MA, USA) equipment, on a
Waters BEH C18 nano-column (200 mm 9 75 lm ID, 1.8 lm). Pep-
tide elution was performed using a chromatographic ramp from 5%
to 60% of mobile phase B during 30 minutes, and flow rate of
300 nL/min. Mobile phase A was water containing 0.1% v/v formic
acid, while mobile phase B was acetonitrile containing 0.1% v/v for-
mic acid. MS data were obtained on a Synapt G2Si ESI Q-Mobility-
TOF spectrometer (Waters) equipped with an ion mobility chamber
(T-Wave-IMS) for high-definition data acquisition analyses. All analy-
ses were performed in positive ESI mode. A lock mass compound
[Glu1]-Fibrinopeptide B (100 fmol/lL) was delivered by an auxiliary
pump of the LC system at 500 nL/min to the reference sprayer of
the NanoLockSpray (Waters) source of the mass spectrometer. Data
were postacquisition lock mass-corrected using the double charged
monoisotopic ion of [Glu1]-Fibrinopeptide B. Accurate mass LC-MS
data were collected in HDMS mode which enhances signal intensi-
ties using the ion mobility separation. Database searching was per-
formed using MASCOT 2.2.07 (Matrixscience) against a custom
database filled with all the UNIPROT entries corresponding to A. ae-
gypti (16 654 sequences; 7 684 696 residues). For protein identifica-
tion, the following parameters were adopted: carbamidomethylation
of cysteine (C) as fixed modification and oxidation of methionine as
variable modifications, 10 ppm of peptide mass tolerance, 0.5 Da
fragment mass tolerance and up to 1 missed cleavage points, and
peptide charges of +2 and +3.
2.10 | Allergenicity test and bioinformatic analysis
Frequency of IgE binding for each spot was determined in the immu-
noblots with all individual sera. Bioinformatics analysis to predict
potential allergenicity were performed using: (i) Allertop V.2 (http://
www.ddgpharmfac.net/AllerTOP)13 which is based on amino acid
descriptors, accounting for residue hydrophobicity, size, abundance,
helix and b-strand forming propensities, (ii) PREAL (http://gmobl.
sjtu.edu.cn/PREAL/index.php),14 which integrates various properties
of proteins, such as biochemical and physicochemical properties,
sequential features and subcellular locations, and (iii) Algpred (http://
www.imtech.res.in/raghava/algpred/)15 which predicts based on sim-
ilarity of known epitope with any region of protein.
3 | RESULTS
3.1 | Proteomic identification of IgE-reactive
proteins
The proteome profile of A. aegypti was obtained by 2D elec-
trophoresis in the IEP range of 3-10 (Figure 1A). Specific IgE
immunoblots were performed after incubation with the serum
pool (Figure 1B). Twenty-five IgE immunoreactive spots were
selected and further analyzed by MS. Immunoblot of a 2D gel
with serum from one nonallergic individual showed no IgE bind-
ing (Figure 1C).
Twenty spots were characterized by PMF. Sixteen belonged to
A. aegypti and showed significant score after Uniprot database
searching. Four proteins showed homology with proteins from A. ae-
gypti and other insects. Their identities were confirmed after Swis-
sProt or NCBI database searching. MS/MS spectra were acquired
from the 20 spots, and identification was further confirmed with the
deduced peptide sequence. Five spots that were not characterized
by PMF were subjected to PFF analysis. Identification was achieved
after database searching against Uniprot.
The 25 spots corresponded to 10 different proteins. Spot nos. 6-
12, 13-17, 19-20, and 21-23 consisted of isoforms or variants with
similar molecular weight and different IEP (Table 2 and Figure 1).
The sequences of these proteins were previously inferred from
genes that were identified in the A. aegypti genome and deposited in
the Uniprot database.16 Except for tropomyosin,11 their natural
counterparts have not been previously identified, purified, or
studied.
Among the identified IgE-reactive proteins, tropomyosin was the
only previously known allergen, named as Aed a 10, with two vari-
ants (Aed a 10.0101 and Aed a 10.0201).11 Two spots (no. 1 and no.
5) corresponded to lysosomal aspartic protease and heat-shock cog-
nate 70 (HSC-70), respectively. Other spots corresponded to pro-
teins with ATP-binding activity (no. 4), calcium ion binding activity
(no. 18), phosphoglycerate mutase activity (nos. 21-23), and voltage-
dependent anion-selective channel activity (no. 24). Variants or iso-
forms of “arginine or creatine kinase” (Uniprot code: Q1HR67) (nos.
6-12) and glyceraldehyde-3-phosphate dehydrogenase (GPDH) (Uni-
prot code: J9HYM2) (nos. 13-17). A hypothetical protein (Uniprot
code: Q16TN9) was also identified (no. 25).
3.2 | Relevance of tropomyosin family in the IgE-
binding protein repertoire of Aedes aegypti
In order to further study the relevance of tropomyosin family in the
IgE-binding protein repertoire, we performed an immunoblotting
inhibition with 2 individual sera, using rAed a 10.0101 and rAed a
10.0201 as inhibitors. Pre-incubation with rAed a 10.0101 inhibited
the IgE binding of the 32 kDa band, which represent the native mos-
quito tropomyosin. rAed a 10.0201 produced partial reduction of the
IgE binding. No changes in the IgE-binding capacity to more than 10
different bands were detected (Figure 1D).
3.3 | Frequency of specific IgE binding
A variable pattern of IgE binding among the individual sera was
observed (Figure 2). We classified a protein as “major allergen” if it
reacted with >50% of sera.17 Tropomyosin and HSC-70 could be
major allergens, as they reacted with 60% of the sera (Table 3).
Lysosomal aspartic protease and “AAEL006070-PA” (Uniprot code:
Q177P3) reacted with 40% of the sera. The other six proteins
reacted with <26.7% of the sera. “Arginine or creatine kinase” and
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GPDH had a lower frequency of IgE binding (13.3% and 6.7%,
respectively). However, the intensity of reactivity to the isoforms or
variants of GPDH was different. Spots 14, 15, and 16 were those
with the highest color intensity. No IgE binding was detected with
the control serum.
Based on the frequency of IgE binding, it seems that there are
no immunodominant allergens in A. aegypti. The combination of the
two tropomyosin variants (Aed a 10.0101 and Aed a 10.0201) and
HSC-70 recognized IgE binding in 11 of 15 patients (73.33%). Add-
ing Aed a 6 (spot no. 24), the percentage increased to 86.7%
(Table 3).
3.4 | Novel Aedes aegypti allergens
The WHO/IUIS Allergen Nomenclature Subcommittee (www.allerge
n.org) has assigned official names to five proteins identified in this
study: Aed a 11.0101 for Q03168 (lysosomal aspartic protease), Aed
a 5.0101 for Q16XK7 (sarcoplasmic Ca+ (EF-hand) binding protein),
Aed a 6.0101 for Q1HR57 (Porin 3), Aed a 7.0101 for Q16TN9, and
Aed a 8.0101 for Q1HR69 (HSC-70) (Table 4).
Bioinformatic analysis using Allertop, PREAL, and ALGPRED pre-
dicted that Aed a 8 is an allergen (Table 3). Multiple sequence align-
ment between Aed a 8 and HSP-70 protein from Dermatophagoides
pteronyssinus,18 Cladosporium herbarum,19 and Penicillium citrinum 20
showed that the overall sequences are highly conserved (Data not
shown). Aed a 5 was predicted as an allergen by Algpred and PREAL
and Aed a 6 by Allertop and Algpred (Table 3).
4 | DISCUSSION
The proteome and transcriptome of A. aegypti have been studied to:
(i) discover potential receptors for insecticidal proteins,21,22 (ii)
understand the mechanisms of infection for some viruses,23,24 (iii)
study the molecular mechanisms associated with mosquito bites,25,26
and (iv) find novel approaches to control the infestation of this mos-
quito.27 However, to the best of our knowledge, the present study is
the first that uses proteomic tools to contribute to the understand-
ing of the role of A. aegypti in allergic diseases, by the elucidation of
its allergenic components. The proteomic approach used represents
an accurate and high-resolution procedure to identify new allergens,
which has been useful to identify food allergens28,29 and allergenic
components from Dermatophagoides farinae,18 Aspergillus fumigatus,30
insect venom,31 and cockroach.32
The manifestation of mosquito allergy is a matter of controversy.
We hypothesize that mosquito allergens are distributed in the body
F IGURE 1 Two-dimensional gel electrophoresis of total proteins from Aedes aegypti. (A) Spots were identified by Coomassie stain, and (B)
specific IgE immunoblot using pooled sera. (C) Serum from a nonallergic individual did not show any significant binding. The proteins showing
immunoreactivity are marked with arrows. Immunoblotting indicating IgE binding of A. aegypti extract (D1) and inhibition assays using rAed a
10.0101 (D2) or rAed a 10.0201 (D3) as inhibitors. Adsorption of sera with 10 lg/ml of recombinant tropomyosins abrogated the reactivity
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and not only in the saliva, as patients with respiratory tract allergic
reactions have specific IgE against body components.
The genome of A. aegypti contains 11 genes which codify for
tropomyosin isoforms and variants.16 We have previously reported
the presence of four of these tropomyosins.11 Two of them
correspond to Aed a 10.0101 and Aed 10.0201 allergens. Spot no. 2
was identified as Aed a 10.0101, and the data suggest that spot no.
3 corresponds to tropomyosins with Uniprot codes Q17H80 and
Q17H82. We were not able to differentiate these variants as no
unique peptides were obtained. However, we hypothesize that spot
F IGURE 2 Specific IgE immunoblot of total proteins from Aedes aegypti, using individual sera. The immunoblots correspond to patient
numbers 1-15. The proteins showing immunoreactivity are marked with arrows and boxes
TABLE 3 Allergenicity of Aedes aegypti components based on the serum IgE reactivity in 15 individuals with respiratory allergies
Spot Protein name
Patient
Frequency of
reactivity (%) Predicted as allergen by1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
1 Lysosomal aspartic protease + + + + + + 40 Nonevaluated
2 Tropomyosin + + + + + + + + + 60 Allertop, PREAL, ALGPRED
3 Tropomyosin + + + + + + + + + 60 Allertop, PREAL, ALGPRED
4 AAEL011197-PA 0 Nonevaluated
5 HSC-70 + + + + + + + + + 60 Allertop, PREAL, ALGPRED
6-12 Arginine or creatine kinase + + 13.3 Nonevaluated
13-17 GPDH + 6.7 Nonevaluated
18 AAEL008844-PA + + + + 26.7 PREAL, ALGPRED
19-20 Tropomyosin + + + + + + 40 Nonevaluated
21-23 AAEL006070-PA 0 Nonevaluated
24 AAEL001872-PA + + + + 26.7 Allertop, ALGPRED
25 AAEL010180-PA + + + + 26.7 Nonevaluated
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no. 3 corresponds to Aed a 10.0201 (Q17H80). Proteins on spot
nos. 19 and 20 appear with apparent molecular weights of 56.9 kDa
and IEP of 4.9 and 5.1. Peptide information suggests that they corre-
spond to tropomyosin Q17H75, or Q17H76. According to this infor-
mation, we believe that it could correspond to a dimer of Aed a
10.0101 (Q17H75).
We have also identified lysosomal aspartic protease (Aed a 4), an
allergen with homologues in A. fumigatus (Asp f 10), Blatella german-
ica (Bla g 2), and Periplaneta americana (Per a 2); 26% of patients
with allergic bronchopulmonary aspergillosis had specific IgE against
Asp f 10.30 In a cockroach-allergic population, Bla g 2 and Per a 2
showed frequency of IgE binding of 57.6%-63.4%.33,34 The 40% of
frequency of reactivity found in this study suggest that Aed a 4 is a
minor allergen.
Aed a 8 is a member of the Heat-shock protein-70 (Hsp70) fam-
ily, which are exploited by dengue virus35 and mosquito-borne fla-
viviruses (encephalitis virus)36 to attach and penetrate mosquito
cells. Hsp70 allergens have been reported in cockroach37 and D. fari-
nae.18 Aed a 8 reacted with the IgE of 60% of the tested sera and it
could represent a major allergen. Similar frequency of reactivity was
observed with Hsp70 from D. farinae.18 Our results suggest that Aed
a 8 is a pan-allergen which deserves further study.
Other potential pan-allergens identified in this study are the
“arginine or creatine kinase” and GPDH. Arginine kinase in mites
belongs to group 20 allergens38 and in shrimp to group 2.39 Argi-
nine kinases from Canis familiaris (dog), Bombyx mori (Silk moth),
Crangon crangon (North Sea shrimp), P. americana and Plodia inter-
punctella (Indian meal moth) are registered in the IUIS allergen
database and detected in insects, shrimp, and wasps.31,40,41 GPDH
has been reported with IgE binding in insects, Gryllus bimacula-
tus,40 banana shrimps, Fenneropenaeus merguiensis,41 Asian wasps,
and Vespa affinis.31 We found that these proteins have an IgE
binding ranging from 6.7% to 13.3%, suggesting that they are
minor allergens.
One of the ultimate goals in allergy research is to implement a
comprehensive panel of component-resolved diagnosis. This requires
the identification and characterization of a complete set of allergens
from the allergenic source and might be hampered by the presence
of cross-reactive molecules which could drive to false-positive
results. We have demonstrated that A. aegypti represents a source
of several IgE-binding proteins. We suggest that a mixture of three
allergens (Aed a 6, Aed a 8, and Aed a 10) may be enough to iden-
tify more than 80% of A. aegypti-allergic individuals. Although these
findings may have a potential clinical implication, they must be con-
firmed in studies using purified natural or recombinant allergens in
well-defined patient populations. Further biochemical, structural, and
immunological studies are necessary to perform a comprehensive
characterization of the complete set of allergens from A. aegypti and
define their clinical relevance.
In a previous publication, we reported that the tropomyosin vari-
ant Aed a 10.0101 may contain the complete repertoire of IgE epi-
topes from the mosquito tropomyosin family.11 The results from our
study confirmed this observation, as rAed a 10.0101 produced
complete inhibition of the IgE binding to the 32 kDa band (which
represents the natural mosquito tropomyosins), while rAed a
10.0201 produced partial inhibition. Furthermore, this experiment
demonstrated that the IgE binding of tropomyosin has no effect on
the reactivity to the rest of the allergens, highlighting the relevance
of these molecules. Interestingly, we found that specific IgE from
patient 8 binds to Aed a 10.0201 but not to Aed a 10.0101 (Fig-
ure 2 and Table 3), suggesting that both tropomyosins should be
considered.
In conclusion, we have identified and characterized a set of
allergens from the mosquito species A. aegypti. Four proteins
with homology to different allergen groups from other allergen
sources were identified, which together with tropomyosin may
partially explain the basis of the cross-reactivity between mos-
quito and other arthropods. Additionally, four proteins with
inferred biological function and one without known biological
function were also identified. Previous studies had focused on
the saliva and salivary glands of A. aegypti, and four allergens
have been reported as factors associated with the cutaneous
reactions that appear after mosquito bites.10,42-45 In this study,
we did not detect these allergens as we used sera from individu-
als with respiratory allergy. We hypothesize that different aller-
genic components may be involved in the variable manifestations
of mosquito allergy. Our results provide a basis for a more com-
prehensive understanding of the relationship between allergens in
A. aegypti and in other arthropod species.
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B. Production and purification of A. aegypti allergens and 
characterization of their molecular and immunological properties 
 
In this part of the thesis, we purified native tropomyosin (Aed a 10) and 
expressed rAed a 8. Obtaining purified natural allergens is the most convenient 
way to study their role in allergies. In the case of mosquito allergens, this task is 
difficult given the low availability of pharmaceutical grade source materials 
(mainly whole mosquito bodies) and the problems associated to the purification 
protocols, which usually requires specialized laboratory infrastructure and is 
time consuming. Molecular cloning is one of the best options to circumvent 
these inconvenients. However, some allergens are highly represented in the 
extracts of other sources and the purification of the natural molecules is a good 
option. 
Tropomyosin from A. aegypti is present in a high amount in the whole 
body extract. We applied a combination of chromatographic techniques for the 
purification of this allergen. The results revealed that this allergen corresponds 
to a mixture of at least four variants with IgE-binding capacity. Two variants 
seem to be most abundant. These allergens were obtained as recombinant 
molecules. Direct ELISA and ELISA inhibition experiments, and immunoblots 
allowed the characterization of these molecules. The two tropomyosins were 
accepted as allergens by the WHO/IUIS allergen nomenclature database with 
the names of Aed a 10.0101 and Aed a 10.0201. 
The study of the Allergenome of A. aegypti revealed that Aed a 8 (Heat 
shock cognate-70) may represent a major allergen. The recombinant version of 
this allergen was expressed in E. coli and used to study its antibody binding 
properties. rAed a 8 was used to immunize mice and to study the immune 
response induced by this molecule. The results showed that rAed a 8 is 
immunogenic and has IgE and IgG-binding capacity. The response induced in 
mice was characterized by high levels of IgG2a, which indicates a possible 
immune-regulatory effect. 
For further information see the following papers: 
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of 4 of the 12 (33%) allergic patients and with rabbit poly-
clonal anti-shrimp tropomyosin. A high degree of cross-re-
activity (60–70%) was detected between natural mosquito 
tropomyosin and Blo t 10, Der p 10 and Lit v 1, and a lower 
degree with Asc l 3 from  A. lumbricoides (<30%). rAed a 
10.0101 inhibited IgE binding to natural  A. aegypti tropomy-
osin; however, rAed a 10.0201 showed a low inhibitory ca-
pacity.  Conclusion: Tropomyosin is a new IgE-binding pro-
tein from  A. aegypti . Two of the 4 variants identified showed 
different degree of cross-reactivity with tropomyosins from 
other arthropods. The potential allergenic role of each vari-
ant should be further investigated.  © 2016 S. Karger AG, Basel 
 Introduction 
 Mosquitoes are insects that are distributed worldwide, 
and they cause IgE-mediated allergic responses in sensi-
tized individuals  [1] . Manifestations of mosquito allergy 
are variable and depend on the route of exposure. When 
the contact with the allergens occurs via skin bites (saliva 
allergens), the symptoms consist of mild or severe local 
or systemic reactions  [1–4] . However, evidence suggests 
 Key Words 
 Aedes aegypti · IgE cross-reactivity · Mosquito allergy · 
Tropomyosin 
 Abstract 
 Background: The mosquito  Aedes aegypti is a potential 
source of important clinically relevant allergens. However, 
the allergenicity and cross-reactivity of most of these has not 
been fully described.  Methods: Natural wild-type mosquito 
tropomyosin was purified by size exclusion and anionic-ex-
change chromatography from an  A. aegypti extract. Further 
characterization was accomplished by MALDI-TOF/TOF. Two 
recombinant variants of tropomyosin were obtained by ex-
pression in  Escherichia coli . Specific IgE measurement by 
 ELISA and skin tests for mosquito extract were performed in 
12 patients with asthma or allergy rhinitis residing on the 
Caribbean island of Martinique. Cross-reactivity between 
natural  A. aegypti tropomyosin and recombinant tropomyo-
sins from  A. aegypti , house dust mite, shrimp and  Ascaris lum-
bricoides was analyzed by ELISA competition.  Results: Four 
variants of natural tropomyosin were purified. A band of
32 kDa in SDS-PAGE representing 2 tropomyosin variants 
(Aed a 10.0101 and Aed a 10.0201) reacted with specific IgE 
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that the inhalation of mosquito emanations and detritus 
deposited in house dust may induce allergic respiratory 
symptoms such as allergic asthma and rhinitis  [5] . This is 
supported by epidemiological studies which show that 
2.5–47% of individuals with asthma and/or allergic rhini-
tis are sensitized to mosquito allergens  [6–8] .
 We found that sera obtained from a cohort of patients 
residing on the Caribbean island of Martinique suffering 
from allergic respiratory symptoms after the inhalation of 
house dust mite allergens recognize several allergens from 
 Aedes aegypti  [9] . We have also demonstrated cross-reac-
tivity between  A. aegypti and house dust mites, shrimp 
and cockroach extracts  [10] . These findings suggest that 
 A. aegypti may contain allergens that participate in the 
pathogenesis of respiratory allergies as inducers of a Th2 
response, and the subsequent development of allergic 
symptoms or as a modulator of the immune response es-
tablished against mites, shrimp and/or cockroaches.
 Tropomyosin is a pan-allergen that belongs to a fam-
ily of phylogenetically conserved proteins with multiple 
isoforms present in both the muscle and nonmuscle cells 
of vertebrates and invertebrates  [11] . Allergenic tropo-
myosins have been described in crustaceans, molluscs, ar-
thropods, insects and helminths  [12–17] . The participa-
tion of tropomyosin in cross-reactivity between mites, 
cockroaches and shrimps has been demonstrated. De-
spite the functional and structural similarity of tropo-
myosins, several of their presentations are nonallergenic 
 [18] . In some regions of tropical countries where allergies 
to arthropods are common, most individuals are exposed 
concomitantly to other tropomyosin sources, such as 
those from helminths. This coexposure may have clinical 
implications, either by modulating  [19, 20] or exacerbat-
ing  [21–23] a previously mounted allergic response. In 
these regions,  A. aegypti and other mosquito species are 
highly prevalent. 
 The aim of this study was to purify natural wild-type 
 A. aegypti tropomyosin variants and to characterize the 
IgE-binding capacity of these molecules. As further char-
acterization, we cloned and expressed 2 full-length re-
combinant tropomyosin variants and compared their an-
tibody-binding capacity with natural tropomyosin. 
 Methods 
 Sera 
 Sera were obtained from 24 (14 males and 10 females) allergic 
patients who attended an outpatient Allergy Clinic in Fort de 
France, Martinique. All patients were skin tested with a panel of 
common standardized inhalant allergens and with a commercially 
available  Aedes communis extract (Stallergènes, Antony, France). 
Patients who developed a wheal diameter >3 mm to the extracts 
were considered to have a positive skin prick test. Twelve of these 
patients had a test that was positive to mosquito extract and other 
arthropods ( table 1 ). Sera were obtained after written consent was 
signed in the context of the study, entitled: ‘Etude Epidémiologique 
des causes Allergiques de l’asthme en Martinique’, which was 
funded and approved by ‘Fonds de’aide à la qualite de soins de ville’ 
from ‘la Caisse Generale de Securite Sociale de la Martinique’ and 
the ‘Comite Departemental de la Martinique contre les maladies 
respiratoires et la tuberculose (CDMMRT)’.
 Preparation of A. aegypti Extract 
 Lyophilized and defatted  A. aegypti raw material was pur-
chased from GREER Labs (Lenoir, N.C., USA) and extracted 1: 40 
overnight (ON) with 0.1  M PBS, pH 7.2 at 4  °  C with constant stir-
ring. After extraction, the mixture was centrifuged at 10,000 rpm 
over 10 min, the supernatant was filtered through a 0.2-μm mem-
brane, dialyzed against distilled water in a 3,500-Da cut-off mem-
brane (Spectra/Por Dialysis Membranes, Houston, Tex., USA) and 
lyophilized until usage. The protein concentration was determined 
by Bradford assay. 
 Shrimp, Mite and Nematode Recombinant Tropomyosins 
 Production of recombinant (r) tropomyosin from the white 
shrimp  Litopenaeus vannamei  (rLit v 1) was performed as follows: 
the nucleotide sequence of tropomyosin of  L. vannamei (GenBank 
EU410072.1) was optimized for codon utilization in an  Escherich-
ia coli expression system, obtained by gene synthesis and cloned 
into the expression vector pET45b+ by GenScript (Piscataway, N.J. 
USA). A single colony of transformed  E. coli BL21 was grown over-
night at 37   °   C in LB medium with ampicillin (LBA). Afterwards, 
the culture was diluted 1: 20 in LBA and grown at 37  °  C to an OD 600 
of 0.5 nm. Protein expression was induced with 1 m M isopropyl-
β-D-thiogalactopyranoside (IPTG) for 4 h. A cell pellet was col-
lected by centrifugation and resuspended in denaturating binding 
buffer (pH 7.8) and then sonicated. His-tagged protein was puri-
fied on an Ni-NTA column under hybrid conditions (ProBond 
Purification System, Invitrogen), lyophilized and stored at –20  °  C. 
Production of recombinant tropomyosins from the mites  Derma-
tophagoides pteronyssinus (rDer p10),  Blomia tropicalis (rBlo t 10) 
and  A. lumbricoides (rAsc l 3) was performed as previously de-
scribed  [17, 24] .
 Purification of Natural Wild-Type Tropomyosin from 
A. aegypti  
 Purification was performed in 2 sequential steps consisting of 
gel filtration and ionic-exchange high-performance liquid chro-
matography. In the first step, the lyophilized whole-body mosqui-
to extract was reconstituted in 2 ml of 0.1  M PBS to a final concen-
tration of 6 mg/ml, filtered through a 0.2-μm membrane and pre-
purified by gel filtration in a HiLoad Superdex 75 prep grade, 
16/600-cm column (GE Healthcare Life Sciences, Amersham, 
UK). The molecule of interest was eluted by applying 0.1  M PBS at 
a flow of 1 ml/min, and the detection was performed at a wave-
length of 280 nm. Several fractions were collected and analyzed by 
SDS-PAGE under reducing conditions. Fractions containing the 
band of 32 KDa were dialyzed in a 3,500-Da cut-off membrane 
(Spectra/Por) against water and lyophilized for further purifica-
tion by anion-exchange chromatography. The mobile phases were 
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phase A: 10 m M sodium phosphate buffer (pH 6.0) and phase B: 
10 m M sodium phosphate buffer (pH 6.0) with 1.0  M NaCl. The 
lyophilized fraction was reconstituted in phase A and injected onto 
a HiPrep QFF 16/10 cm column (GE Healthcare Life Sciences). 
The removal of unbound molecules was carried out in a cleaning 
step with phase A. Bound proteins were eluted through a binary 
gradient of phase A and B at a flow of 3 ml/min, and the detection 
was performed at a wavelength of 280 nm. Fractions correspond-
ing to the peaks that appear between 0.30 and 0.45  M NaCl were 
dialyzed against water and lyophilized for further analysis.
 Passive Elution of Tropomyosin from Electrophoresed Gels 
 The fraction obtained from the HiPreP QFF column showed 4 
main bands, with the 32-kDa band being the most intense. To fur-
ther purify this band, the sample was separated by SDS-PAGE un-
der reducing conditions and the band was excised from the stained 
gel with a clean razor. Gel pieces were placed in microcentrifuge 
tubes, immersed in elution buffer (50 m M Tris-HCl, 150 m M NaCl 
and 0.1 m M EDTA, pH 7.5), crushed using a clean pestle and then 
incubated in a rotary shaker at 37   °   C ON. The eluted protein was 
recovered by centrifugation at 10,000 rpm and filtration through a 
0.45-μm membrane. Eluted protein was further characterized by 
ELISA, ELISA competition and mass spectrometry (MS). 
 SDS-PAGE and Immunoblotting  
 The mosquito extract and purified fractions were separated by 
SDS-PAGE under denaturing conditions using a Mini-PROTEAN 
II apparatus (Bio-Rad, Hercules, Calif., USA). Ten micrograms of 
extract or 2 μg of the purified proteins per slot were separated in 
12% polyacrylamide gels at 120 volts, and the gels were stained 
with GelCode Blue stain reagent (Life Technologies, Carlsbad, Cal-
if., USA). For immunoblot, proteins were electrotransferred from 
the polyacrilamide gel onto 0.45-μm nitrocellulose membranes us-
ing a Trans-Blot Semi-Dry electrophoresis transfer cell (Bio-Rad), 
at 20 v, and blocked with PBS (pH 7.4) and 0.25% Tween 20 (PBS-
T), containing 5% BSA. Membranes were washed twice with PBS-
T and incubated with pooled sera (sera 3, 5, 8 and 9;  table 1 ) from 
allergic individuals, diluted 1: 10 in PBS-T containing 1% BSA for 
2 h at 4  °  C. After washing with PBS-T, the membranes were incu-
bated with 1: 2,000 diluted horseradish peroxidase (HRP)-conju-
gated mouse anti-human IgE Fc (SouthernBiotech Birmingham, 
Ala., USA) for 1 h at 4  °  C, washed again, and then incubated with 
ECL prime detection reagent (Ge Healthcare Life Sciences). Che-
miluminescence was detected using GeneGnome apparatus (Syn-
gene, Cambridge, UK). Otherwise, for the detection of tropomyo-
sin, the electrotransferred and blocked membranes were incubated 
with 1: 5,000 diluted polyclonal antibodies obtained from rabbits 
immunized with shrimp tropomyosin (Pen m 1; Bial Aristegui, 
Lisbon, Portugal), that can also bind to tropomyosins from other 
sources  [12, 25, 26] , and 1: 2,000 diluted HRP-conjugated anti-rab-
bit IgG (Sigma-Aldrich, St. Louis, Mo., USA). Detection of bands 
was performed as above.
 For inhibition experiments with shrimp tropomyosin, nitrocel-
lulose strips with transferred proteins were incubated with 2 ml of 
pooled sera diluted 1: 4 (sera 3, 5, 8 and 9;  table 1 ) previously ad-
sorbed ON with 10 μg/ml of Lit v 1. IgE was detected as described 
before.
 Expression and Purification of Recombinant A. aegypti 
Tropomyosins  
 Production and purification of 2 tropomyosin variants was 
achieved as follows. The nucleotide sequence of 2 tropomyosin 
variants (GenBank EAT46014.1 for Aed a 10.0101 and EAT46008.1 
for Aed a 10.0201) were synthesized at GenScript (Township, N.J., 
USA). The nucleotide sequence of Aed a 10.0201 was modified by 
codon optimization based on the OptimumGene TM algorithm. The 
synthesized nucleotide sequence of Aed a 10.0101 was subcloned 
into pCold IV vector (Clontech, Otsu, Japan) and the nucleotide 
sequence of Aed a 10.0201 was subcloned into pET-14b vector 
(Novagen, Billerica, Mass., USA). The vectors were used to trans-
form  E. coli One Shot BL21(DE3) (Life Technologies). Trans-
formed  E. coli was grown at 37  °  C in LBA with shaking at 250 rpm, 
 Table 1.  Clinical details and sensitization profiles of 12 allergic individuals used in the study
Serum Age,
years
Gender Diagnosis Mean wheal diameter, mm Total
IgE,
IU/ml
 Specific IgE against
A. com-
munis
D. ptero-
nyssinus
D.
farinae
B.
tropicalis
shrimp cock-
roach
A. ae gypti
extract
native
tropo-
myosin
rAed a
10.0101
rAed a
10.0201
1 3 M A 6 10 6 9.5 4 0 1,260 0.379 0.052 0.062 0.077
2 8 M R, C 4 0 0 0 0 0 626.4 0.165 0.047 0.063 0.069
3 4 M A, C 3.5 5 3.5 4 0 0 2,187 0.458 0.386a 0.289a 0.158a
4 9 M A, C 4.5 5 4.5 8 3.5 3 630 0.173 0.075 0.077 0.089
5 11 M A, R, C 4 5.5 6 5 5 3.5 2,095.4 1.679 1.683a 1.417a 0.991a
6 5 M A, C 3 9.5 7 3.5 0 3 324 0.319 0.052 0.078 0.076
7 13 M R, C 6 4 3.5 3.5 0 3 2,832 0.186 0.047 0.065 0.070
8 27 F R 5 0 0 0 0 6.5 545.5 0.355 0.179a 0.480a 0.182a
9 15 M A, R, C >3 >3 >3 >3 >3 >3 1,246 1.239 0.582a 0.403a 0.300a
10 9 M R, C >3 0 0 0 0 0 611 0.111 0.059 0.064 0.067
11 5 M R, C >3 >3 >3 >3 >3 >3 761 0.275 0.061 0.068 0.077
12 37 F R, C >3 0 0 0 0 0 58 0.332 0.051 0.070 0.063
 A = Asthma; C = conjunctivitis; F = female; M = male; R = rhinitis. 
a Positive specific IgE.
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up to an OD 600 of 0.5 nm. The induction of tropomyosin expres-
sion in cells harboring pET-14b/Aed a 10.0201 plasmid was 
achieved by the addition of 0.5 m M IPTG and incubation for 5 h. 
Cells harboring pCold IV/Aed a 10.0101 plasmid were subjected 
to thermal shock at 15  °  C and incubated at this temperature during 
24 h in the presence of 0.5 m M IPTG. Afterwards, the cells were 
harvested by centrifugation at 10,000 rpm for 10 min. Tropomyo-
sin was partially purified by isoelectric precipitation. The cell pellet 
was lysed in 20 m M Tris-HCl, 1.0  M KCl, 10 m M β-mercaptoethanol 
(pH 7.5) and boiled at 97   °   C for 5 min and then centrifuged at 
10,000 rpm for 5 min. The pH of the supernatant was adjusted at 
4.85 with 1.0  M HCl for isoelectric precipitation, and stirred for 
1 h at 4   °   C. The sample was centrifuged again and the precipitate 
dissolved in 20 m M of phosphate buffer (pH 7.4) and 0.5  M NaCl. 
 Purification of rAed a 10.0101 was performed following the 
strategy proposed by Erban  [27] , with some modifications. The 
sample containing the recombinant tropomyosin was subjected to 
ammonium sulfate fractionation. The protein extracted at 45% 
of ammonium sulfate was dialyzed against Tris-buffered saline 
(50 m M Tris- HCl, pH 7.4, and 150 m M NaCl) and the sample 
loaded onto a HiTrap Benzamidine FF (high sub) column (GE 
Healthcare Life Sciences) and then washed with binding buffer 
(0.05  M Tris-HCl, 0.5  M NaCl, pH 7.4). Finally, 0.05  M glycine (pH 
3.0) was used to elute purified protein. Fractions containing re-
combinant tropomyosin were pooled, dialyzed in 3,500-Da cut-off 
membrane (Spectra/Por) and lyophilized until usage. 
 Purification of rAed a 10.0201 was performed in Ni-NTA resin 
(Life Technologies) under native conditions, according to the 
manufacturer’s instructions. Protein fractions were analyzed by 
SDS-PAGE and those containing recombinant tropomyosin were 
pooled, dialyzed as above and lyophilized until usage.
 Enzyme-Linked Immunosorbent Assay 
 For specific-IgE level measurement, microplates were coated 
ON with 0.5 μg of extract or 0.05 μg of purified tropomyosin per 
well, and diluted in 100 μl of 0.05  M carbonate/bicarbonate buffer 
(pH 9.6). After washing 3 times with PBS-T, nonspecific binding 
was blocked for 1 h with PBS-T containing 1% BSA, followed by 3 
more washing steps. Microplates were then incubated for 2 h with 
sera, diluted 1: 8 in PBS-T containing 1% BSA and, after washing, 
incubated for 1 h with 1: 2,000 diluted HRP-conjugated mouse an-
ti-human IgE Fc (Southern Biotech). Finally, microplates were 
washed and incubated with  o -phenylenediamine dihydrochloride 
(Sigma-Aldrich). Reaction was stopped with HCl and absorbance 
was read at 492 nm. All samples were assayed in duplicate. Sera 
from 9 subjects with pollen allergy were used as negative controls. 
‘No antigen’ background values were subtracted from test sera 
data. Three standard deviations above the mean OD 492 nm value 
from the control subject sera were used to determine the cut-off 
for positive IgE binding.
 ELISA Competition Assay 
 To study the cross-reactivity between natural  A. aegypti  tropo-
myosin and tropomyosin from other organisms (rDer p 10, rBlo t 
10, rLit v 1 and rAsc l 3) or between natural  A. aegypti  tropomyosin 
and the 2 recombinant tropomyosin variants, ELISA competition 
assays were performed.  Betula verrucosa extract prepared at Inmu-
notek, SL, Madrid, Spain, was used as negative control. A pool of 
sera from 3 allergic patients (sera 3, 5 and 9;  table  1 ) with IgE 
against purified natural  A. aegypti  tropomyosin were diluted 1: 4 in 
PBS-T containing 1% BSA. Microplates were coated with antigen 
and blocked as described above. Subsequently, 50 μl of serially di-
luted competitor and 50 μl of diluted sera were added to the wells. 
The final dilution of the sera was 1: 8. Microplates were incubated 
ON at 4   °   C. The reaction was developed as described before. The 
pool adsorbed with PBS-T containing 1% BSA without competitor 
served as a positive control. Percent inhibition was calculated us-
ing the following equation: percent inhibition = 100 – [(OD of se-
rum with competitor/OD of serum without competitor) × 100].
 Proteomic Analysis 
 MS analysis was realized at the Hospital Nacional de Parapléji-
cos Proteomic Unit, Toledo, Spain, as previously described  [28] . 
The band of 32 kDa was excised from the 1-dimensional electro-
phoresis gel, reduced with 10 m M dithiothreitol (Sigma-Aldrich), 
alkylated with 55 m M iodoacetamide (Sigma-Aldrich) and digest-
ed with sequencing-grade modified porcine trypsin (Promega, 
Madison, Wis., USA) at a final concentration of 12.5 ng/μl accord-
ing to Shevchenko et al.  [29] . Peptides were desalted on a precol-
umn (Acclaim PepMap 100 C18, 5 μm, 100Ǻ; 300 μm i.d. × 5 mm, 
LC Packings), followed by separation on an UltiMate TM Nano LC 
system (Dionex) using an Onyx Monolithic C18 column (150 × 
0.1 mm, Phenomenex Inc., Torrance, Calif., USA). Fractionation 
of the peptides was performed with a Probot TM Microfraction Col-
lector (Dionex). CHCA (Sigma-Aldrich) was used as a MALDI 
matrix. MS and tandem MS (MS/MS) analysis of offline spotted 
peptide samples were performed using the 4800 plus MALDI TOF/
TOF Analyzer mass spectrometer (Sciex). The parent ion of Glu-1 
fibrinopeptide (Sigma-Aldrich) at m/z 1570.677, diluted in the 
matrix (2 fmol per spot), was used for internal calibration. Up to 
10 of the most intense ion signals per spot position, with s/n >40 
were selected as precursor for MS/MS acquisition, excluding com-
mon trypsin autolysis peaks and matrix ion signal. Peptide and 
protein identifications were performed using ProteinPilot TM soft-
ware v5.0 (Sciex) and the Paragon algorithm  [30] . Each MS/MS 
spectrum was searched against a Uniprot/Swiss-Prot protein se-
quence database entry (October 2013), with the fixed modification 
of carbamidomethyl-labeled cysteine parameter enabled. Other 
parameters, such as the tryptic cleavage specificity, the precursor 
ion mass accuracy and the fragment ion mass accuracy, are MAL-
DI 4800 built-in functions of ProteinPilot software. A search 
against a concatenated database containing both forward and re-
versed sequences enabled the false discovery rate to be kept at <1%.
 Results 
 Purification of Tropomyosin from an A. aegypti 
Extract  
 The fraction collected at retention times of 40–52 min 
in the gel filtration contained a 32-kDa band, which 
bound specific IgE. When separated by ionic-exchange 
chromatography, this band showed a spectrum with 
peaks II and III at 0.30–0.45  M NaCl containing proteins 
of interest ( fig.  1 a). The immunoblotting showed that 
peak II corresponded to a mixture of 4 principal bands of 
50, 32, 27 and 18 kDa, which also reacted with a human 
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serum with positive IgE to  A. aegypti and the rabbit anti-
Pen m 1 polyclonal antibody ( fig. 1 b). The reactivity sig-
nificantly decreased when both human and rabbit sera 
had been incubated with 10 μg of Lit v 1, suggesting that 
the bands contained tropomyosin, which cross-react with 
shrimp tropomyosin. 
 Characterization of Natural Tropomyosins from 
Purified Fractions 
 MS/MS analysis enabled the identification of 4 tropo-
myosin versions, previously reported in Uniprot  (Uni-
prot codes Q17H75, Q17H76, Q17H80 and Q17H82) and 
2 myosin products ( table  2 ). The 32-kDa band excised 
from the SDS-PAGE gel corresponded to a mixture of 2 
tropomyosins (Q17H75 and Q17H80) which showed IgE 
binding capacity. Even though these 2 molecules migrat-
ed at the same level in the gel, our MS/MS analysis was 
accurate enough to determine the sequence of specific 
peptides which enabled us to identify the presence of 
these 2 protein variants. Amino acid sequence alignment 
analysis showed 95.1% identity between Q17H75 and 
Q17H76, and 96.1% identity between Q17H80 and 
Q17H82. However, the percentage of identity between 
Q17H75 and Q17H80, and between Q17H82 and 
Q17H76, was 63% and 63.5%, respectively.
 The band 3 (the mixture of Q17H75 and Q17H80 vari-
ants) showed IgE reactivity with 4 of 12 sera (33.3%) ( ta-
ble 1 ). The IUIS Allergen Nomenclature Subcommittee 
 Table 2.  Proteins obtained from an A. aegypti extract after purification by gel electrophoresis and ionic-exchange 
liquid chromatography and identified by MS/MS analysis
Band No. Protein Uniprot code Coverage, % Theoretical MW, kDa Experimental MW, kDa
1 myosin Q178Y4 19.87 224.21 18
2 tropomyosin Q17H76 76.75 31.001 27
3 tropomyosin Q17H75 78.59 32.722 32
Q17H80 78.87 32.465 32
4 myosin Q178Y4 27.05 224.21 50
5 tropomyosin Q17H76 52.76 31.001 32
Q17H82 47.53 32.376 32
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 Fig. 1. Purification and IgE reactivity of natural tropomyosin from 
 A. aegypti .  a Ionic-exchange chromatography spectrum.  b Peaks 
II and III obtained by ionic exchange contained 5 principal bands 
in the SDS-PAGE (strips 1 and 5) and reacted with serum IgE from 
allergic patients (strips 2 and 6) and polyclonal rabbit anti-shrimp 
tropomyosin (strips 3 and 7). Adsorption of human pooled sera 
with 10 μg/ml rLit v 1 abrogated the reactivity (strips 4 and 8). 
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(www.allergen.org) has assigned to these tropomyosins 
the following official numbers: Aed a 10.0101 for Q17H75 
and Aed a 10.0201 for Q17H80. These allergens share 
60.2% of identity in the amino acid sequence ( fig. 2 ).
 Analysis of sequence alignments showed a greater sim-
ilarity of Aed a 10.0101 with the other arthropod tropo-
myosins than that shown by Aed a 10.0201. The compar-
ative analysis of amino acid sequence of the IgE-bind-
ing epitopes of tropomyosin from mite, cockroach and 
shrimp  [31–33] also showed the greater similarity of the 
Aed a 10.0101 variant in these epitope regions ( fig.  3 ). 
Thus, 4 putative epitopes, corresponding to residues 87–
101 (ALNRRIQLLEEDLER), 137–141 (DEERM), 144–
151 (LENQLKEA) and 249–260 (LQKEVDRLEDEL), 
were completely conserved in the amino acid sequence of 
Aed a 10.0101. The epitope ESKIVELEEEL (residues 
187–197) is modified by a single change EGKIVELEEEL 
in Aed a 10.0101. Only 1 epitope, corresponding to resi-
dues 137–141, was conserved in Aed a 10.0201( fig. 3 ). 
 Tropomyosin from A. aegypti Cross-Reacts with the 
Other Allergenic Tropomyosins 
 ELISA competition assays showed that when  A. aegyp-
ti  tropomyosin was in the solid phase, homologous inhi-
bition was 61.48% at 2 μg/ml of competitor. At this con-
centration, rBlo t 10, rDer p 10 and rLit v1 reached 75, 
73.98 and 61.54% of inhibition respectively, whereas rAsc 
l 3 reached only 23.68% ( fig. 4 ).
 Recombinant Aed a 10.0101 and Aed a 10.0201 
Tropomyosins Showed Different IgE-Binding 
Capacities 
 On SDS-PAGE, rAed a 10.0101 migrated with an ap-
parent molecular weight (MW) of 32 kDa and rAed a 
10.0201 migrated at 34 kDa. Both molecules exhibited 
IgE- and IgG-binding capacities when incubated with hu-
man sera and rabbit anti-shrimp tropomyosin antibody, 
respectively ( fig. 5 ). However, bands with a higher MW 
that may correspond to dimers or trimers were also ob-
10         20         30         40         50
MDAIKKKMQA MKLEKDNALD RALLCEQQAR DANLRAEKAE EEARQLQKKI
60         70         80         90        100
QAIENDLDQT QEALMAVNAK LEEKEKALQN AESEVAALNR RIQLLEEDLE
110        120        130        140        150
RSEERLASAT AKLSEASAAA DESERARKVL ENRALADEER MDALENQLKE 
160        170        180        190        200
ARFMAEEADK KYDEVARKLA MVEADLERAE ERAEAGEGKI VELEEELRVV 
210        220        230        240        250
GNNLKSLEVS EEKANQREEE YKNQIKTLTT RLKEAEARAE FAERSVQKLQ 
260        270        280 
KEVDRLEDEL VMEKEKYREI GDDLDTAFVE LILKE 
10         20         30         40         50
MDAIKKKMQA MKLEKDNAAD KADTCENQAK EANLRADKIM EEVAELTKRL
60         70         80         90        100
TQVTEDHEKF KNTLEQANKD LEEKEKLLTS TEANVAALTR KVQQVEEDLE 
110        120        130        140        150
KSEERSGAAL SKLLEATQSA DENNRMCKVL ENRSQQDEER MDQLSNQLKE 
160        170        180        190        200
ARMLAEDADG KSDEVSRKLA FVEDELEVAE DRVKSGEAKI MELEEELKVV
210        220        230        240        250
GNSLKSLEVS EDKANQRVEE FKRQLKSLTI KLKEAETRAE NAEKNVKKLQ 
260        270        280 
KEVDRLEDKL MNEKDKYKAI CDDLDSTFAE LTGY
Q17H75 (Aed a 10.0101)
Q17H80 (Aed a 10.0201)
 Fig. 2. Amino acid sequences of 2  A. ae-
gypti tropomyosins (Aed a 10.0101 and 
Aed a 10.0201). A sample from ionic-ex-
change chromatography ( fig.  1 b: band 3, 
strip 1) was analyzed by MS/MS. The pep-
tide sequences identified are highlighted. 
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served in the immunoblotting. Cross-inhibition by IgE 
competition ELISA between the natural purified tropo-
myosin mixture and both recombinant variants showed 
that Aed a 10.0101, or an equimolar mixture of Aed a 
10.0101 and Aed a 10.0201, were able to abrogate all the 
IgE binding to the natural tropomyosin mixture. In con-
trast, competition with Aed a 10.0201 only inhibited the 
IgE reactivity to natural tropomyosin up to 30% ( fig. 6 ). 
Aed a 10.0101   MDAIKKKMQAMKLEKDNALDRALLCEQQARDANLRAEKAEEEARQLQKKIQAIENDLDQT 60
Per a 7         MDAIKKKMQAMKLEKDNAMDCALLCEQQARDANLRAEKAEEEARSLQKKIQQIENDLDQT 60
Lit v 1         MDAIKKKMQAMKLEKDNAMDRADTLEQQNKEANNRAEKSEEEVHNLQKRMQQLENDLDQV 60
Der p 10        MEAIKNKMQAMKLEKDNAIDRAEIAEQKARDANLRAEKSEEEVRALQKKIQQIENELDQV 60
Blo t 10        MEAIKKKMQAMKLEKDNAIDRAEIAEQKSRDANLRAEKSEEEVRALQKKIQQIENELDQV 60
Asc l 3         MDAIKKKMQAMKIEKDNALDRADAAEEKVRQMTDKLERIEEELRDTQKKMMQTENDLDKA 60
Aed a 10.0201   MDAIKKKMQAMKLEKDNAADKADTCENQAKEANLRADKIMEEVAELTKRLTQVTEDHEKF 60
*:***:******:***** * *   *:: :: . : ::  **     *::    :: :: 
Aed a 10.0101   QEALMAVNAKLEEKEKALQNAESEVAALNRRIQLLEEDLERSEERLASATAKLSEASAAA 120
Per a 7         MEQLMQVNAKLDEKDKALQNAESEVAALNRRIQLLEEDLERSEERLATATAKLAEASQAV 120
Lit v 1         QESLLKANIQLVEKDKALSNAEGEVAALNRRIQLLEEDLERSEERLNTATTKLAEASQAA 120
Der p 10        QEQLSAANTKLEEKEKALQTAEGDVAALNRRIQLIEEDLERSEERLKIATAKLEEASQSA 120
Blo t 10        QESLTQANTKLEEKEKSLQTAEGDVAALNRRIQLIEEDLERSEERLKVATAKLEEASHSA 120
Asc l 3         QEDLSVANSNLEEKEKKVQEAEAEVAALNRRMTLLEEELERAEERLKLATEKLEEATHTA 120
Aed a 10.0201   KNTLEQANKDLEEKEKLLTSTEANVAALTRKVQQVEEDLEKSEERSGAALSKLLEATQSA 120
: *  .* .* **:* :  :*.:****.*::  :**:**::***   *  ** **: :.
Aed a 10.0101   DESERARKVLENRALADEERMDALENQLKEARFMAEEADKKYDEVARKLAMVEADLERAE 180
Per a 7         DESERARKILESKGLADEERMDALENQLKEARFMAEEADKKYDEVARKLAMVEADLERAE 180
Lit v 1         DESERMRKVLENRSLSDEERMDALENQLKEARFLAEEADRKYDEVARKLAMVEADLERAE 180
Der p 10        DESERMRKMLEHRSITDEERMEGLENQLKEARMMAEDADRKYDEVARKLAMVEADLERAE 180
Blo t 10        DESERMRKMLEHRSITDEERMDGLESQLKEARMMAEDADRKYDEVARKLAMVEADLERAE 180
Asc l 3         DESERVRKVMENRSFQDEERANTVESQLKEAQMLAEEADRKYDEVARKLAMVEADLERAE 180
Aed a 10.0201   DENNRMCKVLENRSQQDEERMDQLSNQLKEARMLAEDADGKSDEVSRKLAFVEDELEVAE 180
**.:*  *::* :.  **** : :..*****:::**:** * ***:****:** :** **
Aed a 10.0101   ERAEAGEGKIVELEEELRVVGNNLKSLEVSEEKANQREEEYKNQIKTLTTRLKEAEARAE 240
Per a 7         ERAESGESKIVELEEELRVVGNNLKSLEVSEEKANLREEEYKQQIKTLTTRLKEAEARAE 240
Lit v 1         ERAETGESKIVELEEELRVVGNNLKSLEVSEEKANQREEAYKEQIKTLTNKLKAAEARAE 240
Der p 10        ERAETGESKIVELEEELRVVGNNLKSLEVSEEKAQQREEAHEQQIRIMTTKLKEAEARAE 240
Blo t 10        ERAETGETKIVELEEELRVVGNNLKSLEVSEEKAQQREEAYEQQIRMMTGKLKEAEARAE 240
Asc l 3         ERAEAGENKIVELEEELRVVGNNLKSLEVSEEKALQREDSYEEQIRTVSARLKEAETRAE 240
Aed a 10.0201   DRVKSGEAKIMELEEELKVVGNSLKSLEVSEDKANQRVEEFKRQLKSLTIKLKEAETRAE 240
:*.::** **:******:****.********:**  * : .:.*:: :: :** **:***
Aed a 10.0101   FAERSVQKLQKEVDRLEDELVMEKEKYREIGDDLDTAFVELILKE-- 285
Per a 7         FAERSVQKLQKEVDRLEDELVHEKEKYKFICDDLDMTFTELAGY--- 284
Lit v 1         FAERSVQKLQKEVDRLEDELVNEKEKYKSITDELDQTFSELSGY--- 284
Der p 10        FAERSVQKLQKEVGRLEDELVHEKEKYKSISDELDQTFAELTGY--- 284
Blo t 10        FAERSVRKLQKEVDRLEDELVHEKEKYKSISDELDQTFAELTGY--- 284
Asc l 3         FAERSVQKLQKEVDRLEDELVHEKERYKSISEELDQTFQELSGYRSD 287
Aed a 10.0201   NAEKNVKKLQKEVDRLEDKLMNEKDKYKAICDDLDSTFAELTGY--- 284
**:.*:******.****:*: **::*: * ::** :* **      
Fig. 3. Multiple-sequence alignment between  A. aegypti tropomyosins (Aed a 10.0101 and Aed a 10.0201) and 
other tropomyosins. IgE-binding epitopes of Pen m 1 are indicated in boxes (described by Ayuso et al.  [32] ). 
Conserved epitopes in Aed a 10.0101 and Aed a 10.0201 are highlighted in red. Differences in the amino acid 
sequences of Der p 10, Blo t 10 and Asc l 3 are indicated in bold type. 
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 Discussion 
 In this work, we report that tropomyosin from  A. 
aegypti has IgE reactivity and its natural source is rep-
resented for at least 4 variants, 2 of them more related 
to tropomyosin from mites and shrimp than to that 
from  Ascaris lumbricoides . Although >3,500 species of 
mosquito have been described, we have focused our 
work on  A. aegypti because this mosquito has experi-
enced a rapid global spread and is commonly found in 
America, central and southern Africa, Oceania, Asia 
and, to a lesser extent, in Europe  [34] , where it acts 
as a vector of several pathogens  [35, 36] . Furthermore, 
 A. aegypti  has evolved to cohabit and feed from humans 
 [37] who may be constantly exposed to the mosquito 
antigens.
 Using a combination of 2 chromatographic tech-
niques and proteomic analysis, 4 tropomyosin variants 
were identified in this study. These variants coeluted 
with truncated myosin on the ion-exchange column, 
which can be explained by the common association of 
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 Fig. 4. IgE competition analysis. Microplate wells coated with nat-
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 Fig. 5.  a Gel electrophoresis and Coomassie staining of rAed a 10.0101 and rAed a 10.0201. Immunoblots of these 
recombinants incubated with pooled sera from allergic patients ( b ) or rabbit polyclonal anti-shrimp tropomyo-
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D
ow
nl
oa
de
d 
by
: 
W
ei
zm
an
n 
In
st
. o
f S
cie
nc
e 
   
   
   
   
   
   
   
   
   
  
13
2.
77
.1
50
.1
48
 - 
7/
1/
20
16
 1
2:
22
:4
6 
PM
 Cantillo/Puerta/Lafosse-Marin/Subiza/
Caraballo/Fernández-Caldas
 
 Int Arch Allergy Immunol 2016;170:46–56 
DOI: 10.1159/000447298
54
these proteins to the thin filament and microfilaments, 
together with actin, in all eukaryotic cells  [11] . A band of 
32 kDa was identified as a mixture of 2 variants, Aed a 
10.0101 and Aed a 10.0201. These molecules have similar 
physicochemical characteristics, inducing them to elut-
ing at the same retention time in gel-filtration and ion-
exchange chromatographic techniques. The mixture of 
the natural tropomyosins reacted with the IgE in 33% of 
the allergic individuals. Further experiments should be 
performed in order to clarify the contribution of each 
variant in the pattern of reactivity observed. The higher 
degree of cross-reactivity between the natural mosquito 
tropomyosin and tropomyosin from mites and shrimp is 
consistent with the amino acid sequence analysis, sug-
gesting the presence of potential IgE cross-reacting epi-
topes as well as with the close taxonomic relationship 
across  these species. 
 The cross-reactivity study allowed us to hypothesize 
that mite tropomyosin is probably the primary source of 
sensitization, which means that sensitization to mosqui-
to tropomyosins is influenced by sensitization to mite 
allergens. This aspect may have important clinical impli-
cations, i.e. the diagnosis of arthropod-induced allergy 
may be biased by cosensitization to  A. aegypti , and this 
mosquito species may represent a source of IgE-cross-
reactive molecules and not be a genuine sensitizing mol-
ecule. On the other hand, it is unknown if exposure to 
 A. aegypti tropomyosin could have a role in the regula-
tion of immune response induced by mite and shrimp 
tropomyosins.
 In Africa and South America, the prevalence of sensi-
tization to mite tropomyosin is approximately 50%  [38, 
39] , higher than those observed in developed countries 
 [40, 41] . These differences are partially explained by the 
presence of other Th2-inducing and cross-reactive anti-
gens, such as  Ascaris  [17, 23] . Our results of specific IgE-
binding and cross-reactivity suggest that  A. aegypti 
tropomyosin may play a role in the sensitization pattern 
of allergic populations residing in areas where mosqui-
toes are highly prevalent. 
 The alignment of amino acid sequences of Aed a 
10.0101 and Aed a 10.0201 with those from other arthro-
pods suggests the presence of putative IgE epitopes, 
which are not yet experimentally verified. Aed a 10.0101 
showed a higher sequence identity with tropomyosins 
from other allergenic sources when compared to Aed a 
10.0201 ( fig. 3 ), including the regions of putative IgE epi-
topes. Based on these observations, we hypothesized that 
Aed a 10.0101 could have a higher IgE reactivity (sup-
ported by the ELISA results with the 12 sera showing that 
the 4 positive IgE sera had higher levels of antibodies to 
this variant) than Aed a 10.0201 ( table 1 ). These results 
suggest that Aed a 10.0101 is more represented in the 
mosquito proteome. Further studies should be per-
formed to evaluate the potential this protein may have 
for the diagnosis of allergy caused by arthropods, since it 
seems to have a wide representation of IgE epitopes re-
lated to tropomyosin.
 In conclusion, we describe that the whole-body ex-
tract of  A. aegypti contains 2 variants of tropomyosin 
which can mediate IgE cross-reactivity with allergenic 
tropomyosins from house dust mites, shrimp and the 
nematode,  A. lumbricoide s, at different levels. The re-
combinant molecules of these variants showed different 
IgE-binding properties. The analysis of the immune re-
sponse elicited by mosquito tropomyosin and other mos-
quito antigens and the establishment of whether or not 
these molecules are present in house dust, or the outdoor 
environment will help to clarify the allergenic role of 
 A. aegypti and to design better schemes for the diagnosis 
and treatment of mosquito-induced allergies.
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 Fig. 6. IgE competition ELISA results. Microplate wells coated with 
natural  A. aegypti tropomyosin were incubated with human pooled 
sera and different concentrations of rAed a 10.0101, rAed a 10.0210 
or an equimolar mixture of these recombinants. Natural  A. aegyp-
ti tropomyosin for homologous inhibition and  B. verrucosa extract 
as unrelated antigens were used. At the highest concentration of 
the competitor rAed a 10.0201, 30% IgE-binding inhibition was 
obtained. 
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ABSTRACT 
 
BACKGROUND: Aedes aegypti is the source of saliva as well as somatic allergens. In this study, we 
performed the immunological characterization of the heat shock cognate-70 allergen Aed a 8, which 
represents a potential major somatic allergen from A. aegypti. 
METHODS: Recombinant Aed a 8 (rAed a 8) was expressed in E. coli, purified and its IgE-binding 
capacity was evaluated by ELISA and immunoblotting using the sera from 14 mosquito skin test positive 
individuals residing on the tropical island of Martinique. The allergenicity of rAed a 8 was also studied by 
the Basophil Activation Test and ELISA competition. BALB/c mice were immunized with rAed a 8 and 
specific IgE, IgG1, IgG2a and IgG3 were measured. Murine IgG1 binding of the whole extract was verified 
by direct ELISA. T-cell activation was studied in splenocytes stimulated with rAed a 8. 
RESULTS: rAed a 8 was expressed as a 74 kDa biologically active protein that reacted with specific IgE in 
6 out of 14 (43%) allergic individuals, and induced the activation of basophils. Mice immunized with rAed a 
8 produced specific IgE, IgG1, IgG2a and IgG3 antibodies. Murine IgG1 reacted with the natural protein 
present in the mosquito extract. rAed a 8 induced proliferation of mice splenocytes. 
CONCLUSION: rAed a 8 preserved the molecular and immunological capacity of the natural counterpart. 
The allergen induced a mixed antibody response characterized by the production of Th1 and Th2 related 
antibodies. Aed a 8 is an important allergen that could be considered in diagnostic tests and in specific-
immunotherapy for mosquito allergy. 
 
 
INTRODUCTION 
Sensitization and allergic reactions induced by 
mosquito allergens have been widely 
described [1]. Some studies have established 
that 2.5–47% of individuals with asthma 
and/or allergic rhinitis are sensitized to 
mosquito allergens [2-4].  
Currently, 4 salivary allergens from A. aegypti 
(Aed a 1, Aed a 2, Aed a 3 and Aed a 4) are 
deposited in the WHO/IUIS Allergen 
Nomenclature Sub-Committee. Additionally, 
we have reported two additional tropomyosins 
variants [5] and other 5 non-salivary allergens 
from this mosquito species, including the 
allergen Heat shock cognate-70, Aed a 8. Aed 
a 8 reacted with the IgE in 60% of a group of 
15 allergic patients from the Caribbean island 
of Martinique indicating that it may represent a 
major allergen. This allergen is a member of 
the Heat shock protein-70 family, chaperones 
that help in the folding of many proteins 
maintaining their correct biological function 
under stress conditions [6]. This protein family 
is one of the most conserved in evolution [7, 
8]. They are allergenic in different species of 
fungi, cockroach and mite [9-11]. In 
mosquitoes, this protein is exploited by 
dengue virus [12] and mosquito-borne 
flaviviruses (encephalitis virus) [13] to attach 
and penetrate mosquito cells.  
The purification of natural mosquito allergens 
and their biochemical characterization is a 
difficult task that may be overcome using 
biologically active recombinant allergens. The 
availability of these molecules will help in the 
understanding of the underlying mechanisms 
and in the design of new diagnostic and 
therapeutic tools [14-16].  
In this study, we performed the immunological 
characterization of rAed a 8. The biological 
active recombinant version of the allergen 
was obtained by expression in bacteria, 
purified and its IgE binding capacity evaluated 
using the sera from a group of allergic 
patients from the Caribbean, where exposure 
to mosquitoes is constant. The allergenic 
activity of this allergen was evaluated by 
basophil activation test and the immunogenic 
and antibody response analysed in the 
splenocytes and sera from immunized mice, 
respectively. 
 
METHODS 
Sera 
Serum was obtained from 14 (11 males and 3 
females, mean age 11.78 years) allergic 
patients who attended an outpatient Allergy 
Clinic in Fort de France, Martinique (Table 1). 
All individuals were skin tested with a panel of 
common standardized inhalant allergens and 
with a commercially available Aedes 
communis extract (Stallergènes, Antony, 
France). Individuals who developed a wheal > 
3 mm to the extracts were considered to have 
a positive skin prick test (SPT). Serum was 
obtained after written consent in the context of 
the approved study entitled: “Etude 
Epidémiologique des causes Allergiques de 
l’asthme en Martinique”, funded and approved 
by “Fonds de’aide a la qualite de soins de 
ville” from “la Caisse Generale de securite 
sociale de la Martinique” and the “Comite 
departemental de la Martinique contre les 
maladies respiratoires et la tubreculose 
(CDMMRT)”. 
 
Preparation of extracts and expression and 
purification of rAed a 8 
An A. aegypti extract was prepared from 
lyophilized and defatted mosquitoes (GREER 
labs, Lenoir, NC, USA), by extraction in PBS, 
as previously described [5]. For the 
expression of rAed a 8, the codon optimized 
nucleotide sequence of the allergen 
(GenBank: DQ440225.1) was synthesized at 
GenScript (Township, NJ, USA). The 
nucleotide sequence was sub-cloned between 
NdeI and XhoI restriction sites of the multiple 
cloning site of pET-14b vector (Novagen, 
Billerica, MA, USA). Plasmid encoding rAed a 
8 was used to transform E. coli One Shot 
BL21 (DE3) (Life Technologies). E. coli cells 
harbouring the expression vector were grown 
at 37°C in LBA medium. Induction was 
achieved by addition of 0.5 mM IPTG. After 
protein expression, the cells were harvested 
by centrifugation at 10,000 r.p.m. for 10 
minutes. The bacterial cell pellet was lysed in 
lysis buffer (20 mM phosphate buffer pH 7.4, 
0.5 M NaCl, 20 mM imidazole) and purified 
using Ni-NTA resin (Life Technologies) under 
native conditions, according to the 
manufacture instructions. Briefly, bacterial 
lysate was added to the resin for protein 
binding. After washing the unbounded 
components, Aed a 8 was eluted with native 
elution buffer (20 mM phosphate buffer pH 
7.4, 0.5 M NaCl, 250 mM imidazole). Protein 
fractions were analysed by SDS-PAGE and 
those containing recombinant tropomyosin 
were pooled, dialysed in 3,500 Da cut-off 
membranes (Spectra/Por Dialysis 
membranes) and lyophilized until usage. 
 
Detection of human IgE 
Serum specific-IgE to the allergenic extract, or 
rAed a 8, was measured by ELISA, as 
described in [5]. Briefly, microplates were 
coated overnight (ON) at 4ºC with 100 µL of 
extract (5 µg/mL) or rAed a 8 (0.5 µg/mL), and 
blocked with PBS with 0.25% tween 20 (PBS-
T), containing 1% BSA. Plates were incubated 
for 2 hours with individual sera, diluted 1:8 in 
PBS-T containing 1% BSA. IgE binding was 
detected with horseradish peroxidase-
conjugated mouse anti-human IgE Fc 
(SouthernBiotech) diluted 1:2,000, for 1 hour. 
The substrate o-Phenylenediamine 
dihydrochloride (Sigma-Aldrich) was added 
and reaction was measured at 492 nm after 
30 minutes.  
Inhibition experiments were performed using a 
mixture of two sera (Table 1) pre-incubated 
with the indicated concentrations of inhibitors. 
Microplates were incubated overnight at 4ºC 
and the reaction detected as described 
before. A P. pratense extract was used as 
negative control. 
 
SDS-PAGE and Immunobloting 
Two µg of rAed a 8 were separated by SDS-
PAGE under denaturing conditions, in 12% 
continuous polyacrylamide gels at 120 volts 
using a Mini-PROTEAN II apparatus (Bio-
Rad, Hercules, CA, USA). After separation, 
gels were stained with GelCode Blue stain 
reagent (Life technologies, Carlsbad, CA, 
USA). Precision Plus Protein All Blue 
Standards (Bio-Rad) were used to determine 
the relative molecular weights of the 
electrophoresed components. For 
immunoblotting, proteins were transferred 
onto 0.45 µm nitrocellulose membrane using a 
Transblot Semydry Electrophoresis transfer 
cell (Bio-Rad) at 20 volts for 30 minutes. Non-
specific binding was blocked with PBS-T 
containing 5% BSA, for 45 minutes. 
Membranes were washed two times with 
PBS-T, then incubated with serum pool 
diluted 1:10 in PBS-T containing 1% BSA, for 
2 hours.  After 3 further washings with PBS-T, 
the membranes were incubated with 1:2,000 
horseradish peroxidase-conjugated mouse 
anti-human IgE (Southern Biotech) for 1 hour, 
and incubated with ECL Prime detection 
reagent (Ge Healthcare Life Sciences, 
Buckinghamshire, England). 
Chemiluminescence was detected in a 
GeneGnome apparatus (Syngene, 
Cambridge, UK). Precision Plus Protein 
WesternC Standards (Bio-Rad), previously 
incubated with Precision Protein StrepTactin-
HRP Conjugate (Bio-Rad) were used to 
determine the relative molecular weights. 
 
Mice immunization 
Female BALB/c mice were immunized 
intraperitoneally (i.p.) with rAed a 8 or PBS 
adsorbed to Alum hydroxide (Brenntag, 
Mülheim, Germany). In total, the animals 
received four injections of 25 µg of antigen 
adsorbed onto 2 mg Alum, in 250 µL every 
two weeks. Fifteen days after the last 
immunization, blood was collected and mice 
sacrificed and the spleens were removed 
under aseptic conditions.  
 
Mice antibody measurement 
ELISA plates were coated with rAed a 8, or 
mosquito extract overnight. Afterwards, the 
sera were added and let to stand overnight. 
For detection of IgG1, IgG2a and IgG3 sera 
were diluted 1:500; and for IgE 1:12 and 
incubated ON. Bound antibodies were 
detected with rat anti-mouse IgG1, IgG2a, 
IgG3 and IgE antibodies (BD Pharmingen, 
San Jose, CA, USA), followed by a HRP-
conjugated goat anti-rat IgG (GE Healthcare, 
Vienna, Austria). ABTS was added and the 
reaction measured at 405-490 nm. 
 
 
 
 
 
Lymphoproliferation 
Splenocytes (2x105 cells/well) from mice 
immunized with rAed a 8 or PBS were 
incubated in round bottom 96 well plates 
(Nunc) with rAed a 8 (125 ng antigen/well – 
7.81 ng antigen/well) or medium alone for 4 
days at 37ºC. Concanavalin A (0.5 µg/well; 
Sigma Aldrich, USA) served as a positive 
control. During the last 16 hours, 3[H]-labeled 
thymidine (0.5 mCi/mL) was added. 
Stimulation indices (SI) were calculated as the 
ratio between counts per minute (cpm) 
obtained in cultures with splenocytes plus 
rAed a 8 and cpm obtained in cultures 
containing splenocytes and medium alone. A 
SI of 2 was defined as positive proliferation. 
 
Basophil activation test 
PBMCs were purified from blood samples 
from donors using Ficoll gradient 
centrifugation. PBMCs were stripped in ice 
cold lactic acid buffer (0.13 M KCl, 0.05 M 
NaCl, 0.01 M Lactic acid, pH=3.9). After 
washing twice with PBS, cells were re-
suspended in 80 µL of PBS and 80 µL of 
serum from an allergic individual and 
incubated for 1 hour at 37ºC. After washing, 
re-sensitized cells were incubated with 
different concentrations of rAed a 8, A. 
aegypti extract, positive controls (fMLP or 
anti-IgE) and medium as negative control for 
15 minutes. Cells were stained with PE-
conjugated anti-human CD63, PerCP 
conjugated anti-human CD123 and APC-
conjugated anti-human CCR3. Basophil 
activation was expressed as the percentage 
of CD63+ basophils.  
 
RESULTS 
Expression of biologically active rAed a 8 
The cDNA coding for Aed a 8 was sub-cloned 
into an expression vector pET14b and 
expressed as a soluble His-tag fusion protein 
in E. coli with a molecular weight of 74 kDa 
(Figure 1A), which corresponds to the size 
inferred from its amino acid sequence. The 
allergen was highly purified by affinity, 
resulting in a purity higher than 90%. Two low 
intensity bands were observed at around 72 
and 50 kDa. The immunoblotting showed that 
the band of 74 kDa reacted with the IgE from 
an allergic individual and weak reactivity was 
detected for the 72 and 50 kDa bands, 
suggesting that they may correspond to 
degradation products (Figure 1B). 
 
 
 
 
Table 1. Clinical details and sensitization profiles of 14 allergic patients sensitized to A. aegypti, 
used in the study. 
Serum 
Age 
(years) 
Gender Diagnosis 
Total IgE 
IU/mL 
Specific IgE 
against A. 
aegypti extract 
(O.D.) 
Specific 
IgE against 
rAed a 8 
(O.D.) 
1* 5 M Rhinitis 324 0.319 0.593 
2 13 M Rhinitis, Conjunctivitis 2832 0.186 0.083 
3 6 M Rhinitis, Conjunctivitis 552 0.530 0.074 
4 4 F Rhinitis, Conjunctivitis 2604 1.221 0.067 
5* 3 M Rhinitis 8.7 1.982 0.151 
6* 11 M Asthma, Rhinitis, Conjunctivitis 2095 1.679 0.120 
7* 11 M Rhinitis, Conjunctivitis 611 0.111 0.093 
8 13 M Rhinitis, Conjunctivitis 1199 0.795 0.070 
9* 8 M Asthma, Rhinitis, Conjunctivitis 1659 0.511 0.129 
10 8 M Rhinitis 626 0.165 0.082 
11 37 F Rhinitis, Conjunctivitis 58 0.332 0.063 
12 15 M Asthma, Rhinitis, Conjunctivitis 1246 1.240 0.068 
13* 27 F Rhinitis 545.5 0.355 3.990 
14 4 M Asthma, Conjunctivitis 2187 0.458 0.066 
Mean 11.78 78.6% M  1182 0.706 0.403 
*Sera from these patients were considered as rAed a 8-specific IgE positive 
 
Figure 1. Expression, purification and IgE-binding of rAed a 8. (A) SDS-PAGE of supernatants from non-induced and 
induced cultures showing a 74 kDa band of interest. More than 90% of purity was achieved after affinity purification. (B) 
Immunoblotting of rAed a 8 with an individual serum from an allergic patient. MW: Molecular weight marker 
 
 
Figure 2. ELISA inhibition assays between A. aegypti extract and rAed a 8. Microplates coated with rAed a 8 or whole 
extract were incubated with a mixture of 2 sera previously adsorbed with different concentrations rAed a 8 or whole 
mosquito extract. P. pretense extract was used as negative control. 
rAed a 8 binds IgE from 43% of HDM-
allergic individuals and has similar 
antibody reactivity as natural Aed a 8 
We further evaluated the IgE frequency of 
reactivity of rAed a 8 in a group of 14 allergic 
patients suffering asthma, rhinitis, and/or 
conjunctivitis by ELISA. rAed a 8 was 
recognized by 6 of the 14 patients (42.8%) 
(Table 1). By ELISA inhibition we compared 
the inhibition capacity of rAed a 8 with the 
whole extract (Figure 2). When the whole 
extract was on the solid phase, rAed a 8 
inhibited in 42% the IgE reactivity of the sera 
against the extract. When rAed a 8 was on the 
solid phase, the whole extract produced a 
similar degree of inhibition (Figure 2). 
 
rAed a 8 induces dose-dependent basophil 
activation 
The allergenic activity of rAed a 8 was 
analysed using stripped basophils sensitized 
with serum from one allergic patient with Aed 
a 8-specific IgE. The upregulation of CD63 
was measured after incubating the cells with 
increasing concentrations of rAed a 8 or A. 
aegypti extract (Figure 3). rAed a 8 induced a 
dose-dependent up-regulation of the marker, 
while the extract produced higher activation at 
1 ng/mL and 0.1 ng/mL. The optimum 
concentration for rAed a 8 was 1000 ng/mL 
and for the extract 0.1 ng/mL. 
 
 
 
Figure 3. Basophil activation test with rAed a 8 and A. 
aegypti extract. Stripped basophils sensitized with the IgE 
from the sera of an A. aegypti sensitized patient were 
stimulated with different concentrations of rAed a 8 or 
whole mosquito extract. Activation of basophils was 
expressed as the percentage of CD63
+
 basophils. 
 
Murine immune response of rAed a 8 
showed strong immunogenic capacity 
Splenocytes were stimulated with different 
concentrations of rAed a 8 to assess the T-
cell reactivity. Splenocytes isolated from rAed 
a 8-immunized mice proliferated upon 
stimulation to different concentrations of the 
recombinant allergen. No proliferation was 
observed in the splenocytes from the mice 
immunized with PBS (Figure 4).  
 
 
 
Figure 4. T-cell proliferation to rAed a 8 in mice 
splenocytes. Splenocytes from mice immunized with rAed 
a 8 or PBS were stimulated with different concentrations 
of rAed a 8. Proliferation was measured by means of the 
incorporation of 3[H]-labeled thymidine. 
 
BALB/c mice immunized with rAed a 8 
produced specific IgE, IgG1, IgG2a and IgG3. 
In the serum of the mice immunized with PBS 
the levels of these antibodies were 
significantly lower (Figure 5A). The antibody 
response was characterized by a high 
production of IgG2a. Furthermore, total IgG 
produced by the mice immunized with rAed a 
8 bound the natural allergen contained in the 
mosquito extract (Figure 5B), indicating that 
they recognized its natural counterpart.  
 
DISCUSSION 
Several studies have suggested that the 
mosquito species A. aegypti contains somatic 
allergens [1, 5, 17]. The WHO/IUIS Allergen 
Nomenclature Sub-Committee has accepted 
the inclusion of 6 novel allergens from A. 
aegypti which react with specific IgE from 
patients with asthma, rhinitis and/or 
conjunctivitis, including the Heat shock 
cognate-70 allergen, Aed a 8. However, the 
role of this, and other allergens, in the onset 
and natural course of allergic responses is still 
under study. In this work, we obtained and 
purified a biologically active recombinant 
allergen, rAed a 8, by expression in E. coli.  
  
Figure 5. Antibody response to rAed a 8 in 
BALB/c mice. (A) Specific-IgE and IgG 
subclasses of the mice. (B) Specific-IgG1 
from mice immunized with rAed a 8 reactivity 
to the whole body mosquito extract. 
 
This molecule showed specific IgE binding 
capacity and was able to inhibit IgE binding to 
the natural allergen extract. Furthermore, 
rAed a 8 induced the activation of basophils 
and showed strong immunogenicity in mice. 
The immune response induced by this 
allergen was characterized by the production 
of high levels of IgG subclasses, suggesting a 
deviation of the response to a Th1 phenotype.    
rAed a 8 was expressed in E. coli and purified 
as a single band of approximately 74 kDa, 
which corresponded to the theoretical 
molecular weight inferred by its aminoacid 
sequence. Using the sera from allergic 
patients (Table 1) and the sera from the 
immunized mice (Figure 5B) we demonstrated 
that rAed a 8 has similar antibody binding 
capacity compared to the natural allergen 
contained in the mosquito extract. In ELISA 
inhibition experiments we demonstrated that 
Aed a 8 accounted for 40% of the total IgE-
binding of the extract. 
Allergens from the Heat shock protein-70 
family have been reported in several fungi 
species, such as Alternaria alternata (Alt a 3) 
[10], Malassezia sympodialis (Mala s 10) [18] 
and Penicillium citrinum (Pen c 19) [19], with 
an IgE-binding frequency of 5% for Alt a 3 and 
41% to 69% in the other mold species. In 
mites, heat shock proteins have been 
identified in D. farinae (Der f 28) [9]; 68.3% of 
a group of 41 house dust mite allergic patients 
presented serum specific-IgE to Der f 28. 
However, when used as skin prick test 
reagent, only 11.5% of the patients were 
positive [20]. Tyr p 28, from Tyrophagus 
putrescentiae, reacted with specific IgE in 
47% of the allergic patients. In our study, we 
observed an IgE-binding frequency of 43%; 
however, the number of patients was low, 
indicating that further studies in representative 
allergic populations should be performed to 
define whether this is a major, or a minor 
allergen. 
One important requirement of the recombinant 
allergens is their capacity to mimic their 
natural counterparts. In our study, we 
demonstrated that rAed a 8 preserved IgE-
binding. Furthermore, the IgG1 produced by 
mice immunized with rAed a 8, recognized the 
natural counterpart contained in the mosquito 
extract (Figure 5B). rAed a 8 induced the 
activation of basophils (Figure 3) and 
lymphoproliferation of mice cells (Figure 4). 
These results suggest that the natural and 
recombinant Aed a 8 share B-cell epitopes 
and that rAed a 8 conserves its allergenic and 
immunogenic capacity.   
Interestingly, the BALB/c mice immunized with 
rAed a 8 produced low levels of IgE and high 
levels of IgG subclasses, specially IgG2a. 
This result was unexpected because the 
presence of IgG2a is an indicator of a Th1 
responses. However, there are several 
studies which indicate that mosquito 
allergens, including Aed a 8, may play a 
protective role in the allergic response. The 
natural course of mosquito bite allergy 
indicates that the patients experience allergen 
desensitization, accompanied with a high 
production of total IgG and IgG4 [21]. It has 
also been suggested that A. aegypti bites 
trigger an atypical allergic reaction in a mouse 
model of mosquito bite allergy, consisting in a 
mixed Th1/Th2 phenotype characterized by 
the production of high levels of IgG2a [22]. 
Furthermore, in a mouse model of allergy, 
oropharyngeal injection of exogenous HSP70 
resulted in significant suppression of the 
inflammatory process during the acute phase 
of allergic inflammation of the airways [23]. 
These data suggest that the HSP70 family 
may have an immunosuppressive activity. It 
seems that rAed a 8 also has this capacity 
and it represents a potential candidate to 
further evaluate its potential use in specific 
immunotherapy. 
In conclusion, we have cloned and expressed 
a 74 kDa rAed a 8, which conserves the 
antibody-binding, allergenic and immunogenic 
capacity. The antibody response induced in 
immunized mice indicates that this allergen 
may have a potential immune regulatory role. 
rAed a 8 represents an important allergen 
recognized by more than 40% of the mosquito 
allergic population. It should be further 
investigated and considered for diagnosis and 
immunotherapy of mosquito induced allergies. 
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C. Cross-reactivity between A. aegypti and other arthropods  
 
In this part of the thesis, we explored cross-reactivity between A. aegypti and 
other arthropod allergens at different levels. The classical concept of cross-
reactivity refers to a phenomenon in which the antibodies raised against a 
molecule bind to a different but structurally similar molecule. Under this concept, 
cross-reactivity may have clinical consequences. In allergy diagnosis, cross-
reactivity may lead to false positives; however, for the allergen specific 
immunotherapy the application of a single molecule may desensitize the patient 
to a broad spectrum of similar molecules. In addition, the capacity of a molecule 
to cross-react with specific IgE, previously produced against a primary 
sensitizer, may induce allergic symptoms. Studies have shown that cross-
reactivity may also involve T-cell epitopes, which, together with the T-cell cross-
reactive B-cell epitopes, are necessary in the exacerbation of the allergic 
response. 
Initially, cross-reactivity between mosquito and other arthropod extracts 
was evaluated in ELISA experiments and the implicated components detected 
in immunoblot inhibition experiments. More than 10 proteins were identified, and 
four of them corresponded to Odorant Binding Protein, Mitochondrial 
cytochrome C, Cyclophilin (PPIase), an unknown protein “AAEL001668-PA” 
and tropomyosin. 
Furthermore, the humoral and cellular cross-reactivity between A. aegypti 
tropomyosins (rAed a 10.0101 and rAed a 10.0201) and rDer p 10 was 
analysed by ELISA, Basophil activation test, ELISA and Basophil activation 
inhibition assays, and lymphoproliferation using splenocytes from immunized 
BALB/c mice. The results showed that the three tropomyosins cross-react at the 
different levels and that the degree of cross-reactivity depended on the degree 
of sequence homology. 
  For further information see the following papers: 
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A B S T R A C T
Background: Cross-reactivity between Aedes aegypti and mites, cockroaches, and shrimp has been previ-
ously suggested, but the involved molecular components have not been fully described.
Objective: To evaluate the cross-reactivity between A aegypti and other arthropods.
Methods: Thirty-four serum samples from patients with asthma and/or allergic rhinitis were selected, and
speciﬁc IgE to A aegypti, Dermatophagoides pteronyssinus, Dermatophagoides farinae, Blomia tropicalis, Peri-
planeta americana. and Litopenaeus vannamei was measured by enzyme-linked immunosorbent assay. Cross-
reactivity was investigated using pooled serum samples from allergic patients, allergenic extracts, and the
recombinant tropomyosins (Aed a 10.0201, Der p 10, Blo t 10, Lit v 1, and Per a 7). Four IgE reactive bands
were further characterized by matrix-assisted laser desorption/ionization tandem time of ﬂight.
Results: Frequency of positive IgE reactivity was 82.35% to at least one mite species, 64.7% to A aegypti,
29.4% to P americana, and 23.5% to L vannamei. The highest IgE cross-reactivity was seen between A
aegypti and D pteronyssinus (96.6%) followed by L vannamei (95.4%), B tropicalis (84.4%), and P americana
(75.4%). Recombinant tropomyosins from mites, cockroach, or shrimp inhibited the IgE reactivity to the
mosquito at a lower extent than the extracts from these arthropods. Several bands of A aegypti cross-
reacted with arthropod extracts, and 4 of them were identiﬁed as odorant binding protein, mitochon-
drial cytochrome C, peptidyl-prolyl cis-trans isomerase, and protein with hypothetical magnesium ion
binding function.
Conclusion: We identiﬁed 4 novel cross-reactive allergens in A aegypti allergenic extract. These molecules
could inﬂuence the manifestation of allergy to environmental allergens in the tropics.
 2017 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Introduction
Mosquitoes are distributed worldwide and may induce allergic
reactions in atopic individuals.1 Sensitization to mosquito bites is
common in the United States, Canada, Japan, Switzerland, and
Finland,2e4 sometimes causing severe systemic reactions, such as
generalized urticaria, angioedema, wheezing, and even anaphy-
laxis.1,5,6 Several allergens from the genera Aedes, Culex, and
Anopheles have been identiﬁed, and 4 saliva-derived allergens from
the species Aedes aegypti have been reported.7e10
In the tropics and subtropics, sensitizations to mites, cock-
roaches, and shrimp are highly prevalent, being important inducers
of allergic reactions.11e18 A (Stegomyia) aegypti, originally from Af-
rica, has evolved to coexist with humans and thrives in a wide
range of climates and habitats,19e21 including tropical and sub-
tropical regions.19,22e24 Mosquito detritus present in house dust
could also be inhaled,25,26 leading to sensitization and induction of
allergic respiratory symptoms in sensitized patients.
Tropomyosin is a panallergen that belongs to a family of
phylogenetically conserved proteins with multiple isoforms pre-
sent in muscle and nonmuscle cells of vertebrates and inver-
tebrates.27e31 We have identiﬁed that A aegypti expresses several
tropomyosin variants that cross-react with tropomyosin from other
arthropods.32 However, other allergens involved in this cross-
reactivity with other arthropods remain to be discovered.
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Several allergens have been described in arthropods, including
tropomyosins, myosins, paramyosins, fatty acidebinding proteins,
glutathione S-transferase, arginine kinase, sarcoplasmic calcium-
binding protein, and hyaluronidase, among others (www.
allergome.org and www.allergen.org). A aegypti has genes that
encode homologues of the previously mentioned allergens. Our
main hypotheses were that a high cross-reactivity between A
aegypti and arthropods may exist and that several molecules, in
addition to tropomyosin, are involved. The aim of this study was to
evaluate the components involved in a potential cross-reactivity
between A aegypti and other arthropods.
Methods
Serum Samples
Serum samples were obtained from 34 patients (15 males and
19 females; mean [SD] age, 15.4 [13.2] years) who attended an
outpatient allergy clinic in Fort de France, Martinique, France
(Table 1). All patients were skin prick tested with a battery of
common standardized inhalant allergens (Stallergènes, Antony,
France). Individuals who developed a wheal larger than 3 mm to
the extracts used were considered as having a positive skin prick
test (SPT) result. Serum was collected after written consent was
obtained from the participants in the study entitled: “Recherche
des causes allergiques de l’asthme en Martinique.” This study was
approved by the “Caisse generale de securite sociale de la
Martinique: DAAM-JP/RJ” and sponsored by the Fond’s d’Aide a la
Qualite des Soins de Ville, Fort de France, Martinique.
Preparation of Allergenic Extracts
All the allergenic extracts, Dermatophagoides pteronyssinus,
Dermatophagoides farinae, Blomia tropicalis, Periplaneta americana,
Betula verrucosa, Litopenaeus vannamei, and A aegypti, were prepared
at Inmunotek S.L. Laboratories, Madrid, Spain. All source materials
were extracted overnight in0.1Mphosphate-buffered saline (PBS) (at
1:20w/v) at 4C in constant stirring.After extraction, themixturewas
centrifuged at 7,840g for 10 minutes and the supernatant ﬁltered
through a 0.2-mm membrane. After ﬁltration, the extracts were
dialyzed against distilled water in 3,500-Da cut-off membrane
(Spectra/Por Dialysis membranes, Houston, Texas) and lyophilized.
Protein content was measured by the Bradford method.
Recombinant Arthropod Tropomyosins
His-tagged recombinant tropomyosins from A aegypti (Aed a
10.0201) and L vannamei (Lit v 1) were obtained by expression in
Escherichia coli and puriﬁed by afﬁnity chromatography using
Ni-NTA resin.32 Production of recombinant tropomyosin from
Dpteronyssinus (Derp10) andB tropicalis (Blo t 10)wasperformedas
describedpreviously.33 Recombinant tropomyosin fromPamericana
(Per a 7) was purchased from Indoor Biotechnologies (Cardiff, UK).
Table 1
IgE Levels to Allergenic Extracts in the Serum Samples From the Studied Populationa
Patient no. Age, y Sex Aedes aegypti Dermatophagoides
pteronyssinus
Dermatophagoides
farinae
Blomia tropicalis Periplaneta
americana
Litopenaeus
vannamei
Total IgE, IU/mL
1b 5.62 M 0.319 0.047 0.052 0.045 0.078 0.050 324
2 32.1 F 2.810 1.404 0.937 0.207 0.155 0.843 466
3b 16.8 M 0.795 0.070 0.065 0.052 0.043 0.045 1199
4 39.08 F 0.065 0.187 0.358 0.398 0.053 0.048 243.86
5 8.4 M 0.142 0.210 0.209 0.749 0.049 0.059 752
6 21 F 0.079 0.204 0.469 0.328 0.062 0.044 306
7 11 M 0.070 0.931 1.825 0.666 0.047 0.044 2030
8 4.17 F 0.097 0.678 0.805 0.338 0.054 0.047 835
9 4.07 M 0.058 0.522 0.295 0.130 0.046 0.042 1067
10 5.61 F 0.248 0.231 2.661 2.330 0.047 0.044 1474
11 6.18 M 0.178 0.062 0.109 0.257 0.056 0.053 697
12b 12.48 F 0.232 0.042 0.046 0.043 0.043 0.048 879
13 4.13 M 0.162 0.303 0.523 0.161 0.462 0.123 1496
14 15.09 M 1.240 1.373 1.820 0.272 0.092 0.509 1246
15c 47.9 F 0.179 0.070 0.080 0.046 0.259 0.053 107
16 25.38 F 0.063 0.771 3.079 3.947 0.050 0.044 1198
17 35.66 F 0.055 0.071 0.068 0.124 0.045 0.053 267.86
18 9.73 M 0.060 0.674 1.142 0.048 0.048 0.051 210
19 39.65 F 0.153 0.251 0.147 0.079 0.231 0.074 123
20c 5.94 F 0.108 0.057 0.091 0.048 0.122 0.050 2436
21 5.26 F 0.063 0.182 0.394 0.671 0.055 0.059 343
22 32.85 F 0.112 0.162 0.227 0.386 0.054 0.077 181
23c 11.05 M 0.153 0.092 0.081 0.057 0.144 0.080 2163.78
24 5.4 F 0.127 1.442 1.242 0.215 0.087 0.048 1047
25 8.92 F 0.073 2.199 2.136 1.947 0.047 0.056 1491
26 1 M 0.066 0.084 0.152 0.473 0.046 0.057 214
27 35.6 F 0.059 0.532 0.251 0.052 0.053 0.051 181.29
28d 4.2 M 0.458 0.325 0.399 0.468 0.064 0.120 2187
29d 4.39 F 1.221 0.908 1.910 1.982 0.241 0.098 2104
30d 18.83 M 0.186 0.208 0.790 1.517 0.045 0.043 2832
31d 2.4 F 0.286 0.137 0.171 0.145 0.048 0.053 304
32d 27.39 F 0.355 0.740 0.680 0.450 0.130 0.120 545.5
33d 3.31 M 1.982 3.900 3.850 1.210 0.140 1.350 2853
34d 13.19 M 3.268 0.920 0.300 0.180 0.160 0.730 2477
Mean (SD) 15.4 (13.2) 44% M 0.46 (0.78) 0.59 (0.78) 0.8 (0.97) 0.59 (0.85) 0.1 (0.09) 0.15 (0.28) 1067.05 (863.06)
aSpeciﬁc IgE levels are indicated as optical density at 492 nm. Optical density at 492 nm of 0.095 was used as cutoff value. Serum samples with higher optical density were
considered as IgE positive and are indicated in bold.
bMonosensitized to Aedes aegypti.
cSensitized to A aegypti and Periplaneta americana.
dSerum samples from these patients were used for preparing the pool of 7 serum samples.
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Determination of Speciﬁc IgE
Plastic Microlon, high-binding microtiter plates (Greiner Bio-
One, Monroe, North Carolina) were coated overnight with 0.5 mg
of extract per well. After washing 3 times with PBS-T (PBS, pH 7.4,
and 0.25% Tween 20), nonspeciﬁc binding was blocked by incuba-
tion for 1 hour with PBS-T that contained 1% bovine serum albumin
(BSA). After 3 additional washing, plates were incubated for 2 hours
with individual serum samples, diluted 1:8 in PBS-T plus 1% BSA,
then washed and incubated for 1 hour with 1:2,000 horseradish
peroxidaseeconjugated mouse anti-human IgE (Southern Biotech,
Birmingham, Alabama). Finally, microplates were washed and
incubated for 30 minutes with the substrate o-phenylenediamine
dihydrochloride (Sigma-Aldrich, St Louis, Missouri). The reaction
was stopped with 3.2% hydrochloride, and optical density was read
at 492 nm. All the experiments were performed at 4C in duplicate.
Serum samples from 9 patients sensitized to pollens were used as
negative controls. The mean of IgE levels from these samples þ3
SDs were used as the cut off for positive IgE levels.
ELISA Inhibition Assays
Cross-reactivity studies were performed using a serum pool
prepared by mixing equal volumes of 7 selected serum samples. All
7 patients had a positive SPT result withmosquito andmite extracts
and detectable speciﬁc IgE against these allergens. Furthermore, 4
of these individuals also had positive SPT result and detectable
speciﬁc IgE to cockroach and 5 to shrimp (Table 1 and Table 2).
Microplates were coated with A aegypti extract and blocked as
described before. Subsequently, 50 mL of serially diluted extracts
(D pteronyssinus, B tropicalis, L vannamei, and P americana) or re-
combinant tropomyosins (Aed a 10.0201, Der p 10, Blo t 10, Lit v 1,
and Per a 7) (inhibitors) and 50 mL of 1:4 diluted serum pool were
added to the wells. Microplates were incubated overnight at 4C.
The reaction was developed as described above. The positive con-
trol consisted of serum pool adsorbed with PBS-T that contained 1%
BSA without inhibitor. B verrucosa extract was used as negative
control.
SDS-PAGE and Immunoblotting
Proteins from the mosquito extract were separated by sodium
dodecyl sulfateepolyacrylamide gel electrophoresis (SDS-PAGE)
under denaturing conditions using a Mini-PROTEAN II apparatus
(Bio-Rad, Hercules, California). Ten micrograms of extract were
mixed with a buffer that contained b-mercaptoethanol and boiled
for 5minutes and then separated in 12% continuous polyacrylamide
gels at 120 V. After separation, gels were stained with GelCode Blue
stain reagent (Life Technologies, Carlsbad, California). Precision Plus
Protein All Blue Standards (Bio-Rad) were used to determine the
relative molecular weights of the electrophoresed components.
Proteins were transferred onto a 0.45-mm nitrocellulose membrane
using a Transblot Semydry Electrophoresis transfer cell (Bio-Rad) at
20 V for 30 minutes. Nonspeciﬁc binding was blocked with PBS-T
that contained 5% BSA, for 45 minutes. Membranes were washed
2 times with PBS-T, then incubated with serum pool diluted 1:10 in
PBS-T that contained 1% BSA, for 2 hours. After 3 further washings
with PBS-T, the membranes were incubated with 1:2,000
horseradish peroxidaseeconjugated mouse anti-human IgE
(Southern Biotech) for 1 hour and incubated with ECL Prime
detection reagent (GE Healthcare Life Sciences, Buckinghamshire,
England). Chemiluminescence was detected with a GeneGnome
apparatus (Syngene, Cambridge, United Kingdom). Precision Plus
Protein WesternC Standards (Bio-Rad), previously incubated with
Precision Protein StrepTactin-HRP Conjugate (Bio-Rad), were used
to determine the relative molecular weights.
Immunoblot Inhibition
SDS-PAGE (12% polyacrylamide, under reducing conditions) and
immunoblotting were performed as described above, except that
transferred nitrocellulose membranes were incubated with
the serum pool, previously adsorbed with 100 mg/mL of the
homologous, heterologous, and control inhibitors.
Excision and In-Gel Protein Digestion of Electrophoresed Bands
Bands of 14.1, 15, 17.9, and 54.3 kDa in Coomassie-stained gels of
electrophoresed A aegypti extract were excised manually, then
deposited in 96-well plates and processed automatically in a
Proteineer DP (Bruker Daltonics, Bremen, Germany). Tryptic
digestion was performed as described by Schevchenko et al,34 with
minor variations. Gel plugs were washed with 50 mM ammonium
bicarbonate (ABC) and with acetonitrile (ACN) before reduction
with 10 mM dithiothreitol in 25 mM ABC solution. Alkylation was
performed with 55 mM iodoacetamide in 50 mM ABC. Gel pieces
were rinsed and dried under a nitrogen stream. Proteomics Grade
Trypsin (Sigma-Aldrich) at a ﬁnal concentration of 16 ng/mL in 25%
ACN/50 mM ABC solution was added for digesting at 37C for 4
hours. The reaction was stopped with 50% CAN and 0.5%
triﬂuoroacetic acid. The tryptic eluted peptides were dried by
speed-vacuum centrifugation and dissolved inMALDI solution (30%
ACN, 15% isopropanol, and 0.5% triﬂuoroacetic acid). An aliquot of
each peptide mixture was deposited onto a 384-well OptiTOFTM
Plate (SCIEX, Foster City, California) and allowed to dry at room
temperature; then an aliquot of matrix solution (3 mg/mL of
a-cyano-4-hydroxycinnamic acid in MALDI solution) was added
and allowed to dry at room temperature.
MALDI Peptide Mass Fingerprinting, MS/MS Analysis, and Database
Searching
Digested bands were characterized by MALDI-TOF/TOF mass
spectrometry (MSþMS/MS) at Centro Nacional de Biotecnología,
Madrid, Spain. For this analysis, samples were automatically
acquired in an ABi 4800MALDI TOF/TOFmass spectrometer (SCIEX,
Foster City, California) in positive ion reﬂector mode (the ion
acceleration voltage was 25 kV to MS acquisition and 2 kV to
MS/MS) and spectra stored into the ABI 4000 Series Explorer Spot.
Table 2
Clinical Characteristics of the Serum Samples Used in the Serum Poola
Patient no. Diagnosis Mosquito
SPT
Dermatophagoides pteronyssinus
SPT
Blomia tropicalis
SPT
Cockroach
SPT
Shrimp
SPT
28 A, C þ þ þ þ þ
29 A þ þ þ þ þ
30 A, AD þ þ þ  þ
31 R þ þ þ þ þ
32 C, AD þ þ þ  
33 R þ þ þ  þ
34 AD, R þ þ þ  þ
Abbreviations: A, asthma; AD, atopic dermatitis; C, conjunctivitis; R, rhinitis; SPT, skin prick test.
aPlus sign indicates positive test result; minus sign, negative test result.
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Peptide mass ﬁngerprinting (PMF) and MS/MS fragment ion
spectra were smoothed and corrected to zero baseline using
routines embedded in ABi 4000 Series Explorer Software,
version 3.6 (SCIEX, Foster City, California). Each PMF spectrum was
internally calibrated with the mass signals of trypsin autolysis ions
to reach a typical mass measurement accuracy of less than 25 ppm.
Known trypsin and keratin mass signals, as well as potential
sodium and potassium adducts (þ21 Da and þ39 Da), were
removed from the peak list. To submit the combined PMF and
MS/MS data to MASCOT software, version 2.5.10 (Matrix Science,
London, United Kingdom), GPS Explorer software, version 4.9, was
used, searching in the A aegypti protein database from
Uniprot-SwissProt repository (UKBsp-p7159_20150327; 17740
sequences; 8088037 residues). The conﬁdence interval for protein
identiﬁcation was set to 95% or greater (P < .05), and only peptides
with an individual ion score above the identity threshold were
considered correctly identiﬁed.
BLASTp analysis was performed with the sequences of the
characterized proteins to identify potential cross-reactive proteins
in mites, cockroach, and shrimp.
Structural Modeling and Bioinformatics Analyses of the Amino Acid
Sequence of Peptidyl-Prolyl Cis-trans Isomerase From A aegypti
A 3-dimensional homology model of A aegypti peptidyl-prolyl
cis-trans isomerase (PPIase) was generated using the SWISS-
MODEL workspace via the ExPASy web server.35 The proposed
3-dimensional structure of the proteinwas modelled using the PDB
template 2biu.1A (human cyclophilin; sequence identity: 73.01%;
z score: 1.28; GMQE: 0.95; QMEAN: 1.60). The amino acid
sequence of PPIase from A aegypti was compared with other
allergenic cyclophilin sequences using the multiple alignment
viewer MView (http://www.ebi.ac.uk/Tools/msa/mview/). The
sequences of cyclophilins from mite (D farinae), mosquitoes (Aedes
albopictus, Anopheles gambiae, and Culex tarsalis), ﬂies (Musca
domestica and Drosophila melanogaster), shrimp (L vannamei),
cockroach (Blattela germanica), bee (Apis mellifera), and human
(Homo sapiens) were used to map the conserved sequences on the
surface of the 3-dimensional structure of themosquito PPIase using
the program ConSurf, which scores the amino acids according to
their degree of conservation.36
Results
Speciﬁc IgE to Mosquito, Mites, Cockroach, and Shrimp Extracts in
Serum Samples From Allergic Patients
Twenty-seven serum samples (79.41%) were positive for
D farinae, 25 (73.53%) for D pteronyssinus and B tropicalis, 22 (64.7%)
for A aegypti, 10 (29.41%) for P americana, and 8 (23.53%) for
L vannamei. Sensitization to at least one mite species was 82.35%
(Table 1).
Tropomyosin Cross-reactivity Between Mosquito and Other
Arthropods
Enzyme-linked immunosorbent assays (ELISAs) using A aegypti
on the solid phase revealed that at 50 mg/mL D pteronyssinus,
L vannamei, B tropicalis, and P americana inhibited the IgE reactivity
in 96.6%, 95.4%, 84.4%, and 75.4%, respectively. The unrelated
extract used as control, B verrucosa, produced 10% inhibition
(Fig 1A). When the recombinant tropomyosins were used as
competitors with A aegypti extract on the solid phase, maximum
inhibitions of IgE reactivity of 55%, 51%, 50%, 41.5%, and 9.3% were
obtained at the higher concentration of Per a 7, Der p 10, Blo t 10, Lit
v 1, and Aed a 10, respectively (Fig 1B).
Involvement of Several IgE-Binding Components in the
Cross-reactivity Between A aegypti and Other Arthropods
Several bands between 10 and 150 kDa were detected in the A
aegypti extract. At least 11 bands (at 14.1, 15, 16.6, 17.9, 20.1, 28.3,
31.8, 46.6, 54.3, 74.2, and 124.1 kDa) reacted with speciﬁc IgE
(Fig 2A). Homologous immunoblotting inhibition of IgE reactivity to
A aegypti extract with 100 mg/mL of inhibitor revealed almost
complete inhibition; no inhibition was observed with the
B verrucosa extract (Fig 2B).
In the case of using mite extract as an inhibitor, the inhibited
bands were those of 74.2, 28.3,17.9, 16.6, and 14.1 kDa. In the case of
cockroach, cross-reactive bands were 124.1, 74.2, 54.3, 46.6, 28.3,
17.9,16.6, and 15 kDa. In the case of shrimp, bands of 74.2, 28.3, 20.1,
17.9, and 16.6 kDa seem to be involved in cross-reactivity. Bands of
74.2, 28.3, 17.9, and 16.6 kDa were inhibited by all the inhibitors.
The 31.8-kDa band of A aegypti previously identiﬁed as tropomy-
osin32 had important reduction in the IgE reactivity when the
serum pool was adsorbed with mite, shrimp, and cockroach
extracts (Fig 2C).
Novel A aegypti Allergens
The MALDI PMF and MS/MS analysis identiﬁed 4 proteins in the
mosquito extract: the band of 14.1 kDa as odorant binding protein
(OBP) (Uniprot Q1HRL7), the band of 15 kDa as mitochondrial
cytochrome C (Uniprot Q1HRI9), the band of 17.9 kDa as PPIase
(Uniprot Q1HRR9), and the band of 54.3 kDa as AAEL001668-PA
(Uniprot Q17KK5), the product of the AAEL001668 gene with a
hypothetical magnesium ionebinding function (Table 3). None of
these proteins had been previously reported as mosquito allergens.
BLASTp analysis found homology of PPIase with Der f 29
allergen from D farinae, and sequence alignment reveasled 81.1%
identity in the amino acid sequences (Fig 3). We further conducted
a comparative structural analysis of PPIase with other related
allergens.
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Figure 1. Enzyme-linked immunosorbent assay inhibition. Microplate wells coated
with Aedes aegypti extract were incubated with pooled sera previously adsorbed
with different concentrations of arthropod extracts (A) or recombinant tropomyo-
sins (B) as inhibitors.
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Structural Analysis of PPIase From A aegypti
The modeled PPIase from A aegypti revealed a 3-dimensional
folding consisting of a b-barrel of 8 antiparallel b-strands and 2
surrounding a-helices (Fig 4A,B). This folding is similar to other
cyclophilins. However, it differs in the b-barrel with 8 antiparallel
b-strands instead of the typical b-barrel in cycliphilins, which
contain 7. Multiple sequence alignment of PPIase from A aegypti
with cyclophilins reported as allergens (Fig 5A) reveals a high
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degree of homology (>71%) with Der f 29 and with Rhi o 2 of
Rhizopus arrhizus. A lower degree of homology (<22%) is observed
when compared with cyclophilins, such as Sola l 5 from tomato
(Solanum lycopersicon), Cat r 1 from Catharanthus roseus, Asp f 11
from Aspergillus fumigatus, Mala d 6 fromMalassezia dermatis, and
Bet v 7 from Betula verrucosa. Two highly conserved residues
(99SMANAGPNTNGSQFFI113 and 121WLDDRHVVFG130 in the
mosquito PPIase sequence) were previously identiﬁed in the
cyclophilins allergen sequences and believed to be potential
candidates for cross-reactivity.37 These regions are indicated with
arrows in Figure 5A. Region 1 is 100% conserved in the mosquito
PPIase, and region 2 contains 2 substitutions (124 G-D and 125
K-R) on the amino acid sequence. Analysis of the surface residue
conservation of the modeled PPIase with cyclophilins from mites,
ﬂies, shrimp, cockroach, bee, and human (Fig 5B) reveals a high
degree of conservation in several surface areas, suggesting a
strong possibility of cross-reactivity among cyclophilins,
including A aegypti PPIase.
Discussion
In the present work, we found that A aegypti cross-reacts with
other arthropods and that several proteins are involved in this
phenomenon. The clinical relevance of cross-reactivity is well
documented for foods, pollens, andmites.38 However, it is less clear
for other allergen sources, such as mosquitoes. In the tropics, mites,
cockroaches, and shrimp represent environmental risk factors for
allergy. Therefore, and because of IgE cross-reactivity, coexposure
to A aegypti allergensmay also have a clinical effect on patients with
allergies. Similar effects have been proposed for A lumbricoides,
which seems to be an enhancer of the allergenic effects of mite
allergens.39e41 The potential effect of mosquito allergens on
allergenic symptoms has not yet been deﬁned, and the results of
this study suggest that further research is clearly needed to clarify
this issue.
Several studies have revealed a prevalence of sensitization to
mosquito from 4% to 47.8%.42e45 The frequency of IgE reactivity to A
aegypti found in this study (64.7%) is one of the highest reported
and is similar to the prevalence of sensitization to mites in allergic
individuals. Although a small number of serum samples were
investigated, this frequency could result from the particular con-
ditions of this Caribbean population, such as differences in climate,
the increasing density of A aegypti,46 and the genetic background of
the population. In addition, cross-reactivity with other arthropod
allergens could also contribute to these ﬁndings. Mosquito speciﬁc
allergens also seem to be involved in the sensitization process
because 3 patients were monosensitized to A aegypti and 3 were
cosensitized to A aegypti and P americana (Table 1). Altogether,
these data suggest that mosquitoes may represent an important
allergen source for some patients in the Caribbean.
The tropics is one of the regions with the highest prevalence of
D pteronyssinus and B tropicalis allergens in the environment. These
2 species are the most common in Cartagena, Colombia,47 Puerto
Rico,48 San José de Costa Rica,49 and Cuba.50 These observations
suggest that D pteronyssinus and B tropicalis are the primary
sensitizers in the allergic population from Martinique.
In tropical regions, the allergenicity of A aegypti and its capacity
to cross-react with mite and other arthropod allergens must be
consideredwhen conducting routine allergen testing. An important
task is to dissect whether the skin test reaction is the result of
cross-reactivity or is a speciﬁc sensitization to several allergen
sources. Whether the speciﬁcity of mosquito sensitization is biased
by cosensitization to mites and other arthropods is a topic that
must be further evaluated. Furthermore, the use of species-speciﬁc
allergens may be helpful to solve this problem.
Immunoblots revealed 11 allergenic bands, ranging from 14 to
124.1 kDa, involved in the cross-reactivity between A aegypti and
the other arthropods. Furthermore, some bands of A aegypti
revealed cross-reactivity restricted to one arthropod. For example,
the band of 14.1 kDa cross-reacts exclusively with mites, the bands
of 124.1, 54.3, 46.6, and 15 kDa with cockroach, and the band of
20.1 kDa with shrimp.
Our results differ from those obtained by Wongkamchai et al.26
Wongkamchai et al26 used serum samples from individuals with
cutaneous allergic reactions, whereas our serum samples were
derived from individuals with respiratory allergies. These authors
identiﬁed only one IgE-reactive band at 42.9 kDa in a whole-body
extract from A aegypti, probably because of the different criteria
used in the selection of the sera. Other studies have found that
allergenic extracts prepared exclusively from saliva or salivary
Table 3
Proteomic and Homology Search Results of New IgE Reactive Bands Isolated From Aedes aegypti
Protein name Uniprot MASCOT
score
E value Coverage, % MS (MS/MS) Function Theoretical
MW, kDa
Experimental
MW, kDa
Identity, %
Odorant-binding protein Q1HRL7 185 5.60E-15 51 7 (2) Odorant-binding 14.1 14.15 NF
Mitochondrial cytochrome C Q1HRI9 140 1.80E-10 40 5 (1) Ion-binding activity 15 15 NF
Peptidyl-prolyl cis-trans
isomerase
Q1HRR9 410 1.80E-37 68 9 (5) Isomerase rotamase 17.9 17.88 Der f 29 (81%)
AAEL001668-PA Q17KK5 540 1.80E-50 63 21 (4) Magnesium ionebinding 54.3 54 NF
Abbreviations: MS, mass spectroscopy; MW, molecular weight; NF, not found.
PPIase MGLPRCFFDLTADNAPLGRVVIELRTDVTPKTCENFRALCTGEKGFGYKGSTFHRVIPNF
Der f 29    MALPRVFFDIAADNQPLGRIVIELRSDVVPKTAENFRALCTGEKGFGFKSSSFHRIIPNF
*.*** ***::*** ****:*****:**.***.**************:*.*:***:****
PPIase MCQGGDFQNHNGTGGKSIYGNKFEDENFILRHTGPGIMSMANAGPNTNGSQFFITTVKTS
Der f 29    MIQGGDFTNHNGTGGKSIYGNKFADENFTLQHTGPGIMSMANAGPNTNGSQFFITTVKTT
* ***** *************** **** *:****************************:
PPIase WLDDRHVVFGSVVEGMDVIRKVESYGNQSGKTSKQIVVSNCGQL
Der f 29    WLDGKHVVFGSVVEGMDIVKKVESYGSQSGKPSKKVTIANCGQL
***.:************:::******.****.**::.::*****
Figure 3. Amino acid sequence alignment of peptidyl-prolyl cis-trans isomerase (PPIase) from Aedes aegypti and its homologue allergen, Der f 29, from the mite Dermato-
phagoides farinae.
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glands contain the allergens involved in allergic skin reactions
caused by mosquito bites.2,4,7
Our SDS-PAGE and immunoblot results allowed the selection of
4 bands to further analysis by MS (Table 3). The identiﬁed proteins
OBP, mitochondrial cytochrome C, and PPIase and the unknown
protein AAEL001668-PA are novel IgE-binding proteins, and except
for PPIase, no homologues of these molecules have been reported
in mites, cockroach, or shrimp. From a taxonomic perspective,
mosquitoes, mites, cockroach, and shrimp are related, and some
degree of cross-reactivity is expected. This assumption correlated
with the results obtained in the ELISAs. However, further homo-
logous proteins shared by these species remain to be described.
In this work, we report the presence of an IgE-binding PPIase
(band of 17.9 kDa) in A aegypti, which seems to correspond to a
potential panallergen. This band had cross-reactivity with all the
inhibitors. In addition, we found a high sequence identity of this
proteinwith the allergen Der f 29. Der f 29 reacted with IgE in 85.6%
of the serum samples tested by immunoblotting51 and in 21% when
analyzed by skin prick test in a Chinese mite allergic population.52
Several allergens homologous to PPIase or cyclophilin from plants
or fungi have been characterized,53e55 suggesting that they may
represent an important group of panallergen.
We further analyzed the potential cross-reactivity of the
mosquito PPIase by a bioinformatics approach that allowed the
comparison of the primary, secondary, and tertiary structures of
this protein with other members of the same protein family. The
predicted secondary structure of the A aegypti PPIase is similar to
other cyclophilins37,56 that contain a b-barrel surrounded by 2
a-helices (Fig 4). Furthermore, its amino acid sequence is similar to
sequences of allergenic cyclophilins frommites and molds (Fig 5A).
These results suggest that A aegypti PPIase may contain
cross-reactive B-cell epitopes. Our analysis predicts that 2 regions
on the amino acid sequence of cyclophilins, reported as putative IgE
binding epitopes, are highly conserved in the sequence of the
mosquito PPIase (Fig 5A). Furthermore, the surface of the modeled
protein reveals several areas highly conserved in cyclophilins from
diverse origins. All together, these results suggest that this protein
could represent a novel panallergen.
The ELISA inhibition experiments revealed that the recombinant
Aed a 10.0201, recombinant Lit v 1, recombinant Der p 10,
recombinant Blo t 10, and Per a 7 inhibited less than 60% the
IgE-binding to the A aegypti extract. Furthermore, allergenic
extracts of these arthropods produced higher inhibition (in some
cases>95%). These results indicate that tropomyosin is not the only
allergen involved in the cross-reactivity between A aegypti and the
other arthropods. A aegypti tropomyosin inhibited less than 10% the
IgE binding to themosquito extract. This resultmay be explained by
the apparent reduced IgE epitope representation in the variant Aed
Figure 4. Structural characteristics of peptidyl-prolyl cis-trans isomerase from Aedes aegypti. (A) Topologic diagram showing the secondary structure elements. (B) Modeled
3-dimensional structure showing a b-barrel of 8 antiparallel b-strands and 2 surrounding a-helices.
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a 10.0201, used in this study, compared with the Aed a 10.0101
variant.32 The use of this variant could result in higher inhibition.
These ﬁndings highlight the need to identify and characterize
the complete set of cross-reactive and species-speciﬁc allergens
frommosquitoes, mites, and other arthropods to better understand
the molecular aspects of cross-reactivity and design improved
strategies that may lead to better diagnosis and treatment of the
allergic population, especially in the tropics where these allergenic
sources are prevalent.
In conclusion, we found that A aegypti cross-reacts with
mites, shrimp, and cockroach and report that several proteins
are potentially involved in this phenomenon, including 4 novel
allergens. Further studies are necessary to clarify the role of
these molecules in the pathophysiology of allergies in the
tropics, subtropics, and other places where mosquitoes are
abundant.
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ABSTRACT 
Background: Dermatophagoides pteronyssinus and Aedes aegypti are important sources of allergens, 
including tropomyosin. The functional and clinical relevance of this cross-reactivity is still a matter of 
debate. In this study we analysed the molecular and cellular cross-reactivity among tropomyosins from A. 
aegypti (Aed a 10.0101 and Aed a 10.0201) and D. pteronyssinus (Der p 10).  
Methods: Sera from 15 Austrian HDM-allergic patients sensitized to Der p 10 were tested for cross-
reactivity with rAed a 10.0101 and rAed 10.0201, by ELISA, basophil activation test and inhibition assays. 
BALB/c mice were immunized with Aed a 10.0101 or Aed a 10.0201 and IgE and IgG antibodies 
measured. The cellular cross-reactivity and T-cell epitope mapping were analysed in splenocytes 
stimulated with the tropomyosins. 
Results: Der p 10-sensitized patients displayed IgE-reactivity to tropomyosins from A. aegypti. Aed a 
10.0101 produced a more pronounced inhibition of the IgE-binding to Der p 10 and was also more potent 
in activating basophils than Aed a 10.0201. Mice immunized with Aed a 10.0101 and Aed a 10.0201 
produced specific IgE, IgG1, IgG2a and IgG3 antibodies which cross-reacted with Der p 10. All 
tropomyosins induced proliferation of mice splenocytes. Five regions in the amino acid sequence were 
identified to contain cross-reactive T-cell epitopes. 
Conclusion: Tropomyosins from D. pteronyssinus and A. aegypti showed humoral and cellular cross-
reactivity, involving 5 potential T cell-activating regions. The cross-reactive potential increases with their 
amino acid sequence homology. A more detailed characterization of tropomyosins will contribute to 
elucidate the clinical impact of tropomyosin cross-reactivity in mites, mosquitoes and other arthropods. 
 
INTRODUCTION 
The inhalation of Dermatophagoides 
pteronyssinus allergens is one of the main 
causes of IgE-mediated allergies worldwide 
(1). The mosquito species Aedes aegypti is 
also a source of several allergens (2, 3). 
However, its role in the onset or exacerbation 
of allergic diseases is still under evaluation. 
HDM and mosquitoes are evolutionarily 
related as part of the Phylum Arthropoda and 
IgE cross-reactivity between them has been 
demonstrated (4). The presence of pan-
allergens, such as tropomyosin, may partially 
explain this phenomenon. A high degree of 
cross-reactivity has been demonstrated 
between HDM and crustaceans (5), mollusks 
(6) and insects (7), with tropomyosin being 
one of the potential allergens involved.  
Tropomyosin is a pan-allergen (8) that 
belongs to a two-stranded alpha-helical coiled 
coil proteins family, which can induce allergic 
sensitization by ingestion (seafood), inhalation 
 
 
(mites, cockroaches), or parasite infection (9, 
10). In developed countries, the IgE frequency 
of sensitization to tropomyosin is low (11, 12). 
However, in Africa and South America, the 
prevalence is approximately 50% (13, 14). 
Several tropomyosin allergens have been 
described in mites (15), helminths (16) and 
insects (17), including mosquitoes (3).  
The molecular aspects of allergenic cross-
reactivity among the different tropomyosins 
have been studied. Ayuso, R. et al. (18, 19) 
described eight peptides which correspond to 
five putative cross-reactive IgE-binding 
epitopes sharing from 56% to 98% of 
homology with tropomyosins from shrimp, 
lobster, house dust mite, and cockroach. 
These regions coincided with five IgE binding 
mimotopes described by Leung N. et al (20). 
T-cell epitopes from shrimp and cockroach 
tropomyosins restricted to multiple MHC class 
II alleles have also been described (21, 22). 
However, to the best of our knowledge cross-
reactivity at the T-cell epitope level has not 
been described. 
It has been demonstrated that natural A. 
aegypti tropomyosin highly cross-react with 
HDM tropomyosin. A. aegypti produces two 
tropomyosin variants; Aed a 10.0101 and Aed 
a 10.0201 (3), which slightly differ in their 
primary structure. Aed a 10.0101 has higher 
homology to other allergenic tropomyosins 
and higher conservation of the putative IgE-
binding epitopes described by Ayuso, R. et al. 
However, a greater number of substitutions 
were observed in Aed a 10.0201. Based on 
ELISA competition experiments and sequence 
analyses, we suggested that Aed a 10.0101 
contains a higher number of IgE binding 
epitopes, is more allergenic and may be more 
cross-reactive than Aed a 10.0201 (3).  
In this study, we analysed the humoral and 
cellular cross-reactivity between recombinant 
HDM tropomyosin (rDer p 10) and A. aegypti 
tropomyosins (rAed a 10.0101 and rAed a 
10.0201). The humoral cross-reactivity was 
tested by immunoassays using human IgE 
and murine antibodies, and the basophil 
activation test. The cellular cross-reactivity 
and T-cell epitope mapping were analysed in 
splenocytes from mice immunized with 
mosquito-derived tropomyosins.   
MATERIALS AND METHODS 
Sera 
In total, 15 patients (9 female, 6 male, median 
age of 25 years, Table 1) allergic to HDM 
were included. All individuals suffered from 
perennial rhinoconjunctivitis and showed 
positive skin prick tests to HDM extract (ALK 
Abello, Hørsholm, Denmark), as well as IgE 
specific for HDM and Der p 10 as determined 
by ImmunoCAP (Table 1). 
Allergens 
Recombinant (r) Der p 10 was expressed as 
described. Whole body extract of A. aegypti, 
and recombinant tropomyosins of A. aegypti, 
Aed a 10.0101 and Aed a 10.0201, termed 
rAed a 10.01 and rAed a 10.02 in the 
following, were produced as described (3).  
Circular dichroism 
Far UV CD spectra of rDer p 10 (280 µg/ml 
0.1M PBS), rAed a 10.01 (250 µg/ml 0.1M 
Tris-HCl,) and Aed a 10.02 (500 µg/ml 0.1M 
PBS) were collected on a Jasco J-810 
spectropolarimeter (Japan Spectroscopic Co., 
Tokyo, Japan) using a 1mm path length 
quartz cuvette. Measurements were done 
between 250 to 190 nm, with 0.5 nm 
resolution at a scanning speed of 50 nm/min. 
Three independent measurements were 
recorded and averaged for each spectral 
point. The final spectra were baseline 
corrected by subtracting the corresponding 
buffer spectrum. Results were expressed as 
the mean residue ellipticity [θ] at a given 
wavelength 
Detection of human IgE 
ELISA plates (Nunc Maxisorp, Thermo Fisher 
Scientific, Waltham, MA, USA) were coated 
overnight (ON) at 4ºC with extract (250 µg/ml) 
or recombinant allergens (0.5 µg/ml), in 
carbonate buffer (pH=9.6). After washing 
twice with PBS containing 0.05% Tween 20 
(PBS-T), non-specific binding was blocked by 
incubation for 6 hours at RT with PBS-T 
supplemented with 1% HSA. Plates were 
incubated ON at 4ºC, with the sera diluted 1:4 
in PBS-T containing 1% HSA. After washing, 
bound IgE was detected with alkaline-
phosphatase conjugated anti-human IgE Ab 
(BD Pharmingen, San Jose, CA, USA) diluted 
1:2,000 in PBS-T containing 1% HSA, for  60 
minutes at 37ºC and 60 minutes at 4ºC. After 
washing, the substrate PNPP was added and 
the reaction was measured at 405-550 nm. All 
experiments were performed in duplicate. 
Sera from three non-allergic individuals were 
used as negative controls. The mean values 
from these samples plus five standard 
deviations were used as the cut off for positive 
IgE levels. For inhibition experiments sera 
 
 
were pre-incubated with the indicated 
concentrations of the recombinant 
tropomyosins. 
Mice immunization 
Female BALB/c mice were immunized 
intraperitoneally (i.p.) with either A. aegypti 
extract, rAed a 10.01 or rAed a 10.02, or PBS 
adsorbed to Alum hydroxide (Brenntag, 
Mülheim, Germany). In total, the animals 
received four i.p. injections of 25 µg of antigen 
adsorbed to 2 mg Alum, in 250 µL every two 
weeks. Fifteen days after the last 
immunization, blood was collected and mice 
were sacrificed and the spleens were 
removed under aseptic conditions. 
Detection of murine antibody responses 
ELISA plates were coated and saturated as 
described above. For detection of IgG1, 
IgG2a and IgG3 sera were diluted 1:500; and 
for IgE 1:12 and incubated ON. Bound 
antibodies were detected with rat anti-mouse 
IgG1, IgG2a, IgG3 and IgE antibodies (BD 
Pharmingen), followed by a HRP-conjugated 
goat anti-rat IgG (GE Healthcare, Vienna, 
Austria). ABTS was added and the reaction 
was measured at 405-490 nm. 
Lymphoproliferation 
Splenocytes (2x105 cells/well) from mice 
immunized with rAed a 10.01 and Aed a 10.02 
were incubated  in round bottom 96 well 
plates (Nunc) with rDer p 10, Aed a 10.01, 
Aed a 10.02 (100 ng antigen/well – 12.5 ng 
antigen/well) or medium alone for 4 days at 
37ºC. Concanavalin A (0.5 µg/well; Sigma 
Aldrich, USA) served as positive control. In 
addition, splenocytes were incubated with 28 
overlapping synthetic 20-mer peptides (1 
µg/well) representing the complete amino acid 
sequence of Aed a 10.01 (Thermo Fisher 
Scientific, Waltham, MA, USA). During the last 
16 hours 3[H]-labeled thymidine (0.5 mCi/mL) 
was added. Stimulation indices (SI) were 
calculated as the ratio between counts per 
minute (cpm) obtained in cultures with 
splenocytes plus tropomyosins and cpm 
obtained in cultures containing splenocytes 
and medium alone. A SI of 2 was defined as 
positive proliferation.  
Basophil activation test  
PBMCs were purified from blood samples 
from donors using Ficoll gradient 
centrifugation. PBMCs were stripped in ice 
cold lactic acid buffer (0.13 M KCl, 0.05 M 
NaCl, 0.01 M Lactic acid, pH=3.9). After 
washing twice with PBS, cells were re-
suspended in 80 µL of PBS and 80 µL of sera 
from HDM-allergic individuals and incubated 
for 1 hour at 37ºC. After washing, re-
sensitized cells were incubated with different 
concentrations of each tropomyosin, positive 
controls (fMLP or anti-IgE) and medium as 
negative control for 15 min. Cells were stained 
with PE-conjugated anti-human CD63, 
PerCP-conjugated anti-human CD123 and 
APC-conjugated anti-human CCR3. Basophil 
activation was expressed as the percentage 
of CD63+ basophils. 
For inhibition experiments, allergens were 
pre-incubated with sera from mice immunized 
with A. aegypti antigens (rAed a 10.01, rAed a 
10.02 and extract) and used for stimulation of 
re-sensitized basophils, as described.  
Table 1. Clinical details and sensitization profiles of 15 HDM with specific IgE against Der p 10, used in the study. 
Patient  
No. 
Age [y] Sex 
Specific IgE [IU/mL] Specific IgE (O.D.) 
HDM rDer p 10 rDer p 10 rAed a 10.0101 rAed a 10.0201 
1 51 F 41 1.07 0.263 0.130 0.236 
2 9 M 385 6.30 0.857 0.778 0.368 
3 8 M 1156 16.8 1.961 1.924 1.215 
4 27 F 443 n.d. 1.141 0.919 1.015 
5 58 M 763 1.98 0.322 0.279 0.219 
6 30 F 694 6.96 0.871 0.860 0.314 
7 30 F 33 11.2 1.279 1.282 1.073 
8 10 M 303 n.d. >2.500 >2.500 >2.500 
9 25 F 242 2.11 0.385 0.306 0.247 
10 64 F 54 55.1 >2.500 >2.500 0.851 
11 12 M 14.9 27.5 0.755 0.536 0.331 
12 7 F 4.07 10.6 0.444 0.483 0.161 
13 15 F 46.9 57.0 1.894 2.081 0.499 
14 8 F 0.37 1.54 0.114 0.113 0.092 
15 40 M 1.47 7.71 0.353 0.460 0.310 
M: Male; F: Female; IU: International units; n.d.: not determined 
 
 
 
 
 
 
Figure 1. ELISA inhibition assays. Sera from 4 HDM allergic individuals were adsorbed with different concentrations of 
rDer p 10, rAed a 10.0101 and rAed a 10.0201, and assays for IgE-reactivity against the three tropomyosins 
 
 
 
 
 
Figure 2. Basophil activation test. Stripped basophils sensitized with the IgE from the sera of 4 HDM-allergic patients 
were stimulated with different concentrations of rDer p 10, rAed a 10.0101 and rAed a 10.0201. Activation of basophils 
was expressed as the percentage of CD63
+
 basophils. 
 
 
 
Figure 3. Cross-reactivity among tropomyosins with murine IgG1. Sera from rAed a 10.0101-mice and rAed a 10.0201-
mice was tested for specific IgG1 against tropomyosins from D. pteronyssinus and A. aegypti. 
 
 
 
 
 
Figure 4. Inhibition of the BAT assay. Allergens at 10 µg/mL and 100 µg/mL were incubated with the sera from rAed a 
10.0101-mice and rAed 10.0201-mice. BAT assay was performed as described. 
 
 
RESULTS 
Characterization of folded biologically 
active rAed a 10.01 and Aed a 10.02 
The analysis of the amino acid sequence 
alignment revealed that Der p 10 shares 
78.9% of identity with Aed a 10.01 and 62.7% 
with Aed a 10.02. To evaluate if these 
allergens also shared a similar secondary 
structure, the far-UV CD spectra of rDer p 10, 
rAed a 10.01 and rAed a 10.02 were recorded 
at room temperature. All spectra showed a 
maximum at about 191 nm and two minima at 
about 208 nm and 222 nm (Online repository). 
These results indicated that rAed a 10.01 and 
rAed a 10.02 are folded and present an α-
helical structure, similar to rDer p 10.  
IgE cross-reactivity of rAed a 10.01 rAed a 
10.02 and rDer p 10  
Fifteen HDM-allergic patients sensitized to 
Der p 10 showed IgE-binding to Aed a 10.01 
and Aed a 10.02 in ELISA, suggesting that the 
3 allergens cross-react (Table 1). We 
observed a tendency for a more pronounced 
IgE reactivity to rAed a 10.01 than to rAed a 
10.02. However, no statistical differences 
were found. 
Next, sera from patients no. 11, 12, 13 and 15 
were individually pre-incubated with 
increasing concentrations of rDer p 10, rAed a 
10.01 and rAed a 10.02 and the inhibition of 
IgE-binding to each tropomyosin was 
assessed (Fig. 1). With one exception, IgE-
binding to rDer p 10 was best inhibited by 
rDer p 10, followed by rAed a 10.01 and rAed 
a 10.02. Aed a 10.01 also best inhibited IgE-
binding to itself followed by rDer p 10 and 
rAed a 10.02. Notably, IgE-binding to solid-
phase bound rAed a 10.02 was best inhibited 
by rDer p 10 and Aed a 10.01    
rAed a 10.01 and rAed a 10.02 induce 
activation of basophils re-sensitized with 
Der p 10-specific IgE 
To assess whether the cross-reactivity of Der 
p 10 and  the mosquito-derived tropomyosins 
induced effector cell activation, stripped 
basophils were sensitized with sera from four 
patients containing high levels of Der p 10-
specific IgE and incubated with rAed a 10.01 
and rAed a 10.02, respectively (Fig. 2). rDer p 
10 served as positive control. Maximum 
basophil activation with rDer p 10 was 
observed at the concentration of 1 and 100 
ng/mL. In all patients, both mosquito 
tropomyosins induced basophil activation. 
 
 
However, rAed a 10.01 induced stronger 
activation of basophils than rAed a 10.02.  
rDer p 10 cross-reacts with murine IgG1 
produced against rAed a 10.01 and rAed a 
10.02 
To further analyze the cross-reactivity 
between tropomyosin in HDM and mosquitos, 
we immunized mice with rAed a 10.01 and 
rAed a 10.02, respectively.  Control mice 
group was immunized with PBS. Thereafter, 
we analysed whether the induced antibodies 
bound rDer p 10. Figure 3 shows that IgG1 
antibodies produced against both A. aegypti-
derived tropomyosins bound rDer p 10. 
Moreover, antibodies induced by 
immunization with rAed a 10.01 reacted with 
rAed a 10.02 and vice versa. Finally, 
antibodies produced against the recombinant 
tropomyosins reacted with their natural 
counterparts in the mosquito extract (Fig. 3). 
Next, we employed the murine sera to inhibit 
the activation of basophils sensitized with Der 
p 10-specific antibodies. rDer p 10, rAed a 
10.01 and rAed a 10.02 were pre-incubated 
with the sera from the mice immunized with 
rAed a 10.01 and rAed a 10.02. The treated 
allergens were used in BAT assays at 10 and 
100 ng/mL (Fig. 4). For the three 
tropomyosins, sera from rAed a 10.01-mice 
produced high inhibition of their capacity to 
activate the basophils, while sera from rAed a 
10.02-mice produced lower inhibition.  
rDer p 10 and A. aegypti tropomyosins 
cross-react at the T-cell level involving 5 
amino acid regions containing T-cell 
epitopes. 
To assess the cross-reactivity of HDM and 
mosquito tropomyosins at the T cell level, 
splenocytes from mice immunized with rAed a 
10.01 and rAed a 10.02 were stimulated with 
different concentrations of rDer p 10 and A. 
aegypti tropomyosins. Splenocytes from rAed 
a 10.01-mice showed similar proliferative 
responses to rAed a 10.01 and rAed a 10.02 
and to a lesser extent to rDer p 10 (Fig. 5). In 
contrast, splenocytes from rAed a 10.02-mice 
proliferated strongly upon stimulation with 
rAed a 10.01 and to a lesser extent to rAed a 
10.02. These cells did not proliferate when 
stimulated with rDer p 10. 
 
 
Figure 5. Lymphoproliferation assays. Splenocytes from 
rAed a 10.0101-mice and rAed 10.0201-mice were 
stimulated with different concentrations of rDer p 10, rAed 
a 10.0101 and rAed a 10.0201. Proliferation was 
measured by means of the incorporation of 3[H]-labeled 
thymidine. 
Next, we stimulated the splenocytes with a 
panel of 28 overlapping peptides representing 
the amino acid sequence of Aed a 10.01 (Fig. 
6 A and B). Peptides covering the regions Aed 
a 1011-40, Aed a 1081-100, Aed a 10111-190 
and Aed a 10221-270 were recognized by 
splenocytes from Aed a 10.01-mice. 
Splenocytes from mice immunized with Aed a 
10.02 responded to peptides covering the 
regions Aed a 1021-50, Aed a 1081-140, Aed 
a 10161-180 and Aed a 10211-285. Based on 
these results, five T epitopes-containing 
regions were detected: region 1 (amino acids 
21-40), region 2 (amino acids 81-100), region 
3 (amino acids 111-140), region 4 (amino 
acids 161-180) and region 5 (amino acids 
221-270) (Fig. 6 C). 
 
 
 
 
 
 
Figure 6. T-cell epitope mapping. Splenocytes from rAed a 10.01-mice and rAed a 10.02-mice were stimulated with 20-
mer peptides covering the complete sequence of Aed a 10.01. Stimulation Index ≥ 2 was considered positive. 
 
 
 
 
 
DISCUSSION 
In this study, we have analysed the humoral 
and cellular cross-reactivity between 
tropomyosins allergens from HDM (Der p 10) 
and two variants from A. aegypti (Aed a 10.01 
and Aed a 10.02). ELISA inhibition, BAT and 
BAT inhibition experiments indicated that at 
the B-cell epitope level, Der p 10 and Aed a 
10.01 cross-react and that a similar epitope 
spectrum is displayed by both molecules. 
However, lower cross-reactivity was observed 
between these two allergens and Aed a 
10.02, indicating a lower B-cell epitope 
spectrum, which correlates with the lower 
degree of homology of Aed a 10.02 with other 
tropomyosins. The three tropomyosins cross-
reacted with murine splenocytes and five 
amino acid regions containing T-epitopes 
seem to be involved.  
The detected regions containing T-cell 
epitopes presented between 55 to 70% of 
amino acid identity and 80 to 95% of amino 
acid similarity when compared within Aed a 
10.01, Aed a 10.02 and Der p 10. T-cell cross 
stimulation has been observed for epitopes 
with 60–80% amino acid similarity and 40–
67% amino acid identity with T-cell epitopes 
from Bet v 1 (23). The higher homology 
observed in our results correlate with the high 
cross-reactivity within HDM and mosquito 
tropomyosins.  
Previous experiments demonstrated the 
presence B-cell epitopes in tropomyosin 
allergens (18-20, 24, 25). Five regions highly 
conserved in the primary structure of several 
tropomyosin (18-20) are more conserved in 
Der p 10 and Aed a 10.01 (3), suggesting that 
they may be more allergenic and produce 
higher cross-reactivity than Aed a 10.02. This 
assumption was confirmed in our work by 
several experiments. ELISA, ELISA inhibition 
and BAT experiments using the sera obtained 
from different Austrian HDM-allergic patients 
with high titters of Der p 10 specific-IgE 
showed that the IgE-binding and inhibition 
capacity achieved with Der p 10 and Aed a 
10.01 was higher than with Aed a 10.02 
(Table 1 and Fig. 1 and 2).  
Interestingly, BAT inhibition experiments 
showed that the murine anti-tropomyosin sera 
from Aed a 10.01-mice contained antibodies 
that highly inhibited the activation of basophils 
induced by the tropomyosins. However, Aed a 
10.02-mice sera produced lower inhibition 
(Fig. 4). Since the inhibitory capacity of the 
mice sera may be explained by the presence 
of IgG antibodies, we hypothesize that IgE 
and IgG B-cell epitopes overlap in the 3-
dimensional structure and that these epitopes 
are more represented in the Aed a 10.01. This 
discovery may have clinical implications, since 
it suggests that the use of tropomyosin in 
immunotherapy strategies may result in the 
induction of blocking antibodies. 
Wai, C.Y.Y. et al. (26) Identified six peptides 
derived from the shrimp tropomyosin, Met e 1, 
which contained T-cell epitopes recognized by 
mice. These peptides showed regulatory 
capacity of the allergic response in a mouse 
model of allergy to Met e 1, which involved the 
production of blocking IgG2a. The six regions 
identified were: T1 (26-45), T2 (56-75), T3 
(86-105), T4 (146-165), T5 (221-240) and T6 
(251-270). When compared with the regions 
identified in our study we found that T1, T2 
and T3 partially coincide with regions 1, 2 and 
3 described by us, and that T4, T5 and T6 are 
mostly contained in region 4 and 5 where the 
sequence identity and similarity between Aed 
a 10.01 and Met e 1 is higher than 70% and 
80%, respectively. These findings indicate 
that the regions T4, T5 and T6, and to a 
lesser extent T1, T2 and T3 described by Wai, 
C.Y.Y. et al, and the regions described in our 
study, may involve the same T-cell epitopes. 
Although we didn’t evaluate the regulatory 
role of our peptides, we hypothesize that the 
IgG response and the BAT blocking capacity 
of the mice sera are indicative of a potential 
capacity to induce protective response in a 
similar way as Wai, C.Y.Y. et al. reported. 
Furthermore, we believe that using a 
tropomyosin allergen in an immunotherapy 
approach may result in the induction of 
protection against a broad spectrum of 
tropomyosins from different species, which is 
explained by the presence of cross-reactive T-
cell epitopes. Some studies support this 
hypothesis. For instance, sublingual 
immunotherapy for house dust mites resulted 
in an improvement of shrimp allergy (27) and 
subcutaneous immunotherapy has also been 
reported to be associated with a decrease in 
specific serum IgE and resolution of shrimp 
and squid allergy (28). 
The clinical significance of cross-reactivity 
relies on different aspects. Patients sensitized 
to a primary sensitizing allergen may develop 
allergic symptoms upon exposure to a cross-
reactive homologue molecule containing 
cross-reactive B-cell epitopes (29, 30). Our 
experimental data using specific IgE from 
HDM allergic patients, sensitized to Der p 10, 
demonstrated that Der p 10 and A. aegypti 
tropomyosins cross-react at the B-cell epitope 
 
 
level, from a molecular and functional point of 
view. Since the mosquito species A. aegypti is 
not present in Austria, we assume that D. 
pteronyssinus is the primary sensitizer and 
exposure to cross-reactive mosquito 
tropomyosin may lead to allergic symptoms 
through D. pteronyssinus-specific IgE. 
Another possibility is that the presence of 
cross-reactive T-cell epitopes may result in 
the clonal expansion of the T lymphocytes 
elicited by the primary sensitizer; leading to an 
exacerbation of the immune response and the 
allergic symptoms (10, 31, 32). Accordingly, 
the presence of cross-reactive T and B-
epitopes shared in the structure of the 
tropomyosins analysed indicates that both 
phenomena may occur between HDM and 
mosquito tropomyosins. 
We used BALB/c mice for the cellular cross-
reactivity studies and T-cell epitope mapping. 
This may not mimic the natural sensitization 
process in humans, since different HLA 
molecules and different T-cell epitopes may 
be involved. However, Ravkov, E. et al. (21) 
reported 17 T-cell epitopes from shrimp 
tropomyosin restricted to multiple MHC class 
II alleles. We observed that 9 peptides 
reported by Ravkov, E. et al. significantly 
coincide with regions 1, 3, 4 and 5 from our 
study, suggesting that the T-cell epitopes 
recognized by the immunized mice may be 
the same that the human population 
recognizes through different HLA classes. 
Although we are referring to allergens from 
different species, the high homology among 
tropomyosins from shrimp and mosquito 
support this conclusion. 
In conclusion, we have demonstrated that 
tropomyosins from HDM and A. aegypti 
display humoral and T-cell cross-reactivity 
involving five potential T cell-activating 
regions. Different degrees of humoral cross-
reactivity were observed depending on the 
degree of homology. As previously suggested, 
a higher homology resulted in higher degree 
of cross-reactivity. It seems that this cross-
reactivity occurs independently from a natural 
exposure to these allergens. Our results may 
have important clinical impacts which should 
be further analysed. 
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A. A. aegypti as a source of allergens 
 
Allergy diseases have become a global health problem that affects the lifestyle 
of the population and, in some cases, puts the life of the individuals at risk. 
Several sources of allergens have been well characterized and many IgE-
binding components have been identified, purified and registered in the allergen 
databases. Despite these efforts, and the advances made in the field of 
Allergology, several allergen sources remain to be identified and further studied. 
As we previously explained, we had reasons to believe that mosquitoes, 
including the species A. aegypti, are a source of important allergens to which 
the individuals may be exposed during the mosquito bite, by inhalation, or 
further contact. As a result of this exposure, an allergic response may be 
induced in the atopic individual, or may exacerbate the allergic response 
previously initiated against a related, or non-related species, such as mites, 
cockroaches and shrimps. 
The WHO/IUIS nomenclature system provides general requirements to 
consider a protein as an allergen. These molecules must satisfy biochemical 
criteria that define the molecular structure of the proteins, and immunological 
criteria, which define their importance as an allergen (159). The biochemical 
criteria should provide indications, whereby other investigators can identify the 
same allergen and make comparative studies. These criteria are based on 
establishing protein purity and physicochemical properties (160). In general, 
having the protein sequence available is one of the most important 
requirements. The immunological criteria include demonstrating that the purified 
allergen has allergenic activity, both in vitro and in vivo by IgE-binding assays 
and mediator release experiments. Preferably, at least 50 sera should be 
screened to determine the prevalence of IgE reactivity, and allergens can be 
included in the nomenclature if the prevalence is >5% and if they elicit IgE 
response in as few as 5 patients.  
Considering these criteria, our results demonstrate that the mosquito A. 
aegypti is a source of allergens. We have reported several IgE-binding proteins 
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with their physicochemical characteristics including molecular weights, 
isoelectric points and partial sequences, and their capacity to bind the IgE from 
allergic individuals and cross-react with similar allergens. For the mosquito 
extracts, and some recombinant allergens (rAed a 8 and rAed a 10), their 
capacity to induce the activation of basophils was also demonstrated. In the 
case of rAed a 10 variants and rAed a 8, we demonstrated that they conserve 
their capacity to induce lymphoproliferation. Furthermore, T-cell cross-reactive 
epitopes from A. aegypti tropomyosin were identified. Altogether, these 
discoveries demonstrate that A. aegypti allergens have the molecular and 
immunological requirements to induce an immune response leading to the 
development of allergic symptoms. 
Although our experimental data demonstrate that A. aegypti is a source 
of allergens, in real life, the onset of the allergic response requires that the 
atopic individual is exposed to these molecules. The presence of mosquito 
material in the air and settled house dust has been demonstrated. However, 
further studies directed to demonstrate the correlation between allergen 
exposure and the allergic response are needed. We have made some 
advances in this topic, demonstrating that more than 50% of the allergic 
patients from the Municipality of Medellin, Colombia, suffering from allergic 
rhinitis, have positive SPT to a whole body A. aegypti extract (See attachment 
1). Measuring the presence of mosquito allergens in house dust and in the air is 
important to determine whether mosquito exposure is a risk factor for 
respiratory allergies, as has been demonstrated for mites, cockroaches and 
other insects. 
 
B. Identification of IgE-binding proteins and their relationship with 
allergic diseases 
The first step that we followed to study whether A. aegypti is a source of 
allergens was the identification of IgE-binding proteins. Currently, there are 
different approaches to achieve this task. One of them is the purification of the 
natural molecule from the source, which usually is time consuming and requires 
the availability of large amounts of raw material. However, it is advantageous 
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because it guarantees the use of the natural allergen. We used this approach to 
identify and purify native tropomyosin from A. aegypti in a two steps protocol 
involving size exclusion and ionic exchange chromatography. The purified 
tropomyosin consisted of a mixture of several variants or isoforms. The most 
abundant were Aed a 10.0101 and Aed a10.0201. This task was possible, in 
part, because tropomyosin is abundant in the mosquito extract. The purification 
of tropomyosin follows a strategy involving ammonium sulphate precipitation 
and isoelectric precipitation (161). However, in the case of A. aegypti the 
presence of several proteins that remain bound to tropomyosin (mainly myosin) 
is a problem that can be solved by direct elution from the electrophoresed gel. 
Other researchers have combined partial purification steps, such as acetone 
precipitation and boiling, followed by ionic exchange chromatography (162, 
163).  
The use of proteomic tools has become one of the preferred options to 
identify allergens because it allows the analysis of the whole spectrum of 
proteins expressed by an organism. The identified molecules have already 
undergone the expression and translational modifications experienced naturally. 
Nowadays, as a result of the application of proteomic in the discovery of novel 
allergens, the field of allergy research has included in the “omic” era the 
concept of “Allergenome” (151, 164-166).  
Within this project, we successfully identified allergens from A. aegypti in 
a large scale. A total of 10 different IgE-binding proteins, some of them 
including variants, or isoforms, were identified. Furthermore, five novel allergens 
were deposited in the allergen database. 
One intriguing question about mosquito allergy consists in determining 
the role that their allergens play in the different manifestations of mosquito 
allergy. Several studies have established that saliva-derived allergens, which 
are injected into the skin during the mosquito bite, induce cutaneous allergic 
reactions. Four allergens, Aed a 1, Aed a 2, Aed a 3 and Aed a 4, are involved 
in this cutaneous reactions (62, 106, 109, 167). As a result of our research, five 
novel A. aegypti allergens were reported and several IgE-binding proteins 
identified. None of the allergens that we identified correspond to the previously 
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reported salivary-allergens. The difference may be due to the different 
populations used in the IgE-binding screenings and the source of the raw 
materials used. We used the sera from patients residing in tropical regions and 
suffering respiratory allergies. In other studies, sera from patients residing at 
different latitudes and suffering cutaneous allergic responses were used to 
study the relevance of mosquito allergens. These differences strongly suggest 
that mosquito allergens may play different roles in allergic diseases depending 
on the location of the mosquito and the route of exposure. In tropical regions, 
and other latitudes where mosquitoes are abundant, the individuals may be 
exposed to their antigens by different routes of exposure and experience 
cutaneous as well as other clinical manifestations of allergic diseases. Within 
the group of allergens that we identified, several correspond to homologues of 
allergens from other sources, like tropomyosin (168, 169), heat shock cognate-
70 (151), cyclophilins (170-172), among others, which further suggests that 
mosquito body-derived proteins may play a role as allergens. 
The results from the study of the Allergenome of A. aegypti allowed 
advances in the component resolved diagnosis of mosquito allergy. Although a 
variable pattern of sensitization was observed in a group of 15 allergic 
individuals from the Caribbean Island of Martinique, we observed that a mixture 
of three allergens (Aed a 6, Aed a 8 and Aed a 10) may be enough to identify 
more than 80% of A. aegypti allergic individuals. This result has a considerable 
impact because it indicates that a diagnosis tool based on the use of a reduced 
number of mosquito allergens may successfully identify mosquito allergic 
individuals. 
 
C. Is A. aegypti a primary sensitizer? 
An open question is whether mosquito allergens represent a group of allergens 
with the capacity to induce an immune response leading to the appearance of 
allergic symptoms, or whether the IgE-binding capacity of some of these 
proteins is the result of a cross-reactivity process. 
From an experimental point of view, a way to define whether an allergen 
source is the primary sensitizer involves the demonstration that some patients 
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are mono-sensitized to their allergens and the results of competition, or 
inhibition assays which show that the response is of a higher affinity (173, 174). 
We used two populations of patients for the different studies. One population of 
15 house dust mite allergic patients from Austria sensitized to Der p 10 
(tropomyosin). All the patients showed cross-sensitization to A. aegypti 
tropomyosins (rAed a 10.0101 and rAed a 10.0201) at the molecular and 
functional level. However, inhibition experiments using 4 individual sera showed 
that Der p 10 produced higher inhibition of the IgE-binding against itself and the 
mosquito tropomyosins. These results are in agreement with the fact that in 
Austria there is no A. aegypti, suggesting that mite allergens are the primary 
sensitizers which cross-react with mosquito proteins. In another study analyzing 
a population from the Caribbean Island of Martinique, where mites and A. 
aegypti cohabit, the results of competition assays with whole extracts showed 
that D. pteronyssinus, B. tropicalis and A. aegypti extracts produce similar 
inhibition of the IgE-binding. However, in almost all the patients, the levels of 
serum IgE was higher against mites than the levels against mosquito. In this 
population 3 out of 34 patients showed specific IgE to A. aegypti alone, and 
three co-sensitization to A. aegypti and P. americana.  
Altogether, these results suggest that in some cases, A. aegypti may act 
as a primary sensitizer and that A. aegypti allergens strongly cross-react with 
arthropod-derived allergens. In areas where these species cohabit, independent 
sensitization to each of them may occur. More data and studies in other 
communities are needed to definitively answer this question, since exposure to 
mites and mosquitoes varies widely. Epidemiological studies are warranted. 
 
D. Recombinant A. aegypti allergens and the contribution to the 
study of mosquito allergens 
 
A limiting factor for the study of allergens is the low availability and difficulties to 
obtain purified molecules. In the case of mosquitoes, this is evident, since 
neither native proteins, nor allergens, have been obtained as purified 
molecules. The scientific community, in addition, has been interested in finding 
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new therapeutic tools to help in the improvement of the diagnosis and 
immunotherapy of allergic diseases. Molecular cloning has provided a practical 
and efficient tool to obtain highly purified molecules for these purposes. The era 
of molecular cloning of mite allergenic molecules was initiated in 1980s with the 
report of a cDNA clone coding for the allergen Der p 1 (175, 176). Since that 
time, many recombinant allergens from variable sources have been obtained as 
recombinant proteins, accelerating the comprehension of the role of these 
molecules in the mechanisms and pathophysiology of allergic diseases. 
Furthermore, the relative easiness with which these molecules can be produced 
and modified has helped to design improved approaches for the diagnosis and 
therapy of these diseases. 
Recombinant allergens can replace native allergens if they conserve 
similar folding and biochemical properties as the natural protein. In this study, 
three recombinant mosquito allergens where expressed in E. coli and purified. 
Two variants of tropomyosin (rAed a 10.0101 and rAed a 10.0201) and rAed a 8 
were obtained. The three allergens showed a similar capacity to bind IgE and 
IgG antibodies, to activate basophils, to induce the immunization of mice and to 
induce lymphoproliferation as compared with the native allergens. The 
tropomyosin variants showed an α-helical folding similar to Der p 10. Altogether, 
these results demonstrate that the three allergens may be used in replacement 
of the natural proteins for allergy research, diagnosis and treatment. The study 
of these molecules helped to establish that the mosquito allergens may also 
induce the initiation of an immune response and activate the mechanisms that 
lead to the release of mediators of the allergic response. We have also further 
investigated the importance of A. aegypti tropomyosins in mosquito sensitized 
patients and studied its molecular and functional cross-reactivity. 
We demonstrated that Aed a 8 is an important allergen recognized by 
more than 40% of the mosquito allergic population. An important discovery 
related to the immune response induced by rAed a 8 in mice was that high 
levels of IgG antibodies were produced, especially of the subclass IgG2a which 
has been suggested as a marker of a successful specific immunotherapy and 
as a blocking antibody that inhibit the interaction of the IgE with the allergens in 
mouse models of allergy (177, 178). These results are similar to those obtained 
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in other studies showing that mosquito allergens, including heat shock protein-
70, may induce a protective immune response that potentially protects against 
the allergic response (77, 179). The potential regulatory effect of Aed a 8 must 
be further studied and considered in the design of new approaches of 
immunotherapy for mosquito allergies. 
 
E. Allergenic cross-reactivity among A. aegypti and other 
arthropods: The role of mosquito tropomyosins 
 
According to the evolutionary relationship and the demonstration of the 
presence of shared allergens (some of them pan-allergens) among A. aegypti 
and other arthropods, it was expected to detect allergenic cross-reactivity. Our 
results with tropomyosins from A. aegypti and the identification of a large set of 
cross-reactive allergens from this mosquito, confirmed this hypothesis. 
However, we further studied this phenomenon at the molecular and functional 
levels, and reported a group of potentially cross-reactive allergens.  
Cross-reactivity between groups of allergens may occur with different 
antibody classes. We initially focused on IgE given its direct involvement in Th2 
and allergic responses. Using ELISA, immunoblotting and inhibition assays, we 
found that A. aegypti strongly cross-react with shrimp (L. vannamei), followed 
by mites (D. pteronyssinus followed by B. tropicalis) and cockroach (P. 
americana). The observed cross-reactivity involved at least 11 bands identified 
in a 1-dimensional immunoblotting. We further characterized five of these 
bands: Odorant Binding Protein, Mitochondrial cytochrome C, Cyclophilin 
(PPIase), an unknown protein “AAEL001668-PA” and tropomyosin. 
Interestingly, tropomyosin and cyclophilins are protein families which are highly 
conserved in their primary and tertiary structure among several species from 
different Phylum and considered pan-allergens (180-182). The 3 other proteins 
are also highly conserved in different species and represent potential pan-
allergens.  
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For the identification and characterization of these cross-reactive molecules, we 
used a set of more than 30 sera from allergic patients from Martinique. As 
mentioned previously, this island has a tropical climate and house dust mites, 
cockroaches, mosquitoes and other insects are abundant. They represent the 
main risk factors for allergic sensitization and allergic diseases. Sensitization to 
shrimps and crabs is also very frequent (183, 184). In this population, 
sensitization to A. aegypti was 64.7% among allergic individuals. This 
prevalence is one of the highest ever reported (122, 185, 186) and similar to the 
prevalence of sensitizations to mites in allergic individuals. This result, together 
with the high cross-reactivity observed, indicates that mosquitoes are 
environmental factors that should be considered in health programs for 
prevention and protocols of diagnosis and treatment of allergic diseases in 
tropical areas. 
Cross-reactivity involving IgE-binding epitopes indicates that the allergic 
response elicited against a primary sensitizer may be stimulated by exposure to 
an allergen containing the same, or similar epitopes in its structure, resulting in 
the appearance of the allergic responses (80, 81). It is necessary that cross-
reactivity between two or more molecules occurs by recognition of similar IgE-
binding epitopes and cross-activation of effector cells. However, in some cases 
IgE-cross binding may not lead to an allergic response in the exposed patient 
and is limited to a simple reactivity with no clinical consequences.  
The cross-reactivity phenomenon among allergens has immunological 
and clinical consequences that go beyond IgE-binding. In addition to the IgE-
binding epitopes, IgG-binding epitopes may also participate in the cross-
reactivity phenomenon. In this case, the production of IgG subclasses 
throughout a desensitization process against a particular allergen may lead to 
the decrease or disappearance of this response to a different, but cross-reactive 
molecule (177). 
We analyzed the cross-reactivity between tropomyosins from mite (Der p 
10) and A. aegypti (Aed a 10.0101 and Aed a 10.0201). By IgE-binding assays, 
basophil activation and inhibition experiments, we confirmed that Der p 10 and 
both tropomyosins cross-react, and that the degree of cross-reactivity correlated 
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with the degree of homology between these allergens. Cross-reactivity between 
these tropomyosins occurs with human and murine IgE and murine IgG and the 
results suggest that the IgG and IgE-binding epitopes are co-localized on the 
structure of the allergen. These results suggest that the antibody cross-
reactivity between tropomyosins from A. aegypti and mites may lead to the 
activation of the allergic cascade, independently of which molecule is the 
primary sensitizer. This phenomenon occurs because these molecules share B-
cell epitopes that bind to the IgE on the surface of effector cells, leading to the 
IgE cross-linking and activation and degranulation. 
Cross-reactivity may also occur at the level of T-cells, involving T-cell 
epitopes that may, or may not, correspond to the IgE-binding epitopes. 
Furthermore, a protein that is neither a primary sensitizer, nor an allergen, may 
have T-cell cross-reactive epitopes. From this assumption, some immunological 
and clinical implications may be postulated as follows (82, 187). Cross-reactive 
T cells elicited by allergen exposure will: (1) be selectively expanded and 
boosted by exposure to additional allergens containing the conserved epitope 
and (2) generate help for any B cell specific for an allergen cross-reactive at the 
T-cell level through a classic antigen bridge–linked T-cell/B-cell help 
mechanism, regardless of whether the IgE response is cross-reactive.  
Using murine splenocytes, we found that there is T-cell cross-reactivity 
among mite and mosquito tropomyosins and that this phenomenon involves five 
regions containing T-cell epitopes. The presence of these epitopes may lead to 
the boost and expansion of T cells and generate help to B cells.  
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1. The mosquito species A. aegypti is an important source of allergens that 
may play a role in the pathogenesis of allergic diseases, especially in 
tropical and subtropical areas, where the allergic population may be 
monosensitized, or polysensitized to A. aegypti and other arthropods.  
2. Two groups of different allergens seem to play independent roles in the 
different manifestations of mosquito induced allergic diseases, i.e., 
salivary and somatic antigens. 
3. More than 10 allergens are involved in mosquito allergy.  
4. These allergens may potentially participate in the activation of the allergic 
cascade because they present the B-cell and T-cell epitopes needed for 
the stimulation of the lymphocytes and effector cells that mediate the 
emergence of the inflammatory symptoms.  
5. The mixture of three mosquito allergens may be enough to identify more 
than 80% of the mosquito sensitized population. 
6. Some of the A. aegypti allergens cross-react with other arthropod-
derived allergens at the molecular and functional level.  
7. The studies with A. aegypti tropomyosin revealed that cross-reactivity 
may occur with IgE and IgG subclasses and that IgE-cross binding may 
lead to cross-activation of effector cells like basophils.  
8. These cross-reactive allergens share T-cell cross-reactive epitopes that 
may boost the immune response generated by the primary sensitizer. 
9. Mosquito allergens may be produced as recombinant molecules that 
mimic the natural allergens in their structural and immunological 
properties.  
10. Aed a 8 is a potential major allergen that should be further studied. 
11. Studies of the immune response elicited by rAed a 8 in mice indicated 
that this allergen may have an intrinsic immunoregulatory role.  
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The impact that this project represent for the scientific and medical 
community are manifested in the following claims, which are reported for 
the first time: 
1. The Allergenome of A. aegypti was studied by the application of proteomic 
tools, revealing 25 IgE-binding spots that corresponded to 10 different proteins. 
2. The native tropomyosin from A. aegypti was purified and its antibody-binding 
capacity studied. 
3. Three biologically active recombinant allergens from the A. aegypti body 
(rAed a 10.0101, rAed a 10.0201 and rAed a 8), were expressed in E. coli. 
4. The IgE-cross reactivity among A. aegypti and mites, shrimp and cockroach, 
together with the molecular components involved were studied and reported. 
5. Five amino acid regions from the sequence of Aed a 10.0101 that contains T-
cell cross-reactive epitopes were reported. 
6. Six novel A. aegypti allergens were deposited in the database of the 
WHO/IUIS Allergen Nomenclature Sub-committee (www.allergen.org): Aed a 5 
(Sarcoplasmic Ca+ (EF-hand) binding protein), Aed a 6 (Porin 3), Aed a 7 (Un-
defined protein), Aed a 8 (Heat shock cognate-70), Aed a 10 (Two variants of 
tropomyosin, Aed a 10.0101 and Aed a 10.0201) and Aed a 11 (Lysosomal 
aspartic protease). 
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Clinical Impact of mosquito Aedes aegypti in allergic respiratory diseases. 
Sánchez J1,2,3, Toro Y1 , Cantillo JF2, Martínez D2 . Cardona R1, Puerta L 2,3. 
1. Group of Experimental and Clinical Allergy, IPS Universitaria, University of Antioquia. Medellín, 
Colombia.  
2. Institute for Immunological Research, University of Cartagena. Cartagena, Colombia. 
3. Foundation for the Development of Medical and Biological Sciences (FUNDEMEB). Cartagena, 
Colombia. 
 
BACKGROUND: Allergic reactions to Aedes aegypti are associated with saliva 
allergens introduced in the skin by mosquito bites. However, several allergens 
have been described in the body of this insect, suggesting that they may 
participation in the induction of allergic respiratory diseases. 
 
OBJECTIVE: To investigate the clinical relevance of the A. aegypti mosquito in 
allergic rhinitis. 
 
METHODS: Skin Prick Test (SPT) with whole body extracts of A. aegypti, Blomia 
tropicalis and Dermatophagoides spp., were performed in 29 patients with rhinitis 
and 12 healthy subjects (controls) residing in Medellín, a tropical city in Colombia.  
 
All subjects signed informed consent forms for this study and were challenged with 
either 200 μL of saline, or 200 μL of an extract of A. aegypti (Inmunotek SL, 
Madrid, Spain) containing 1 mg of protein/ml and diluted in the same saline 
solution. Each patient received a final concentration of 200 µg of protein per 
challenge.  In addition, serum IgE, IgG and IgG4 levels to A. aegypti whole body 
extract was determined by ELISA. 
 
RESULTS: Eighteen (18) patients with rhinitis (62%) were SPT positive to the A. 
aegypti extract. All subjects in the rhinitis group except 2 (27 individuals; 93.1%) 
were SPT positive to mite extracts. One control subject showed positive SPT to A. 
aegypti. Ten of eighteen (55.5%) allergic patients with positive SPT to A. aegypti 
were positive by nasal challenge test (see Figure 1). Two patients with a positive 
nasal challenge and SPT to mosquito extract were SPT negative to mites. None of 
the individuals tested were positive with the saline challenge test. In the group of 
allergic patients (n = 29), the frequency of positive IgE, IgG and IgG4 levels to A. 
aegypti was 27.5, 69.0 and 28.0 %, respectively. 
 
CONCLUSION: A. aegypti can induce signs and symptoms of allergic rhinitis in 
patients with allergic rhinitis in a tropical environment. Whether, or not sensitization 
to A. aegypti is induced by cross-reactivity with other allergenic sources, such as 
mites and cockroaches, the positive nasal provocation test indicates that IgE 
sensitization to A. aegypti may be clinically relevant and could be induced not only 
by mosquito bites but also by the inhalation of their allergens. The potential 
allergenic role of each A. aegypti protein should be further investigated. 
 
 
Summary of the results. 
 
 
 
Figure 1. Description of the patient population and the main results. 
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